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Background. Previous studies have detected HIV-specific T cells in the female genital tract of 
chronically HIV-infected and highly exposed but persistently seronegative (HEPS) women using 
cells isolated by cervical cytobrushing. A major limitation of these studies has been the low cell 
yields obtainable by cervical mucosal sampling from the female genital tract. There have been 
few studies exploring the utility of in vitro expansion of T cells derived from the female genital 
tract to overcome these limitations.  The aim of this study was to investigate the feasibility of 
polyclonal in vitro expansion to improve yields of T cells recoverable from cervical cytobrush 
samples during HIV infection; to characterize the impact of in vitro expansion on the frequency, 
specificity and quality of cervical mucosal T cell responses pre- and post-expansion; and to 
compare these cervical responses with responses detected in blood. 
Methods. Cervical cytobrush-derived and blood-derived T cells from 68 chronically HIV-
infected women were examined either ex vivo (n=5) or following in vitro expansion (n=63) for 
the magnitude, epitope targeting, maturational status and polyfunctionality in response to 
stimulation with HIV Gag Du422 peptides.   Seven different expansion methods were compared, 
including anti-CD3, anti-CD3 in combination with anti-CD28, or Dynal anti-CD3/CD28 beads at 
differing bead to target cell ratios (3:1, 1:1, 1:5) in the presence of varying combinations of 
growth promoting cytokines (IL-2, IL-7 and IL-15).  Initial experiments focused on measuring 
HIV-specific responses by IFN-  ELISPOT while later experiments used polychromatic flow 
cytometry to simultaneously evaluate four T cell functions (CD107a, IFN-γ, TNF-α, and MIP-1β).  
T cell maturational status pre- and post-expansion was determined by differential staining with 
CD45RO, CCR7 and CD27.   Functional HIV-specific T cell responses in blood and in the female 
genital tract before and after in vitro expansion were compared to the HIV clinical status of the 
women (CD4 counts in blood and plasma viral loads).  
Results. This study found that T cells derived from the female genital tract of HIV-infected 
women were predominantly effector memory in phenotype, which have limited proliferative 
but rapid effector function capacity. Despite this, in vitro expansion of cytobrush-derived T cells 
was achieved in 54/63 (85.7%) of HIV-infected women.  Of the 7 alternative expansion methods 
compared, Dynal beads (1:1) in the presence of IL-2, IL-7 and IL-15 resulted in the highest 
yields compared to ex vivo in both blood (7.1-fold) and at the cervix (5.6-fold) but resulted in an 
accumulation of central memory T cells following expansion. In contrast,  anti-CD3 in the 
presence of IL-2 resulted in conservation of effector memory dominated T cell memory profile 
following expansion but yielded significantly fewer cervical T cells than Dynal bead expansion 











responses were detected in mucosal T cell lines from HIV-infected women and both the 
magnitude (p=0.002; R=0.7) and specific HIV Gag regions targeted by cervical T cell lines 
(p<0.0001; R=0.5) correlated significantly with those detected in blood. Similarly, following 
Dynal bead expansion, the functional profile (CD107a, IFN-γ and TNF-α) in response to Gag 
stimulation by CD8+ T cells in blood and at the cervix correlated significantly (p<0.05). While 
the majority of Gag-specific T cell responses in the female genital tract and blood were mono-
function, low frequencies of HIV Gag-specific polyfunctional (median of all 2+, 3+ and 4+ 
responses) CD8+ T cells were detected at the cervix (median net frequency of 1.96%) and blood 
(median net frequency of 1.08%) of HIV-infected women and the frequency of polyfunctional 
CD8+ T cell responses were significantly associated between blood and cervix, irrespective of 
expansion methods tested (p<0.05). A significant inverse relationship was observed between 
plasma viral load and CD8+ T cells producing CD107a in fresh blood, expanded blood and 
expanded cervical lines (p<0.05). In addition, the polyfunctionality of cervical Gag-specific CD8+ 
T-cells was positively related to blood CD4 count (p=0.03) and inversely related to plasma viral 
load (p=0.04). 
Conclusion. This study shows that HIV-specific cervical T cells can be isolated by cytobrushing 
and in vitro polyclonal expansion is a useful approach to increase the number of T cells available 
from mucosal sites. Dynal beads (1:1) in the presence of IL-2, IL-7 and IL-15 resulted in the best 
yields of cervical T cells while anti-CD3 in the presence of IL-2 best conserved the ex vivo T cell 
profile.  Expanded T cell lines, irrespective of expansion method used, generally maintain their 
cytokine response profile to HIV antigens. This study shows that HIV Gag-specific blood and 
cervical T cells were largely mono-functional with polyfunctional T cells being detected in 
women with high blood CD4 count and low plasma viral load. Most importantly, this study 
confirms that HIV-specific Gag T cell responses detected in the polyclonal expanded female 
genital tract T cells are associated with those measured in blood during HIV infection. Studies of 
mucosal T cell responses are technically challenging and an important contribution of the 
present study is the development and comparison of in vitro expansion methods to improve the 
















This study has resulted in the following publication: 
Bere, A., Denny, L., Burgers, W.A. and others. 2010. Polyclonal expansion of cervical cytobrush-derived T cells to 
investigate HIV-specific responses in the female genital tract. Immunology. 130(1):23-33.  
Bere, A., Denny, L., Hanekom, W. and others. 2010. Comparison of polyclonal expansion methods to improve the 
recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women. Journal of 

















Table of Contents 
1.1 The HIV pandemic ............................................................................................................................. 3 
1.1.1 The HIV burden in Sub-Saharan Africa ................................................................................................ 3 
1.1.2 The HIV burden in South Africa ............................................................................................................... 4 
1.2  HIV Genetic diversity and variability ........................................................................................ 5 
1.2.1 HIV-1 variability ............................................................................................................................................. 6 
1.2.2 Mutation ............................................................................................................................................................. 6 
1.2.3 Recombination ................................................................................................................................................ 6 
1.2.4 Host immune selection pressure ............................................................................................................ 7 
1.2.5 Availability of target cells ........................................................................................................................... 8 
1.3  HIV-specific T cell responses in blood ...................................................................................... 8 
1.3.1 Evidence for the role of protective T cell immunity in blood ..................................................... 9 
1.3.2 Magnitude and breadth of Gag-specific T cell responses ........................................................... 11 
1.3.3 Polyfunctional T cell responses in HIV ............................................................................................... 12 
1.4  T cell differentiation during chronic HIV infections .......................................................... 14 
1.4.1 Generation and Characteristics of Memory T Cells....................................................................... 15 
1.4.2 Properties of memory T cells.................................................................................................................. 17 
1.4.3 T cell differentiation in HIV infection.................................................................................................. 19 
1.5  Organization of the female genital tract ................................................................................ 20 
1.5.1 Vagina ................................................................................................................................................................ 20 
1.5.2 Ectocervix ........................................................................................................................................................ 20 
1.5.3 Cervical Transformation Zone ............................................................................................................... 21 
1.5.4 Endocervix ...................................................................................................................................................... 21 
1.6 HIV transmission in the female genital tract ......................................................................... 22 
1.6.1 HIV Infection and the female genital tract ........................................................................................ 22 
1.6.2 Susceptibility of the female genital tract to HIV-1 infection ..................................................... 22 
1.6.3 Mechanisms used by HIV to cross the female genital mucosal   barrier ............................. 25 
1.6.4 Local mucosal propagation of HIV and dissemination ................................................................ 27 
1.6.5 Factors associated with protection from HIV infection in the female genital  tract ...... 29 
1.7  HIV preferentially targets the mucosal immune system ................................................. 31 











1.8.1 Cervicovaginal CTL responses during acute HIV infection ....................................................... 33 
1.8.2 Cervicovaginal CTL during chronic HIV infection ......................................................................... 34 
1.8.3 Polyfunctional HIV-specific T cell responses in mucosal    compartments ........................ 36 
1.9  HIV diversity between compartments .................................................................................... 36 
1.10 CTL diversity between compartments ..................................................................................... 38 
1.11 Memory T cell subsets in mucosal compartments .............................................................. 39 
1.12 Challenges in conducting mucosal studies ............................................................................. 39 
1.13 Polyclonal T cell expansion .......................................................................................................... 40 
































1.1  The HIV pandemic 
 
Acquired immunodeficiency syndrome (AIDS), discovered more than twenty five 
years ago, has caused an estimated 25 million deaths worldwide (UNAIDS, 2008). 
AIDS is caused by the Human Immunodeficiency Virus type 1(HIV). Recent 
estimates suggest that nearly 33 million people are infected worldwide (UNAIDS, 
2008). More than 90% of new HIV infections occur in developing countries, with 
Sub-Saharan Africa being the most highly impacted region (Figure1.1). Furthermore, 
approximately 67% of all people living with HIV are situated in this sub-region and 
more than 75% of all AIDS deaths in 2007 occurred here (UNAIDS, 2008). Sexual 
transmission of HIV accounts for the majority of new infections worldwide, with 




Figure 1.1. The global view of adults and children living with HIV around the world (UNAIDS, 
2008).  It is estimated that 33 million people (30-36 million) were living with HIV in 2007.  Sub-
Saharan Africa is the most impacted region (Taken from UNAIDS, 2008) 
 
1.1.1 The HIV burden in Sub-Saharan Africa 
Although Sub-Saharan Africa generally has the highest HIV disease burden 
internationally (Figure 1.1), epidemics within Sub-Saharan African countries differ 
considerably from country to country in terms of prevalence and mode of 











transmissions of HIV, although injectable drug use is an increasingly important factor 
in some of the HIV epidemics in sub-Saharan Africa (including those in Kenya, 
Mauritius, South Africa and the United Republic of Tanzania). Mother to child 
transmission remains the epidemic‟s driving force in children in these regions 
(UNAIDS, 2008) and an estimated 90% of children (younger than 15 years) in Sub-
Saharan Africa became infected with HIV in 2007 either during pregnancy, birth or 




Figure 1.2. The estimated HIV prevalence in adults (15-49 years). Sub-Saharan Africa generally 
has the highest HIV disease burden (taken from UNAIDS, 2008).   
 
1.1.2 The HIV burden in South Africa 
South Africa currently has the largest number of people living with HIV in the world. 
It is estimated that 5.7 million South Africans lived with HIV in 2007 (representing 
about 10% of the South African population) and an estimated 1.8 million people have 
died of AIDS-related disease since the epidemic began (UNAIDS, 2008). In South 
Africa, HIV is disproportionately associated with lower-income areas with 29% of 
people living with HIV residing in urban informal settlements despite only 9% of the 
South African population aged 2 years and older living in these areas (UNAIDS, 
2008). Young women aged between 15–24 years in particular in South Africa face 











infections among this age group. HIV incidence among 20–29 year old women in 
2005 was approximately 5.6%, which is more than six times higher than for men in 
the same age group (0.9%) (UNAIDS, 2008). Currently, the HIV prevalence in South 
Africa in women attending government antenal clinics is stabilizing, with prevalence 
rates of 30% being recorded in 2005 compared to 29% in 2006 (UNAIDS, 2008). 
There was a decrease in the percentage of young pregnant women (15–24 years) 
found to be infected with HIV, suggesting a possible decline in the annual number of 
new infections. The drop in prevalence rate among adolescents in South Africa might 
be due to large scale information campaigns and condom distribution nationally, 
although there are huge concerns about the consistently high and rising prevalence 
among older antenatal clinic attendees (UNAIDS, 2008).  
 
The identification of biological cofactors that promote or inhibit transmission of HIV 
in the female genital tract and understanding the modes of viral dissemination to 
blood is fundamental since it will provide insight into the development of an effective 
vaccine or microbicide against this mucosally acquired infection. 
 
1.2 HIV Genetic diversity and variability  
There is a huge genetic diversity of HIV. Phylogenetic analysis reveals that two 
genetically different types of HIV exist and these are HIV-1 and HIV-2 (Robertson et 
al., 2000). HIV-1 is classified into three genetic groups, namely a major group (group 
M), an outlier group (group O) and a non-M/non-O group (group N) (Robertson et al., 
2000). HIV-1 group M, which is responsible for the global pandemic, is further 
subdivided into nine different genetic subtypes or clades designated by the letters 
from A-D, F-H, J and K (Robertson et al., 2000). These different subtypes show 
regional distribution, raising the question whether regional subtype-matched vaccines 
are necessary. It has been shown that strains belonging to the same subtype can differ 
by up to 20% in the env gene and inter-subtype genetic distances can reach up to 35% 
(Shankarappa et al., 1999). HIV is continuously evolving, and factors such as 














1.2.1 HIV-1 variability 
There is a mixture of closely related yet genetically distinct genomes within an 
individual and these are referred to as quasispecies (Eigen, 1993; 1996). HIV-1 strains 
within an individual can differ by as much as 10% in sequence (Shankarappa et al., 
1999), while the intersubtype distances can be as much as 35% in the env gene. There 
are two mechanisms that result in the vast variability of HIV-1 and these are mutation 
and recombination. The high variation among gene sequences of HIV-1 strains 
belonging to different lineages is mainly caused by high mutation, recombination and 
replication rates, as well as host immune pressure.  
 
1.2.2 Mutation 
HIV has an enormous evolutionary capability due to a high rate of point mutations, 
namely 3x10-5 substitutions per site per generation (Mansky and Temin, 1995). The 
high error rate of HIV RT results in misincorporation of nucleotides and is a major 
source of mutations throughout the viral genome and a determinant for rapid viral 
evolution (Ji et al., 1994; Ji and Loeb, 1994). Rapid evolution of HIV-1 has been 
shown to correlate with rapid disease progression (Mikhail et al., 2005; Mullins & 
Jensen, 2006), although it is not clear whether the virus is evolving due to high viral 




Recombination occurs frequently and a circulating recombinant form (CRF) is a virus 
that carries sections of two or more subtypes in a mosaic genome (Fang et al., 2004). 
A recombinant lineage is designated a CRF when related forms are found in multiple 
epidemiologically unlinked individuals. Recombination occurs at an average rate of 3 
events per genome per round of replication, ranging from 2-20 crossovers (Hu & 
Temin, 1990). Other studies have reported that recombination rates of 2.8 per genome 
per viral replication cycle (Zhuang et al., 2002). Detectable recombination requires 
infection with more than one virus at the cellular level. Recombination can occur 
between viruses of the same subtype (intra-subtype) (Philpott et al., 2005) or viruses 
of different subtypes (inter-subtype). Inter-subtype recombination is a result of the co-
packaging of viral genomes from two genetically distinct viruses into a single viral 











47% of sequences in a subtype C epidemic (Rousseau et al., 2007). Recombination is 
most frequently identified when it is between subtypes (Charpentier et al., 2006; 
Yirrell et al., 2002).  
 
1.2.4 Host immune selection pressure  
One of the major challenges facing the development of an effective vaccine is the 
extensive global diversity of HIV. Host immune pressure and availability of target 
cells are both factors driving variability of the virus. The rapid turnover of HIV-1 is 
also a contributor, as HIV-1 has been shown to produce 108 to 109 virions per day (Ho 
et al., 1995; Wei et al., 1995), although it is estimated that 27-66% are defective 
(Sanchez et al., 1997). Previous studies have suggested that HIV shows stronger 
effects of positive Darwinian selection (a phenomenon whereby there is a selective 
pressure forcing change) than any other organism studied so far (Rambaut et al., 
2004). There is evidence of positive selection exerted both by neutralizing antibodies 
(Greenier et al., 2005; Richman et al., 2003) and by the host immune cellular immune 
response (Allen et al., 2000; Barouch et al., 2005; Borrow et al., 1997). The role of 
immune selection pressure in driving the global sequence variability of HIV is evident 
in studies on the adaptation of HIV-1 to CD8+ T cell responses at the population level 
(Moore et al., 2002). However, the level of this sequence variability is different for 
different HIV genes and this is because certain mutations in some genes such as gag, 
a structural gene, pose a fitness cost to the virus. In support to this, there are studies 
which have shown the reversion of HIV-1 virus to wild type when transmitted to HLA 
mismatched individuals. This suggests a cost to the viral replicative capacity that may 
be incurred by acquisition of the relevant escape mutation (Barouch et al., 2005; 
Fernandez et al., 2005; Matano et al., 2004). Conversely, the env gene is a structural 
gene but there is rapid evolution which is noticeably associated with strong 
autologous neutralizing antibody responses (Liang et al., 2003; Price et al., 1997; Wei 
et al., 2003). Consequently, greater variability of HIV is formed when the virus is 
trying to escape from immune pressure. The more the viral regions targeted by HIV-
specific T cells, the more the virus will mutate in trying to escape from the immune 
pressure leading to more variability of the virus within an individual as well as within 













1.2.5 Availability of target cells 
HIV has been shown to predominately use the CCR5 coreceptor during early stages of 
infection (Connor et al., 1997) and virus which utilises this coreceptor are referred to 
as the R5 virus. However, during the late stages of infection, the virus switches to 
shows increased tropism of CXCR4 and this phenotypic switch has been shown to 
coincides with the first immunological and clinical signs of disease progression 
(Connor et al., 1997). The switch from X5 to X4 and the availability of different cells 
expressing receptors for HIV-1 infection are evidence for genetic variation 
(Overbaugh and Bangham, 2001). However in some individuals, virus may attain dual 
tropism characteristics, with X4 viruses still retaining their ability to use CXCR5 
coreceptor (Doms and Peiper, 1997). 
 
1.3 HIV-specific T cell responses in blood  
 
HIV-1 specific CD4+ T helper (Th) cells and CD8+ cytotoxic T cells (CTLs) have 
been shown to play an important role in the immune control of HIV (Brander and 
Walker, 1999; Goulder et al., 1999; McMichael and Rowland-Jones, 2001). The 
magnitude and frequency of HIV-specific CD8+ T cells are greater than CD4+ T cells 
(Betts et al., 2001; Ramduth et al., 2005). Despite this, CD4+ T cells are important in 
initiating functional CD8+ T cell responses as well as for the development of effective 
CD8+ memory responses (Janssen et al., 2003; Sun et al., 2004) in both mouse studies 
(Janssen et al., 2003; Sun et al., 2004) and studies in HIV infection (Lichterfeld et al., 
2004). This is mainly because CD4+ T cells primarily secrete IL-2 cells upon antigen 
recognition (Lichterfeld et al., 2004), which is a growth factor for antigen-specific 
cells, and is responsible for their proliferation.  
 
T cells are also important in secreting cytokines such as IFN- , an antiviral cytokine 
and has been implicated with control of diseases. IFN-  is a TH 1 cytokine that is key 
for cell-mediated immunity (as reviewed in Schroder et al., 2004).  It is an antiviral 
cytokine that induces a number of anti-viral proteins (such as Mx, dsRNA protein 
kinase, ribonucleic acid nuclease, and nitric oxide), which in turn inhibit viral 
replication, degrade single stranded RNA, and inhibit protein synthesis (as reviewed 











which is required for the recruitment of neutrophils and monocytes, while MIP-1  is a 
chemokine, and is responsible for the recruitment of lymphocytes and monocytes (as 
reviewed in Clore and Gronenborn, 1995). MIP-1  binds the HIV co-receptor CCR5, 
thus may compete with HIV for binding to CD4+ T cells expressing this molecule. 
CD107a is a surrogate marker for cytotoxicity. During the degranulation process, 
CD107a is transiently expressed on the inner membrane of the cytotoxic granule (Suni 
et al., 2005), which then becomes exposed during degranulation and it can be detected 
on the surface of the cell (Betts et al., 2003). 
 
Primary HIV infection is associated with a rise in HIV viremia and a decline of CD4+ 
T cells in the peripheral blood (Borrow et a., 1994; Koup et al., 1994; Borrow et al., 
1997). The decline in numbers of circulating CD4+ T cells (lymphopenia) is due to 
both HIV-mediated cell killing and to re-trafficking of cells to the lymphoid tissues 
and other organs (Fauci, 1993a). Following the emergence of HIV-specific CD8+ 
CTLs, the plasma viral load subsequently falls to a level of steady-state (set point) and 
the level of this is believed to predict the rate of disease progression to AIDS (Fauci, 
1993a). A period of clinical latency follows after primary infection and, during this 
period, the immune system slowly deteriorates due to continuous HIV viral 
replication (Pantaleo et al., 1993a). The correlation between blood CD4 T cell loss 
and the emergence of opportunistic infections is a well-defined indicator used for 
many years by clinicians as a measure of disease progression in HIV infected 
individuals (Egger et al, 2002). However, recent findings have suggested that 
measuring CD4 counts in blood alone may not be representative of the rapid and 
severe effect of HIV observed on the immune system (Brenchley et al, 2004, Douek et 
al, 2003). HIV disease, however, is not uniformly expressed in all individuals and 
small proportions of individuals infected with the virus develop AIDS and die within 
months following primary infection (Mellors, 1997). The rate of disease progression 
is affected by host and viral factors such as virulence of the individual strain of virus, 
host genetics such as human leukocyte antigen (HLA) alleles, host immune response 
and co-infection with other viruses (Pantaleo et al., 1993a; Fauci, 1993a).   
1.3.1 Evidence for the role of protective T cell immunity in blood 
Evidence for the importance of HIV-specific CTL responses in the control of HIV 











al., 1995, Pitcher et al., 1999, Rosenberg et al., 1997) and primate models of HIV 
infection (Jin et al., 1999; Metzner et al., 2000; Schmitz et al., 1999; Kuroda et al., 
1999). In rhesus macaques, depletion of CD8+ T cells resulted in viral re-emergence 
in animals that were previously controlling simian immunodeficiency virus (SIV) 
infection (Jin et al., 1999; Metzner et al., 2000; Schmitz et al., 1999). The magnitude 
of anti-HIV CTL responses correlated significantly with control of HIV in humans 
(Kalams et al., 1999; Rosenberg et al., 1997) and SIV in macaques (Hel et al., 2002). 
Furthermore, several studies have shown that immunologic pressure mediated by 
SIV- and HIV-specific CTL often resulted in HIV escape mutations in the HIV 
epitopes being targeted (Goulder et al., 1997; 2001; Price et al., 1997; Leslie et al., 
2004; Chopera et al., 2008). The emergence of HIV-specific CD8+ T cells in acute 
untreated individuals was found to be temporally associated with the initial decrease 
of viremia and inhibition of viral replication (Koup et al., 1994; Borrow et al., 1994; 
Yang et al., 1997). In addition, robust HIV-specific CTL responses with enhanced 
proliferative capacity have been reported in long term non-progressors compared to 
individuals with a more typical progression (Klein et al., 1995, Pantaleo et al., 1995, 
Pitcher et al., 1999, Rosenberg et al., 1997). The expression of certain HLA class I 
alleles has been strongly correlated with lack of escape and non-progressive HIV 
infection (Goulder et al., 1997; Migueles et al., 2000; Altfeld et al., 2003). In 
macaques, current HIV vaccine strategies which induce high frequencies of anti-viral 
CD8+ T cells have been shown to be effective in the control of pathogenic SHIV 
(Amara et al., 2001; Casimiro et al., 2005; Shiver et al., 2002) and SIV challenges 
(Johnson et al., 2005; Wilson et al., 2006).  
 
Most HIV-infected individuals, however, progress to AIDS in the absence of effective 
antiretroviral therapy despite strong CTL responses (McMichael and Rowland-Jones, 
2001). This has been partially attributed to the impairment of CD4+ T helper cell 
function during chronic HIV-infection (Rosenberg et al., 2000) and exhaustion of 
CD8+ CTL (Appay et al., 2000; Wherry et al., 2003; Brenchley et al., 2003). These 
studies point to the idea that vaccines that stimulate T helper and CTL responses to 
HIV may be able to control the virus early in infection, thus increasing the chances of 











1.3.2 Magnitude and breadth of Gag-specific T cell responses 
Studies have shown that HIV-specific T cell responses against all HIV proteins can be 
detected in blood from HIV-infected individuals, although Gag and Nef are the most 
commonly recognized by both CD4+ and CD8+ T cells (Betts et al., 2001; Ramduth 
et al., 2005; Addo et al., 2003; Kaufmann et al., 2004; Zuniga et al., 2006).  Of all 
HIV proteins, Gag in particular (especially the p24 region) is highly conserved by 
HIV and important in the packaging of the capsid (McMichael and Rowland-Jones, 
2001). The immunodominance of Gag-specific CD4+ and CD8+ T cells has been 
documented in both subtype C and B HIV infections (Kiepiela et al., 2007; Addo et 
al., 2003; Kaufmann et al., 2004).  
 
There has been some controversy surrounding the direct role of HIV-specific T cells 
in the control of HIV.  HIV-specific CD8+ T cell responses that preferentially target 
Gag have been associated with better control of HIV (Ramduth et al., 2005; 
Masemola et al., 2004; Zuniga et al., 2006), in particular the p24 region of Gag 
(Zuniga et al., 2006). No correlation was, however, found between the magnitude and 
breadth of total HIV-specific T cell responses (including the whole genome) and viral 
load (Ramduth et al., 2005; Masemola et al., 2004; Zuniga et al., 2006). Conversely, 
studies in HIV-infected untreated individuals reported a positive correlation between 
total magnitude of HIV-specific T cell responses and viral load indicating that 
generally the magnitude of T cell responses to HIV were tracking viraemia and that 
the magnitude and breadth of total HIV-specific T cells might only be a reflection of 
high antigen load (Masemola et al., 2004; Betts et al., 2001). Furthermore, Gray et al. 
(2009) found that the magnitude of early HIV-specific T cell IFN-γ responses did not 
play a role in determining viral set-point at 12 months post infection. A longitudinal 
study conducted on chronically HIV-infected therapy naive individuals showed that 
Gag-specific IFN-γ responses declined over time (Geldmacher et al., 2007b). This 
observation is mainly as a result of T cell exhaustion due to extended exposure of the 
immune system to high antigenic loads. 
 
These studies confirm the importance of measuring T responses against highly 
conserved Gag regions which may affect replicative capacity of the virus (Leslie et 











Because Gag is a structural protein, it is likely that few mutations will be compatible 
with viable progeny with the result that the virus cannot mutate to escape immune 
pressure (Yusim et al., 2002). Because there are so many conflicting studies on the 
association between the magnitude and breadth of IFN-  T cell responses to HIV and 
markers of HIV disease progression (viral load and CD4+ counts), it is likely that 
control of HIV infection cannot be explained by measuring IFN-  responses alone. 
The importance of Gag p24 T cell responses in blood in the control of viremia 
suggests that this region of HIV might be the most attractive region to focus research 
on and include in a vaccine candidate.  
 
1.3.3 Polyfunctional T cell responses in HIV 
Because measurement of IFN-  alone (as a correlate of protection against HIV) 
yielded conflicting results, there is an urgent need for identification of immunological 
markers associated with protection against HIV. T cells are capable of secreting a 
broad range of cytokines and chemokines and T c lls capable of simultaneous 
secretion of multiple cytokines are referred to as „polyfunctional‟ (Betts et al, 2006). 
In addition to being able to secrete multiple cytokines and exhibit multiple functions, 
polyfunctional T cells have been shown to produce more of each individual cytokine 
per cell than a monofunctional cell (Precopio et al., 2007; Darrah et al., 2007; Duvall 
et al., 2008). Several recent studies have shown a significant association between the 
frequency of HIV-specific polyfunctional CD4+ and CD8+ T cells and control of HIV 
(Boaz et al., 2002; Kannanganat et al., 2007b; Betts et al., 2006; Almeida et al., 2007).    
 
The association between polyfunctional CD4+ T cells to HIV and long-term survival 
was first demonstrated by Boaz et al. (2002) and later by Kannanganat et al. (2007b). 
Betts et al. (2006) found that long-term non-progressors had significantly higher 
frequencies of polyclonal CD8+ T cells compared to chronically HIV-infected 
individuals, characterized by simultaneous expression of IFN-γ, TNF-α, IL-2, MIP-1  
and CD107a. Similarly, the control of HIV-1 replication in individuals who were 
HLA-B27+ (an HLA allele associated with long-term survival) was associated with 
the ability of B27-HIV-specific CD8+ T-cells to accumulate multiple effector 












The cause and effect relationship between polyfunctional T cell responses and control 
of viraemia remains to be determined however. Some have argued that association 
obtained between polyfuction and HIV control is a consequence rather than the cause 
of lower viral loads (Rehr et al., 2008; Streeck et al., 2008). In support of this, in HIV-
infected individuals who had initiated anti-retroviral therapy (ART), immune 
reconstitution in the absence of high levels of viraemia was associated with the 
emergence of polyfunctional CD4+ T cells producing both IL-2 and TNF-α 3 months 
after therapy started (Rehr et al., 2008). Streeck et al (2008) similarly reported partial 
restoration of T cell functionality in HIV-infected individuals initiating ART (Streeck 
et al., 2008a). In this study, a switch from polyfunctionality to monofunctionality was 
noticed after primary HIV-infection which was absent in CTL responses to other viral 
infections such as cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Influenza 
(Streeck et al., 2008a). It has therefore been proposed that impairment in T cell 
polyfunction may be a consequence of ongoing viral replication from acute to chronic 
HIV infection (Streeck et al., 2008a; 2008b). 
 
In vaccine studies, rhesus macaques immunized with live attenuated chimeric virus 
between SIV and HIV (SHIV) 89.6 and challenged with SIVmac239 mounted 
polyfunctional SIV-specific CD8+ T cells (Genesca et al., 2007; Sun et al., 2008). 
Recently, HIV candidate vaccines based on recombinant DNA and the poxvirus 
vector NYVAC (Harari et al., 2008) and DNA prime formulation (5-valent env and 
monovalent gag) followed by a 5-valent Env protein boost (Bansal et al., 2008) have 
been shown to elicit both CD4+ and CD8+ polyfunctional responses against the 
inserts but protection against infection has not been assessed. The finding that T cell 
polyfunction may be an important correlate of protection against HIV has emphasized 
the importance of the quality rather than quantity of responses generated (Seder et al., 
2008). The importance of polyfunctional T cells has also been documented in other 
infections (Precopio et al., 2007; Darrah et al., 2008). In humans, immunization with 
recombinant vaccinia virus generated polyfunctional virus-specific CD8+ T-cells 
(Precopio et al., 2007) and mice challenged with leishmania polyprotein induced Th 












1.4 T cell differentiation during chronic HIV infections  
 
Robust CD8 T-cell responses have been observed in humans during the acute phase of 
HIV infection (Pantaleo et al., 1997) and in other viral infections such as EBV (Callan 
et al., 1998). It is estimated that at the peak of T cell clonal expansion, antigen-
specific CD8 T cells can divide approximately every 6 to 8 hours with an estimated 
104- to 105-fold expansion in humans (Wherry and Ahmed, 2004).  Along with this 
dramatic proliferation, CD8 T cells also undergo activation and differentiation. A 
summary of CD8+ T cells differentiation in response to an acute viral infection 
(where virus is cleared) is shown on Figure 1.3.  
 
 
Figure 1.3. The dynamics of a CD8 T-cell response to acute viral infection. (A) CD8 T-cell 
response to an acute viral infection undergoes an expansion phase, resulting in the generation of 
effector CD8 T cells and viral clearance. The expansion phase is followed by a death phase, when 90 to 
95% of the effector T cells die. The surviving effector CD8 T-cell pool further differentiates and 
generates a memory T-cell population that is maintained long term in the absence of antigen. (B) 
Memory CD8 T-cell generation following a linear model of differentiation. Antigenic stimulation 
causes naïve CD8 T cells to proliferate and acquire effector functions. The effector T cells that survive 
the death phase further differentiate, giving rise to memory T cells that continue to differentiate in the 
absence of antigen and acquire the ability to persist in the absence of antigen via homeostatic turnover 











1.4.1 Generation and Characteristics of Memory T Cells  
It was previously thought that the differentiation of memory T cells is through a linear 
differentiation model where memory cells are derived from effector T cells (Wherry 
and Ahmed., 2004., Ahmed et al., 2009). This assumption was largely based on the 
idea that differentiation is a unidirectional process and that T cells that are well 
differentiated are unlikely to revert to a less differentiated state (Ahmed et al., 2009). 
In the linear differentiation model, T cells either become senescent terminally 
differentiated T cells, which die by apoptosis soon after the pathogen is clear, or 
differentiate into effector memory T cells that express low levels of CD62L (also 
known as L-selectin), do not express CC-chemokine receptor 7 (CCR7) or home to 
lymphoid tissues, and are replication incompetent. These cells can give rise to long-
lived central memory T (TCM) cells that express CCR7 and CD62L, and undergo 
homeostatic proliferation in lymphoid tissues. This clonal burst of naïve cells is 
largely driven by the strength of signals that a naïve T cell receives via the T cell 
receptor (TCR) together with co-stimulatory molecule CD28 (Gourley et al., 2004; 
Tan et al., 2001). However, it is possible that the less differentiated T cells might 
represent a divergent pathway of differentiation (bifurcative differentiation). This 
model proposes that following antigen recognition, one T cell can give rise to two 
daughter cells with different differentiation fates: the distal daughter cell gives rise to 
TCM cells and the proximal daughter cell gives rise to TEM cells and effector T cells, 
which undergo apoptosis following pathogen clearance. This type of differentiation 
could be achieved through asymmetric cell division or other mechanisms capable of 
generating heterogeneity. A third possible model (referred to here as the self-renewing 
effector model) suggests that a naive T cell can develop into a TCM cell or an effector 
T cell that can self-renew. These cells can home to lymphoid tissues and undergo 
homeostatic proliferation. It is proposed that these cells give rise to TEM cells that 
can migrate to sites of infection but do not self-renew. Senescent terminally 
differentiated effector T cells are proposed to derive from these TEM cells. APC, 












Figure Possible models of memory T cell differentiation. (A) In the linear differentiation model, 
stimulation of naive T cells with antigen (in the presence of co-stimulatory signals and inflammatory 
cytokines) results in the generation of effector T cells. Effector T cells either become senescent 
terminally differentiated T cells, or home to lymphoid tissues, and are replication incompetent. (B) The 
bifurcative differentiation model proposes that following antigen recognition, one T cell can give rise 
to two daughter cells with different differentiation fates. (C) The self-renewing effector model suggests 
that a naive T cell can develop into a TCM cell or an effector T cell that can self-renew. (Taken from 
Ahmed et al., 2009) 
 
Homeostatic cytokines are likely to play a major role in driving T cell proliferation, 
differentiation and survival (Sallusto et al., 2004; Rochman et al., 2009). Previous 
studies have implicated the common γ-chain family cytokines IL-2, IL-7, and IL-15 as 
important general regulators of peripheral T cell homeostasis (reviewed in Kovanen 
and Leonard, 2004). IL-2, a product of activated T cells, supports expansion of 
antigen-activated CD4+ and CD8+ T cells (reviewed in Malek et al., 2004). IL-7 is 
produced by nonlymphoid cells and plays a crucial role in promoting expansion of 











compartments. IL-15, also produced by nonlymphoid cell types, directs NK cell and 
NK-T cell development, as well as CD8+ memory T cell function and homeostasis 
(reviewed in Kovanen and Leonard, 2004). In addition to IL-2, IL-7 and IL-15, IL-4 
and IL-9 can also act as T cell growth factors (Kanegane et al., 1996). It is critical to 
investigate T cell differentiation in HIV infection to determine whether there are 
particular subsets of cells that are involved in viral control.  
 
1.4.2 Properties of memory T cells 
Memory T cells with distinct functional properties can be identified based on the 
expression of certain cell surface Wherry and Ahmed, 2004). The expression of co-
stimulatory molecules CD27 and CD28 and differing isoforms of CD45 have been 
used to dissect the heterogeneity of memory T cells (Michie et al., 1992; Sallusto et 
al., 1999). Naïve T cells express CD45RA and the transition from naive to memory 
status is connected to the loss of CD45RA expression and gain of CD45RO 
expression (reviewed in Esser et al., 2003). Upon in vitro activation of naïve 
CD45RA+CD45RO- T cells, a subset of transitional CD45RO-CD45RA- T cells can 
be observed before conversion to a CD45RO+CD45RA- memory T cell phenotype 
(Prince et al., 1992). Memory T cells are predominantly divided into central memory 
and effector memory T cells (Sallusto et al., 1999).  
Central memory T cells express CD62L (L-selectin) and the chemokine (C-C motif) 
receptor 7 (CCR7) which is the receptor that binds CC chemokine ligand 19 (CCL19) 
but is also the receptor associated with central memory retention in secondary 
lymphoid organs (reviewed in Salusto et al., 2004). Central memory T cells can 
circulate from the blood to secondary lymphoid organs and maintain their ability for 
secondary proliferation (Geginat et al., 2003a; 2003b; reviewed in Sallusto et al., 
2004). In contrast, effector memory T cells express low levels of CD62L and do not 
express CCR7 or home to lymphoid tissues (Geginat et al., 2003a; 2003b; reviewed in 
Salusto et al., 2004). Effector memory T cells are unlikely to divide in response to a 
secondary infection, but are capable of producing large quantities of perforin and 
granzyme B as well as being able to migrate to sites of inflammation, such as the skin 
and gut (Sallusto et al., 1999). Although central memory cells express little perforin 
and granzyme, their ability to acquire these functions rapidly upon secondary 











immunity for persisting infections (Burgers et al., 2009). Studies in mice, however, 
demonstrated that central and effector memory T cells were equally efficient at 
cytotoxic killing upon reactivation in vivo (Barber et al., 2003). The phenotypic 
changes that occur from naïve to memory transition are summarized on Figure 1.4. 
Other T cell markers such as CD57 and CD127 (IL-7 receptor) have been used to 
identify and characterise memory T cells (reviewed in Ma et al., 2006). CD127 is a 
marker for homeostatic survival of T cells. In addition, CD127 is mainly expressed on 
naïve T cells. CD57 identifies senescent T cells and both in vivo and in vitro studies 
have shown that cells that express this surface molecule are incapable of proliferating 
after antigen-specific stimulation and undergo activation-induced apoptosis 
(Brenchley et al., 2003).  
 
 
Figure 1.4. The phenotypic changes that occur from naïve to memory transition. (A) Memory 
CD8 T-cell properties that change during the naïve to effector to memory transition are listed. (B) 
Phenotypic changes that occur during the naïve to effector to memory transition are listed, including 
differences between the effector memory (TEM) and central memory (TCM) subsets of memory CD8 












1.4.3 T cell differentiation in HIV infection 
During HIV infection, the host immune system is chronically activated, which leads 
to immune exhaustion and dysfunction and ultimately progression to AIDS in the 
absence of successful antiretroviral therapy (Papagno et al., 2004). Details of how 
HIV-1 infection leads to chronic HIV infection are covered in section 1.7. The 
association between T cell exhaustion and HIV/AIDS disease progression is still not 
well understood.  
 
The skewing towards an effector memory T cell phenotype has been observed for 
both HIV-specific CD4+ and CD8+ memory T cells during HIV infection (Tilton et 
al., 2007; Champagne et al., 2001). Recent studies showed that terminally 
differentiated HIV-specific CD8+ T cells (CD45RA+CCR7-) cells, known as 
terminally-differentiated effector cells expressing RA or TEMRA) were associated 
with viral control in HIV infection (Northfield et al., 2007, Addo et al., 2007). In early 
HIV infection, the presence of these cells has been associated with lower viral set 
point (Northfield et al., 2007) and a greater frequency of these cells was observed in 
individuals controlling HIV infection compared to those HIV progressors (Addo et 
al., 2007). In contrast, Burgers et al. (2009) found that less differentiated phenotypes 
of both total and HIV-specific CD8+ T cells response profile correlated with a lower 
viral set point while a more differentiated profile correlated with a higher viral load 
set point. The frequency of central memory and intermediate populations of CD8+ T 
memory cells (CD45RO-CD27-CCR7-) in both total and HIV-specific memory CD8+ 
T cells were inversely associated with viral set point (Burgers et al., 2009). HIV 
controllers were shown to have a greater percentage of HIV-specific CD4+ central 
memory cells than HIV viremic individuals (Potter et al., 2008). Similarly, Ladell et 
al. (2008) reported reduced levels of total CD4+ central memory cells associated with 
higher viral loads indicating that maintanence of CD4 central memory cells are 
important for control of HIV disease progression. The preservation of total CD4+ 
central memory cells has also been shown in elite controllers compared to HIV-
infected treated individuals (van Grevenynghe et al., 2008).  
 
These studies demonstrate a link between HIV disease progression and the presence 











activation may be critical in driving memory cell differentiation. In contrast to blood 
of HIV-infected women, there is limited information available on T cell 
differentiation and maturational status in the female genital tract.  
 
1.5 Organization of the female genital tract  
 
The lower genital tract in women is comprised of four discrete anatomical regions 
including (a) the vaginal opening, (b) the vaginal mucosa, (c) the ectocervix, and (d) 
the endocervix (Figure 1.5). It also consists of two main types of epithelium including 
the squamous and columnar epithelium. 
 
1.5.1 Vagina  
The female vagina can be subdivided into the introitus (vaginal opening) which is 
covered by a keratinized stratified squamous epithelium resembling skin, and the 
distal and proximal vagina which are covered by non-keratinized stratified squamous 
epithelium (Pudney et al., 2005). The vaginal epithelial barrier changes markedly at 
different stages of the menstrual cycle and in response to exogenously administered 
hormones such as progesterone (Marx et al., 1996). Hormonal cycling has been 
shown to affect lymphocyte and plasma cell densities in the vagina (Wira et al., 2000; 
2003) and, in the acidic environment that predominates here, this compartment has 
been shown to inhibit lymphocyte proliferation (Hill and Anderson, 1992).  
 
1.5.2 Ectocervix  
The ectocervix consists of five layers of epithelium completely covered with an 
extension of the vaginal stratified squamous epithelium (reviewed in: Coombs et al., 
2003; Pope and Haase 2003). This multilayered epithelium acts as a physical barrier 
against invading pathogens (reviewed in Shacklett et al., 2009b). Compared with the 
vagina, the ectocervical mucosa contains higher numbers of CD4+ T cells and CD1a+ 
dendritic cells (Pudney et al., 2005). Immune cells present in this region have been 
implicated in the sexual transmission of HIV-1, and there is strong evidence that HIV 
infection is more common in the ectocervix than in the vagina in women without 












1.5.3 Cervical Transformation Zone  
The transformation zone represents an abrupt transition situated at the intersection 
between the ectocervix and the endocervix (Pudney et al., 2005; Figure 1.5). This 
zone is constantly altered in response to hormonal fluctuation, pregnancy and aging 
(Jacobson et al., 1999). This site is a rich source of lymphocytes and antigen 
presenting cells containing more immune cells than any other region within the outer 
female genital tract (reviewed in Coombs et al., 2003). Accumulation of CD8+ T cells 
at this site provide evidence that the transformation zone functions as an 
immunologically dynamic barrier to invading pathogens (Kobayashi et al., 2002). As 
the transformation zone also harbors higher concentrations of CD4+ T cells, this site 
has been implicated in both in HIV-1 transmission and HPV clearance (Pudney et al., 
2005).  
 
Figure 1.5. A representative figure of an adolescent healthy cervix showing the endocervix, and 
ectocervix (A) and a magnified section shows the single-layer columnar epithelium, transformation 
zone and the squamocolumnar junction (B)  [modified from Coombs et al., 1999]. 
 
1.5.4 Endocervix 
The endocervical canal is approximately 2.5 cm long and consists of a columnar 











(reviewed in Coombs et al., 2003). Although this section of the genital tract contains 
the lowest number of T cells and macrophages, it is lined with mucus, innate defences 
including compounds such as secretory leukocytes protease inhibitor (SLPI) and 
Lactoferrin (reviewed in Shacklett et al., 2009b). 
 
1.6  HIV transmission in the female genital tract 
 
HIV transmission across the genital mucosa involves several steps including survival 
of the virus or HIV-infected cells in mucosal secretions, transport across or passage 
through the epithelial barrier and infection of target cells within the mucosa (reviewed 
in Kozlowski and Neutra, 2003). The strategies that HIV may use to infect cells in the 
mucosa depend of the site of infection within the female genital tract.  
 
1.6.1 HIV Infection and the female genital tract  
The mucosa surface of the female genital tract serves as the site of entry for a variety 
of bacterial and viral pathogens (Prakash et al., 2001). Higher densities of immune 
cells in the lower genital tract (ectocervix and transformation zone) compared with the 
upper genital tract suggest that most infections will take place in this region (Cohen et 
al., 1999., Bulmer et al., 1998; Pudney et al., 2005). Knowledge of the type and 
distribution of cells in the lower genital tract, including those responsible for the 
inductive and effector arms of cellular immunity are important to understanding the 
pathogenesis of HIV and other important sexually transmitted infections in women 
(Prakash et al., 2001) and in critical to designing appropriate prevention strategies to 
induce local protective immunity or block mucosal infection (Pudney et al., 2005).  
 
1.6.2 Susceptibility of the female genital tract to HIV-1 infection 
Studies have demonstrated that susceptibility to HIV infection following sexual 
contact is likely to be influenced by multiple factors, including the presence of other 
pathogenic infections (Chlamydia, Herpes simplex virus type 2 (HSV-2), Human 
papillomavirus (HPV) and other sexually transmitted infections; reviewed by Pope 
and Haase (2003). In particular, conditions or infections that disrupt an intact mucosa 
barrier such as cervical dysplasia, pelvic inflammatory disease, and neoplasia have 











et al., 1995a; 1995b; Kreiss et al., 1994; Augenbraun et al., 1994). Elevated numbers 
of CCR5+ Langherhans cells are present in the cervicovaginal area of women with 
sexually transmitted infections (Zaitseva et al., 1997; Patterson et al., 1998).  
 
The amount of HIV present in the challenge inoculum (viral load in transmitting 
partner‟s genital secretions) and the effectiveness of the local mucosal immune 
system throughout the female reproductive tract have been shown to influence the 
infectiousness of HIV-1 (Lee et al., 1996). Furthermore, efficiency of heterosexual 
transmission of HIV in humans has been associated with higher viral loads in blood of 
the transmitting partner (Lee et al., 1996; Quinn et al., 2000).  
 
Susceptibility to HIV-1 infection is also increased by the use of hormonal 
contraceptives which has been shown to result in thinning of the genital epithelium 
(Martin et al., 1998; Mostad et al., 1997). Changes occurring before, during and after 
ovulation which affect epithelial morphology and cellular densities have also been 
implicated in increased susceptibility to HIV (Wright et al., 1994). The expression of 
HIV receptors and co-receptors (CCR5 and CD4, respectively) by T cells and 
epithelial cells peak in the upper reproductive tracts during ovulation (reviewed in 
Wira and Fahey, 2008). Following ovulation and during the secretory phase of the 
menstrual cycle, CTL and Natural Killer cell activity in the uterus are suppressed 
(reviewed in Wira and Fahey, 2008). Furthermore, small mucosal lacerations 
produced in the vaginal mucosa during sexual intercourse or mucosal irritants such as 
repeated exposure to Nonoxynol-9 (reviewed in Pope and Haase, 2003) also increase 
permeability of the tissue and facilitate entrance of HIV-1 locally in susceptible cells 
(Rasheed et al., 1996; reviewed in Pope and Haase, 2003; Marx et al., 1996).  
Thinning and breaches in the mucosal barrier could quickly expose susceptible cells 
in the submucosa to HIV facilitating viral entry. This would increase the likelihood of 
establishing and rapidly disseminating infection (reviewed in Pope and Haase, 2003) 
 
The prospect that trauma associated with heterosexual intercourse may be associated 
with shedding or recruitment of T lymphocytes into the genital tract lumen has also 
been suggested (Bardeguez et al., 1997). Although micro-trauma is likely to be a 
involved in transmission of HIV, non-traumatic uptake of virus has also been 











2004; Maher et al., 2005; reviewed in Hladik and Hope, 2009). A study on non-
traumatic oral SIV inoculation of rhesus macaques indicated that the mucosal and 
lymphoid tissues in the head (oral mucosa, esophagus, submandibular and cervical 
lymph nodes) contained the majority of SIV infection foci (Milush et al., 2004) 
indicating that infection can take place by passive viral diffusion. The stratified 
squamous epithelium in the oral and esophageal mucosa is similar to the epithelium 
present within the vaginal mucosa suggesting a similar mechanism of entry at each of 
these mucosal sites (Milush et al., 2004). Factors that can increase the risk of infection 
with HIV are summarized in Figure 1.6. 
 
Figure 1.6. Factors that can increase the risk of infection with HIV include: ectopic protrusion of 
endocervical columnar epithelium into the ectocervix; thinning of the squamous epithelial layer; 
bacterial vaginosis; vaginal drying; inflammation, which leads to an increase in the number of target 
cells in the submucosa; trauma; ulcerative infections that might allow more ready access of virus to 
sub-epithelial dendritic cells (DCs) expressing C-type lectins, such as DC-specific intercellular 
adhesion molecule 3 (ICAM3)-grabbing non-integrin (DC-SIGN), and CD4+ T cells (taken from 














1.6.3 Mechanisms used by HIV to cross the female genital mucosal  
 barrier 
Upon exposure to HIV, cervical mucus has been shown to be very effective in 
trapping HIV-infected seminal cells or free virus (reviewed in Lenderman et al., 
2006). Despite this, cell-free HIV gains access to its target cells; which include 
Langerhans cells, intra-epithelial CD4+ T cells, and CCR5+ Dendritic cells.  
Lederman et al. (2006) argued that it would be more difficult for cell-associated HIV 
to breach this barrier. Dendritic cells also express DC-SIGN, a member of the C-type 
lectin receptors (CLRs) family, which are involved in HIV attachment and 
internalisation into non-degrading endosomal compartments (Turville et al., 2001). 
Dendritic cells are predominantly specialized Langerhans cells, expressing Langerin 
but not DC-SIGN and mannose receptor. It has been suggested that HIV-1 infection 
can be initiated by transmission to intraepithelial Langerhans cells in the stratified 
squamous epithelium/ectocervix either as cell free virus or bound to Langerhans cells 
in the epithelium without infecting them (reviewed in Kozlowski and Neutra, 2003).  
Figure 1.7 summarizes the possible pathways of HIV invasion in the mucosa of the vagina 
and uterine ectocervix. 
 
Alternatively, Milush et al. (2004) has suggested that HIV transmission may be 
occurring across microscopic breaks between squamous epithelium cells that provide 
access for the virus to infect the CD4+ cells and CCR5+ cells present in the mucosa 
and submucosa (Figure 1.7). Squamous epithelial cells of the exocervix are connected 
by desmosome muscles which are the weakest form of intercellular junctions (Kress 
et al., 2004). This keeps the cellular membranes 30nm apart from one another (Kress 
et al., 2004).  Although still significantly smaller than a HIV particle (100-150 nm), it 
is possible that few viral particles in the inoculum may be able to permeate through 


















Figure 1.7 Pathways of HIV invasion in the mucosa of the vagina and uterine ectocervix. 
Characteristic phenotypic cell receptors and receptors relevant for HIV binding and infection are shown 
on the top of the figure (A). The possible pathways of HIV penetration are summarized in B. (a) Free 
HIV virions or HIV-infected donor cells are trapped in mucus, resulting in penetration of the free 
virions into gaps between epithelial cells or attachment of HIV-infected donor cells to the luminal 
surface of the mucosa and secretion of virions on contact. (b) HIV can also fuse with the surface of 
intraepithelial CD4+ T cells, followed by productive infection of these cells. (c) Infected donor cells or 
free virions can immigrate along physical abrasions of the epithelium into the mucosal stroma. (d) 
Virions can transcytose through epithelial cells near or within the basal layer of the squamous 
epithelium (e) Once within the stroma, virions can productively infect stromal DCs or be internalized 
into the endocytic compartments of DCs and pass from the stromal DCs to CD4+ T cells (f) 
Productively infected CD4+ T cells and stromal DCs, and stromal DCs or intraepithelial LCs harboring 
virions in endocytic compartments, can emigrate into the submucosa and the draining lymphatic and 











The single layer of columnar epithelium that lines the endocervix contain CD4+ 
bearing cells that express the necessary HIV co-receptors (CCR5 and CXCR4) 
required for infection (Howell et al., 1997; Figure 1.7). The columnar epithelial 
monolayer associated with the endocervix represents a less formidable barrier for HIV 
to cross than the multilayer squamous epithelium of the ectocervix or vagina (Pope et 
al., 2003). Although the architecture of the cervix possesses a number of potential 
routes by which infection can take place, cervical mucous largely provides an 
excellent barrier by trapping most of the virus (Miller et al., 2005). The ultimate goal 
of an HIV vaccine would be to prevent initial mucosal infection or the establishment 
of persistent HIV-infection.  
 
While various studies have implicated Langerhans cells in transmitting HIV to 
neighbouring cells and T cells (reviewed in Kozlowski and Neutra, 2003; Lenderman 
et al., 2006; Turville et al., 2001). It has been recently demonstrated that the C-type 
lectin langerin receptor expressed on Langerhans cells can act as a natural barrier to 
HIV transmission by sequestering and targeting viral particles for degradation 
(deWitte et al, 2007). It has now emerged, however, that activated Langerhans cells 
are prone to HIV infection while immature Langerhans cells clear invading HIV via 
langerin (de Jong and Gientenbeek, 2009). It is important to identify the immune cells 
that reside in the lower genital tract and understanding the processes they are involved 
in would be beneficial in developing therapeutic strategies. 
 
1.6.4 Local mucosal propagation of HIV and dissemination 
Once HIV has successfully crossed the mucosal barrier, the first cells thought to be 
infected are intraepithelial and subepithelial dendritic cells, local subepithelial CD4+ 
T cells and macrophages (reviewed in Hladik and McElrath, 2008). These cells 
subsequently migrate to local draining lymph nodes and transmit the virus to CD4+ T 
cells present in these lymph nodes (Spira et al., 1996), in the form of an „infectious 
synapse (McDonald et al., 2003) [Figure 1.7 and Figure 1.8]. 
 
Because of the high volumes of lymphocytes that traffic through lymph nodes each 
day, HIV would be capable of rapidly spread from these regional nodes throughout 
the body and infect new cells in a relatively short period of time, most efficiently to 











and McElrath, 2008). In carrying out their normal function of conveying pathogens 
and antigens to the draining lymphatic tissues to induce an immune response, virus-
carrying DCs can also disseminate infection to large numbers of CD4+ T cells to 
amplify and further disseminate the infection (reviewed in Pope and Haase, 2003). It 
is this rapid dissemination of the virus to lymph nodes that is likely to compromise the 
ability of the host‟s immune response to contain or eradicate the infection at the 
mucosal site of exposure (Pope et al., 2003).  
 
Studies of vaginal transmission in the SIV–rhesus macaque model point to 
opportunities at the earliest stages of infection in which a vaccine or microbicide 
might be protective, by limiting the expansion of infected founder populations at the 
portal of entry (Haase et al 2005; Miller et al., 2005). A recent study in macaques has 
identified the initial influx of CD4 T cells into the genital mucosa as being a key to 
dissemination of infection since CD4 T cell recruitment to this site is followed by a 
secondary inflammatory process, probably driven by RANTES and other chemokine-
producing cells within inflammatory infiltrates (Li et al., 2009). Li et al. (2009) 
showed that the influx of CD4 T cell target cells to the genital mucosa is preceded by 
production of MIP-3α by the endocervical epithelium in response to virus which 
recruits plasmacytoid Dendritic cells. In turn, plasmacytoid Dendritic cells produce 
MIP-1α and MIP-1β to recruit CCR5+ CD4 T cell which serve as targets for HIV 
infection (Li et al., 2009).  
 
Despite the prediction that systemic HIV infection is rapid, key studies with SIV in 
primates have demonstrated that this only occurs few days after initial infection and 
all viral replication is local for the first week of infection (Miller et al., 2005; 
Reynolds et al., 2005). Theses findings collectively suggest that productively HIV 














Figure 1.8 Overview of sexual transmission of HIV to women and events during acute HIV 
infection. After crossing the cervicovaginal mucosal barrier, DCs, CD4+ T cells and macrophages in 
the underlying submucosa are infected. Infection is subsequently propagated and disseminated, thereby 
establishing the lymphatic tissue reservoir that spreads infection to other organs and peripheral tissues. 
Innate and adaptive host defenses (left column) are directed at the different stages to prevent 
transmission and contain infection (taken from Pope and Haase, 2003; adapted from Haynes and 
Shattock, 2008). 
 
1.6.5 Factors associated with protection from HIV infection in the female genital 
 tract 
The female genital tract is equipped with a variety of physical barriers and innate 
defences (reviewed in Coombs et al., 2003; Wira et al., 2005; Shacklett et al., 2008; 

















local flora and a mucous layer. Secretory leukocyte protease inhibitor (SLPI) and 
lactoferrin, a milk protein, are found in a variety of secretions and exhibit anti-HIV 
activity in vitro (Ma et al., 2004; Berkhout et al., 2004). The chemokine RANTES and 
several defensin family members (Levinson et al., 2009) have also found in the 
female reproductive tract (reviewed in Shacklett et al., 2008). HIV-1-specific 
antibodies, particularly those capable of virus neutralization, and cytotoxic T cells 
have been considered in prevention and local limitation of viral infection at mucosal 
sites of HIV-1 or SIV entry (Shacklett et al., 2009; reviewed in Mestecky et al., 2009).  
 
Reduced HIV susceptibility has been associated with a number of genetic 
polymorphisms (reviewed in: Iqbal and Kaul, 2008; Kulkarni et al., 2003). The 
CCR5-Δ32 mutation confers near complete resistance to sexual HIV acquisition 
(Reviewed in Kulkarni, 2003). Natural HIV resistance has also been linked to 
polymorphisms of innate immune molecules, such as an SDF-1 3‟ UTR mutation in a 
group of HEPS individuals, and with human leukocyte antigen (HLA) haplotypes 
including HLA-B18, HLA-A2 ⁄ 6802, HLA-DRB1*01, and HLA-A11 (reviewed in 
Iqbal and Kaul, 2008). 
 
Studies estimating the risk of HIV transmission per unprotected heterosexual sex act 
have suggested that HIV transmission risk can range from 3 to 50 per 10,000 
unprotected exposures (reviewed and Galvin and Cohen, 2004), with a probability of 
transmission per coital act is approximately 0.1–1% (Gray et al, 2001). This means 
that the protective efficacy of the genital mucosal barrier is 99–99.9%, which is much 
higher than that for preventative vaccines available for almost any infection, much 
less for HIV (reviewed in Iqbal and Kaul, 2008). However, various factors such as 
higher viral load and genital ulceration are thought to mainly influence infectivity 
(Gray et al., 2001). Clearly, both the innate and adaptive responses constitute 
“protective” immunity against HIV infection and HIV disease progression (reviewed 
by Shacklett et al., 2009; Mestecky et al., 2009). A summary of factors that might 












Figure 1.9 A summary of factors that might decrease the risk of infection with HIV include: a 
thicker squamous epithelium; a mucous layer that physically traps virus; and physical properties 
leading to HIV inactivation such as low pH and peroxides. These include hydrogen peroxide (H2O2) 
from lactobacilli; innate immune defense molecules, such as defensins, interferons, secretory leukocyte 
protease inhibitor (SLPI); absence of CC-chemokine receptor 5 (CCR5), either genetically [through 
homozygosity for a 32-base-pair deletion in the coding region of CCR5 (known as the CCR5 32 
allele)] or induced (by endogenous chemokine ligands) [Taken from Lederman et al., 2006] 
 
1.7 HIV preferentially targets the mucosal immune system 
 
While the vaginal and rectal mucosa are the predominant sites of HIV entry, recent 
studies demonstrated that the gastrointestinal mucosa is the site of initial viral 
replication (Derdeyn et al., 2005; Mehandru et al., 2005; Mattapallil et al., 2005; 
Brenchley et al., 2006). Studies of sexual transmission of SIV via the female genital 
mucosa in rhesus macaques have confirmed that CD4+ CCR5+ T cells become 
rapidly infected after virus inoculation (Spira et al., 1996). In addition, there is a rapid 
and massive depletion of memory CD4+CCR5+ T cells (>80%) which reside in the 
gastrointestinal, vaginal and respiratory tracts within the first few days of viral entry 











peripheral blood or lymph nodes. This is believed to be due to the fact that large 
populations of activated CD4 T cells expressing the CCR5 receptor reside at this site 
(Li et al., 2005; Guadalupe et al., 2003).  
 
Productive HIV-1 infection of T lymphocytes requires cellular activation because 
activated CD4+ T cells express CCR5 (Veazey et al., 1998; Mattapallil et al., 2005). 
Resting CD4+ T cells infected with SIV or HIV-1 have about five times fewer copies 
of viral RNA than do infected activated CD4+ T cells (Zhang et al., 1999). 
Furthermore, T lymphocytes that traffic to the cervical epithelium of normal healthy 
women were found to exhibit higher activation states compared to blood T cells 
(Prakash et al., 2001).   
 
Human mucosal surfaces are estimated to cover about 400 m2 whereas the surface of 
the skin is only 2.3 m2 (Holmgren et al., 2005). The frequency of HIV-infected CD4+ 
T cells in the chronic phase of SIV/HIV infection is too low (0.001-1% of CD4+ 
cells) to account for the ongoing depletion by viral infection (Mattapallil et al., 2004; 
Douek et al., 2002; Haase et al., 1999; Lassen et al., 2004).  
 
It has been postulated that the extent of early memory CD4+ T-cell depletion in the 
mucosal tissues sets the stage for the course of HIV disease progression (Derdeyn et 
al., 2005). Despite rapid depletion of mucosal T cells during acute infection, studies 
have shown that primates that were able to partially reconstitute mucosal CD4+ T 
cells progress to AIDS at a slower rate than those that were unable to reconstitute 
their CD4+ T cell population (reviewed in Picker and Watkins 2005). The mucosal 
immune system is therefore the reservoir for viral replication in chronic infection; 
persistence and CD4+ T cell loss in the HIV-1 infected individuals (Derdeyn et al., 
2005; Mattapallil et al., 2005; Macal et al 2008). The integrity of the mucosal immune 
system and the ability to maintain CD4+ T cells above a certain threshold in particular 
seems to the determining factor for progression to AIDS (Brenchley et al., 2006). It 
was proposed that this massive depletion of T cells in the gut allows disease-causing 
bacteria that live in the intestines to leak out and circulate more widely in the body, 
further burdening the immune system. This factor contributes to the higher levels of 
immune activation in HIV-infected individuals.  Mucosal HIV replication continues 











are not able to control mucosal replication (Guadalupe et al., 2003; 2006; Brenchley 
et al., 2004; Mehandru et al., 2006; Macal et al., 2008).     
 
1.8 Evidence for the protective role of T cells in    
 cervicovaginal mucosa 
 
While there is clear evidence that CTLs in blood play an important role in controlling 
HIV replication systemically, little is known about CTL responses to HIV in the 
genital tract.   
  
1.8.1 Cervicovaginal CTL responses during acute HIV infection 
Studies of the kinetics of CTL induction in genital tissues have mainly been 
conducted in animal models as these are difficult to address in humans (Miller et al., 
2005; Reynolds et al., 2005). Miller et al. (2005) showed that intravaginal inoculation 
of rhesus macaques with 109 copies of SIV RNA per ml produced systemic infection 
in more than 80 % of the inoculated animals 6-10 days post-inoculation. Inoculations 
were conducted without damaging the mucosal lining. This high viral dose resulted in 
~104 copies of SIV RNA per μg of cervical and vaginal tissue from two animals at 2 
hours and five of six animals 1 day after intravaginal inoculation (Miller et al., 2005). 
In another study, Reynolds et al. (2005) found that viral dissemination peaked in all 
tissues and blood between 10-14 days after infection following vaginal exposure of 
macaques to SIVmac239 and SIVmac251.  Despite the high dose intra-vaginal SIV 
challenge used in these experiments (109 copies of viral RNA), relatively low 
concentrations of SIV RNA were detected in the cervical and vaginal tissues of 
infected macaques, restricted to only a few foci and most of the virus was trapped and 
cleared in cervicovaginal fluids (Miller et al., 2005) [Figure 1.8]. Following infection, 
there was a period of early local mucosal viral replication preceding systemic 
dissemination. These studies suggest that HIV-specific CTL present at the local site of 
infection during initial exposure could control or prevent infection before it spreads 
systemically (Belyakov et al., 2005).  
 
Notably, high frequencies of both mucosal and systemic SIV-specific CTL responses 











that the CTL response to HIV in mucosal tissues after initial infection was “too little 
and too late” to contain viral replication and dissemination (Reynolds et al., 2006). 
 
1.8.2 Cervicovaginal CTL during chronic HIV infection 
HIV-1 specific CTLs in the female genital tract have also been detected in chronically 
HIV-infected women (Gumbi et al., 2008; Musey et al., 1997; 2003; Kaul et al., 2003, 
Shacklett et al., 2003). Although direct control of HIV by these cells has not been 
demonstrated, cervical HIV-specific CTL have been shown to secrete the antiviral 
cytokine gamma interferon (IFN-γ) and display cytolytic function in response to 
various HIV epitopes in chronically HIV-infected individuals (Musey et al., 1997; 
2003; Kaul et al,. 2003; Shacklett et al., 2000a; 2003). 
 
The concept that mucosal cytotoxic T cells are important in controlling viral 
replication within local tissues and eliminating HIV-infected T cells at the sites of 
viral entry was suggested in studies of highly exposed but persistently HIV 
seronegative (HEPS) sexworkers (Kaul et al., 2000). Kaul et al. (2000) reported that 
~69% of HIV-1–resistant sex workers in Nairobi had HIV-specific CD8+ T cells at 
their cervices. The epitope specificity of HIV-specific cytotoxic T cells detected in the 
genital tract of Kenyans HEPS was shown to differ from that of blood CTL and 
maintenance of mucosal CD8 response appeared to be dependent on the persistence of 
HIV exposure (Kaul et al., 2001b). Several HEPS women were shown to 
subsequently seroconvert in the absence of detectable CTL escape and this was most 
strongly correlated with a break from sex work (Kaul et al., 2001b). Break from sex 
work and late sero-conversion was also associated with a loss in HIV-specific CD8+ 
responses in the genital tract and a switch in the epitope specificity of theses CD8+ 
responses (Kaul et al., 2001c; Kaul et al., 2001d).  Kaul et al. (2003) further showed 
that mucosal T cell responses specific for HIV-1 subtype C peptides could be detected 
in 80% of chronically HIV-infected women. Genital CD8+ cell responses to HIV 
were present at similar or higher frequencies than responses detected in blood (Kaul et 
al., 2001d). In addition to cytokine production, various chemokines (including MIP1β 
and RANTES) and antimicrobial peptides are secreted in the reproductive tissues 











secreations of HIV-untreated sex workers compared to low risk women (Iqbal et al., 
2005). 
 
The importance of genital tract CTL in protecting against sexually acquired HIV 
infection is also described in mice (Belyakov et al., 1998a; 1998b; 1998c). Mice 
vaccinated with recombinant vaccinia virus expressing HIV gp160 had detectable 
mucosal HIV-specific CTL and these CTLs were found to be essential for resistance 
to mucosal challenge with this recombinant virus (Belyakov et al., 1998a). Belyakov 
et al. (1998b) suggested that these mucosal HIV-specific CD8+ T cell might play a 
more direct role than systemic CTL responses in immune mediated protection against 
viral challenges in these animals. Studies in primates infected with SHIV-ku2 
demonstrated that intrarectal immunization of rhesus macaques with a peptide vaccine 
adjuvanted with E. coli heat liable toxin mutant LT (R192G) was more effective than 
systemic immunization in reducing the set point plasma viral load subsequent to 
SHIV challenge and this was largely due to reduction of mucosal viral reservoir 
seeding the bloodstream (Belyakov et al., 2001). 
   
In macaques, Murphey-Corb et al. (1999) showed that only animals which developed 
strong SIV env-specific CTLs in the jejuna lamina propria after exposure to SIV intra-
rectally were protected against a mucosal challenge with SIV. Another study showed 
that immunization of macaques with an adjuvanted SIV gp120 and p7 subunit vaccine 
induced SIV-specific CD4+ T cell proliferative responses in the iliac lymph node 
draining rectal and vaginal mucosal surfaces and protected macaques against rectal 
challenge with SIVmac32HJ5 (Lehner et al., 1998).  
 
The role played by CTL in controlling local HIV-1 infection and prevention of viral 
transmission clearly needs to be determined. HIV-specific T cells are capable of 
destroying HIV-infected cells and their presence in the genital tract may serve to 
control local viral replication and thus reduce the likelihood of transmission to sexual 
partners. Vaccine induced cellular responses and innate immunity in the mucosal 
tissues should complement systemic immunity in controlling viral replication, 
reducing the viral reservoir and preventing virus transmission at mucosal entry sites 












1.8.3 Polyfunctional HIV-specific T cell responses in mucosal   
 compartments  
Polyfunctional HIV-1 specific T cells have previously been identified at mucosal sites 
such as in lung (Brenchley et al., 2008) and rectal tissue (Critchfield et al., 2008; 
Ferre et al., 2009). HIV-specific polyfunctional T cell responses were present at 
higher frequencies in the lung compared to blood (Brenchley et al., 2008). Critchfield 
et al. (2008) showed that polyfunctionality in rectal mucosal Gag-specific CD8+ T-
cell responses was associated with the extent of CD4 depletion and inversely related 
to plasma viral load during chronic infection. They found no difference in the 
frequency of rectal and blood polyfunctional responses (defined as triple positive for 
CD107a, IFN-γ and TNF-α). Ferre et al. (2009) reported that the frequency of 
polyfunctional responses in rectal mucosa in HIV controllers was significantly higher 
than non-controllers and that the frequency and complexity of mucosal responses was 
generally elevated at the mucosa of controllers compared to blood. The existence and 
function these cells in the female genital tract compartment have not been determined.  
 
1.9 HIV diversity between compartments 
 
Previous studies have shown that HIV is readily detectable in genital secretions 
(Sullivan et al., 2005; Ellerbrock et al., 2001; Poss et al., 1998). The amount of HIV 
detectable in cervical secretions were found to correlate with viral load in blood 
(Chakraborty et al., 2001; Vettore et al., 2006; Hart et al., 1999) as does the efficacy 
of transmission (Quinn et al., 2000). There has been no reported incidence of HIV 
transmission in individuals with blood viral loads ≤ 1,500 copies per ml (Quinn et al., 
2000). This implies that blood-derived CTL and the impact these have on systemic 
viremia has indirect impact on the amount of virus available at the genital mucosa 
during transmission.   
 
Within chronically HIV-infected individuals, substantial genetic diversity in plasma-
derived HIV exists, with each HIV variant being a closely-related but genetically 
distinct quasispecies (Gupta et al., 2000; Philpott et al., 2005). Comparison of HIV 
phylogenetic relatedness between genital and blood-derived HIV during chronic 











compartments, suggesting that distinct anatomical sites are unique microenvironments 
for HIV diversification (Poss et al., 1998; Ellerbrook et al., 2001; Overbaugh et al., 
1996; Philpott et al., 2005). Recombination between cervical and blood strains of HIV 
were shown to contribute to the rapid evolution of viral sequence in distinct 
compartments (Philpott et al., 2005). Although differences between viral species 
present in each compartment were identified, Poss et al. (1998) suggested that the 
genital and blood compartments are only partially independent of one another and that 
there is a continual process of migration of a restricted population of HIV-infected 
cells to mucosal sites from systemic circulation, followed by localized HIV expansion 
and independent evolution of the new quasispecies. They suggest that the genital 
mucosa is continually challenged with new viral variants which might be better 
adapted to the mucosal sites (Poss et al., 1998). Understanding changes in HIV 
species between these two compartments is crucial for studying the effects of 
systemic or antiviral therapy and the epidemiology of viral transmission (Coombs et 
al., 2001). 
 
Compartmentalisation in HIV genotype and phenotype has also been described in 
brain and tissue lymphocytes (Kober et al., 1994; Wong et al., 1997) during chronic 
but not acute HIV infection (Wong et al., 1997). Zhang et al. (2002) the relatively 
homogenous viral strains present during acute HIV-infection diversifies under 
selective and distinct immune pressure in the different compartments as HIV disease 
progresses. HIV replication may also be affected by local conditions in each 
compartment, including the presence of different immune and other cell types, 
cytokine milieu, and inflammatory signals (Philpott et al., 2005).  
 
Compartmentalisation could also arise as a result of independent migration of HIV-
specific HIV-infected memory T cells homing to tissue compartments in which they 
were initially primed. These mucosal homing T cells make a small and transient 
contribution to the systemically circulating pool of lymphocytes which would reduce 
the likelihood that they would be detected in peripheral blood assessment (Mackay et 
al., 1992; Poss et al., 1998). The mechanism by which HIV species are selectively 
transmitted and subsequently undergo sequestration, and evolution in different tissue 
compartments will be important for understanding early immune responses against 











1.10 CTL diversity between compartments 
 
Because of the presence of detectable compartment-specific diversity in HIV 
genotype, many groups have speculated that HIV-1 specific immune responses at the 
genital mucosa are also likely to differ from those detectable in blood (Musey et al., 
2003). There are, however, conflicting reports about similar HIV-specific T cell 
compartmentalization.  
 
Studies in macaques have shown that, during acute SIV infection, there are significant 
differences between mucosal and peripheral blood HIV-specific CTL frequencies that 
reflect early differences in HIV infection kinetics and spread (Reynolds et al., 2005). 
Reynolds et al. (2005) showed that HIV-specific immune responses following genital 
infection predominate in genital tissue and draining lymph nodes, and are of greater 
magnitude compared to blood responses even after one month of infection (Reynolds 
et al., 2005).   
 
In contrast, while some studies have reported differences in HIV-specificity between 
CTL responses at the cervix and in blood (Shacklett et al., 2000), others have found 
that these compartments are largely overlapping in their HIV specificity (Musey et al., 
2003; Kaul et al., 2000). In the most comprehensive study conducted to date, HIV-
specific CTL responses were found to be overlap in the majority of HIV regions 
investigated (comprehensive HIV genome scan; Ibarrondo et al., 2005). Ibarrondo et 
al. (2005) found that the discordant CTL responses were found only in those that were 
of a low frequency in either compartment (Ibarrondo et al., 2005). They found 
concordant negative or positive results between compartments in 85% of screened 
peptide pools following whole HIV genome scan. A limitation of this data is that 
genomic regions were separated into fairly large peptide pools, which would 
significantly impact on the resolution of the HIV specificities which can be 
differentiated.   
 
While HIV clearly has a systemic phase of infection and CTL responses directed 
against Gag in the blood do correlate with better disease outcome (Kiepiela et al., 
2007), it can be argued that the impact of systemic immunity on transmission and 











in transmission.  It is therefore important to compare responses detected in blood with 
those detected at the genital mucosa.  
 
1.11 Memory T cell subsets in mucosal compartments 
 
The generation and maintenance of early differentiated cells capable of self-renewal 
and survival abilities in HIV infected individuals is essential in the establishment of a 
“protective” immune response (reviwed in Woodland and Kohlmeier et al., 2009; 
Ahmed et al., 2009). The importance of maintaining the GALT CD4+ central memory 
pool has been described during SIV infection (Veazey et al 1998; 2000; 2003; Picker 
et al., 2004) and in HAART-treated HIV-infected individuals (Macal et al., 2008). 
Macal et al. (2008) showed that GALT is predominantly populated with central 
memory phenotypes with a minor proportion of effector memory irrespective of HIV 
status. In addition, CD4+ T-cell restoration following initiation of HAART was 
shown to be associated with the frequency of central memory T cells in GALT. In 
addition, the frequency of CD4+ central memory T cells in GALT were found to be 
associated with better mucosal CD 4 + T -cell restoration (Verhoeven et al., 2008).   
 
More differentiated T cell phenotypes are largely expected at the cervicovaginal area 
due to increased bacterial flora in this compartment compared to peripheral blood 
system (Nkwanyana et al., 2009). A recent study by Nkwanyana et al. (2009), 
reported that ex vivo cytobrush T cells were mostly of the effector memory phenotype 
(Nkwanyana et al., 2009).   
 
1.12 Challenges in conducting mucosal studies 
 
Technical and operational difficulties associated in sampling tissue from mucosal sites 
remains a major obstacle to the broad inclusion of mucosal assessment into studies of 
HIV pathogenesis. The invasiveness of mucosal sampling procedures and the limits 
imposed by low cell yields also makes the comprehensive assessments of mucosal site 
by standard laboratory analysis difficult. The difference in tissue composition at 
distinct mucosal sites (gut versus genital tract) also impacts on assay standardization 











another also makes standardization and assessment difficult, especially in the female 
genital tract where T cell yields are under the influence of hormones (Prakash et al., 
2001).  
 
While cervical mucosal sampling is largely invasive, several sampling methods of the 
cervix and lower gastrointestinal tract have been developed and were found to be well 
tolerated (Anton et al., 2000; Shacklett et al., 2000a; Kaul et al., 2003). With all of 
these methods, viable cell recovery is low and this has resulted in few studies being 
published comparing the breadth, magnitude and specificity of T cell responses in 
mucosal tissues and blood (Shacklett et al., 2000; Kaul et al., 2000; Gumbi et al., 
2008). All of these studies encountered high frequencies of spontaneous IFN-γ 
production measured by ELISpot (Shacklett et al., 2000) and intracellular cytokine 
staining (Gumbi et al., 2008). There is a continuing need to develop and optimise 
protocols for accessing mucosal specimens and for performing the broadest range of 
immunological analysis using the limited samples recoverable. Polyclonal expansion 
of T cells provides a useful tool in combating limitations of T cell availability 
especially at mucosal sites.  
 
1.13 Polyclonal T cell expansion  
 
There have been few published studies focusing on use of polyclonal expansion of 
mucosal T cells to improve mucosal cell yields in order to do more comprehensive 
analysis of HIV-specific responses at mucosal sites (Ibbarondo et al., 2005). Bulk 
expansion of T cells in vitro have been widely and effectively used to increase yields 
of T cells to study the pathogenesis of various diseases such as malaria particularly in 
the context of low cell yields or magnitude responses (Wang et al., 2004; Winstone et 
al., 2009; Goonetilleke et al., 2006; Hanke et al., 2007; Keating et al., 2005; Todryk et 
al., 2009, Shacklet et al., 2003b).  
 
Techniques used to polyclonally expand T cells include: (i) immobilised anti-CD3 
(Yang et al., 1996); (ii) immobilised anti-CD3 with anti-CD28 (Azuma et al., 1992; 
Levine et al., 1996); (iii) anti-CD3 and anti-CD28 covalently linked to super-











et al., 2002) or bi-specific monoclonal antibodies directed at both CD3 and CD4 or 
CD8 (Jones et al., 2003). The latter reagent is, however, not currently commercially 
available. Addition of IL-2, IL-4, IL-7, IL-9 and IL-15 has also been shown to be 
important T cell growth factors during polyclonal expansion (Kanegane et al., 1996; 
Chen et al., 2006; Geginat et al., 2001; Kalamasz et al., 2004). IL-7 has been shown to 
be essential for naive T-cell survival and homeostatic proliferation (Lalvani et al., 
1997; Tan et al., 2001; Schluns et al., 2000). IL-15 has been shown to be essential for 
memory T cell in vivo renewal (Tan et al., 2002).  
 
Polyclonal expansion of biopsied rectal material using a bispecific antibody has been 
used to generate sufficient cells within 2-3 weeks for comprehensive analysis by IFN-
 ELISpot, using pooled overlapping peptides spanning the entire HIV-1 genome 
(Shacklett et al., 2003b). Ibbarondo et al. (2005) reported 75-85% concordance 
between HIV-specific IFN-  responses pre- and post expansion of biopsy-derived 
rectal mucosal T cells. They showed that expansion does not alter phenotype or 
specificity of antigen-specific T cell population as majority of T cell populations 
remained dominant following expansion. There is an urgent need for the development 
of methods that can similarly be applied to cervical cytobrush samples to improve cell 
yields rapidly in order to conduct simultaneous, high-resolution determination of T 
cell responses against various viral genes and multiple viral infections. 
 
Although polyclonal expansion offers the advantage of improving cell yields from 
mucosal samples, this approach also presents challenges due to the increased 
susceptibility of these cells to microbial contamination from mucosal compartments 
such as intestines (Shacklett et al., 2003b) or the genital tract (Kaul et al., 2001). 
Contamination can be eliminated by the use of antibiotics targeted at combating 
mucosal compartment-specific microbes (Shacklett et al., 2003b).  
 
Some authors have identified expansion bias and epitope skewing introduced by 
expansion which may favour outgrowth of certain populations at the expense of others 
as an important challenge imposed by polyclonal expansion (Shacklett et al., 2000; 
Jones et al., 2003; Ibarrondo et al., 2005). The differences in T cell maturational status 











these compartments following expansion, as distinct memory subsets also have 
differing capacities to expand (Sallusto et al., 2004).  
 
Previous studies have shown that distinct memory subsets of T cells differ in their 
ability to clonally expand and become activated following stimulation. Naïve T cells 
have higher activation thresholds and proliferate less vigorously than memory T cells 
(Sallusto et al., 2003). In addition, naive T cells require co-stimulation with anti-
CD28 whereas memory cells do not (Gourley et al., 2004; Tan et al., 2001). A loss of 
naive cell populations (CD45RA+) with expansion of memory cell populations 
(CD45RA-) has been reported following expansion (Roth et al., 1994). 
 
The lack of robust and validated assays that directly measure mucosal immune 
responses is a serious hurdle blocking progress in the field. This makes development 
and optimization of such assays an urgent priority. This thesis explores the use of in 
vitro polyclonal expansion to bulk up cytobrush-derived cervical T cells making it 
possible to asses the breath and specificity of T cells using fewer mucosal cells. It is 
critical to evaluate various techniques available to expand T cells and determine 
which population of T cells is favourable following expansion. This is pivotal in 
assessment of antigen specific responses in compartments such as blood and mucosa 
























1.14 Aims and objectives 
 
Overall aim of this dissertation 
To investigate the feasibility of polyclonal in vitro expansion to improve yields of T 
cells recoverable from cervical cytobrush samples during HIV infection and then to 
compare the frequency, specificity and quality of cervical mucosal T cell responses 
with those detected in blood of chronically HIV-infected women.   
 
Rationale for assessing mucosal immune responses 
There have been few studies investigating the frequency, specificity or function of 
HIV-specific T-cell responses in the female genital tract of HIV-infected women. The 
predominant route of HIV transmission in Sub-Sahara Africa is via the genital mucosa 
(UAIDS, 2008) and >40% of HIV-infected women from this region are shedding HIV 
in their genital secretions (Gumbi et al., 2008; Nkwanyana et al., 2009). The female 
genital tissues release distinct HIV-1 quasispecies that are different from the 
populations present in the blood (Ellerbrook et al., 2001; Overbaugh et al., 1996; 
Philpott et al., 2005). Previous findings indicate that compartmentalization is 
maintained through immune response pressures on viral selection (Gupta et al., 2000). 
Understanding HIV transmission in the female genital tract and the immune pressures 
molding this is vital to creating better treatment and prevention regimens. 
 
Rational for using polyclonal T cell expansion 
An important limitation of all mucosal sampling methods, but cervical cytobrushing 
in particular, is the small number of cells obtainable from mucosal sites which makes 
it difficult to conduct in depth analyses on freshly isolated mucosal cells. Cervical 
cytobrushing is well-tolerated and relatively non-invasive compared to cervical or 
rectal biopsy. It is also more informative at the cellular level than cervical lavage 
since it targets the cervical transformation zone which is rich in T cells and 
macrophages (Passmore et al., 2006). This is also the zone implicated in HIV 
transmission (reviewed in Pope and Haase 2003; Coombs et al., 2003). Cervical 
cytobrushing is, however, constrained by the small number of cell it yields.  Previous 
work from this laboratory has shown that a single cervical cytobrush yields an 











2009), a quantity insufficient to perform comprehensive mapping of HIV-1-specific 
CD8+ T-lymphocyte responses even with cell-sparing assays such as ELISpot 
(Shacklett et al., 2000). Polyclonal in vitro expansion methods have been effectively 
used to overcome the technical barrier of small numbers of cells available from other 
mucosal sites such as the gut (Shacklett et al., 2003b Ibarrondo et al., 2005).  
 
Specific objective 1 
To evaluate HIV-1-specific CTL responses from cytobrush-derived cervical mucosal 
T cells in chronically HIV-infected women following polyclonal in vitro expansion  
with anti-CD3 in the presence of IL-2 (Chapter 2).   
 
Hypothesis 
Polyclonal anti-CD3 expansion is a well-characterized technique in expanding T cells 
derived from blood and it expands most T cell clonotypes (Yang et al., 1996). It was 
hypothesized that polyclonal anti-CD3 expansion would improve yields of T cells 
recoverable from cytobrush and allow comprehensive mapping of the cervical T cell 
responses to HIV Gag peptides. Since Musey et al. (2003) has previously shown that 
>60% of HIV-specific responses in the female genital tract were directed against Gag 
and since the aim of this study was to map individual HIV epitopes in detail, this 
study focused on Gag only. 
 
Specific objective 2 
To optimize and compare polyclonal T cell expansion protocols based on anti-CD3 
and IL-2 to improve the frequency of cervical samples capable of being expanded; 
and increase the yield of cervical T cells obtainable for study (Chapter 3). 
 
Hypothesis 
Since robust expansion of T cells is central to the success of these studies, there is an 
urgent need for the development of expansion methods that can generate the highest 
yield of T cells, within the shortest period of time in order to conduct simultaneous, 
high-resolution studies of T cell responses to HIV. Distinct memory subsets of T cells 
differ in their ability to clonally expand and become activated following stimulation 











representing a more differentiated phenotype than those present in blood, will have 
reduced proliferative capacity and therefore ability to expand. 
 
Specific objective 3 
Using the optimized T cell expansion protocols developed in Chapter 3, the aim of 
this final Chapter was to compare HIV Gag-specific T cell responses at the cervix and 




Evaluation of HIV-specific immune responses at the genital mucosa will provide 
important information for the better understanding of virus–host interaction during 
HIV infection and transmission. Recent studies revealed that polyfunctional T cells 
are capable of producing more of each individual cytokine per cell than a 
monofunctional cell (Precopio et al., 2007; Darrah et al., 2007; Duvall et al., 2008) 
and there is an added value in measuring multiple functions compare to a single 
functional assessment of IFN-γ (Betts et al., 2006; Crithfield et al., 2008). Studies by 
Chritchfield et al. showed that rectal CD8+ responses are robust compared to PBMC 
difference and are related to blood CD4 count and plasma viral load between 
compartments in polyfunctionality. Brenchley et al. (2008) showed that lung had 
more polyfunctional HIV-specific T cells compared to blood. Gumbi et al. (2008) 
showed that the frequency of HIV Gag-specific T cell responses were not associated 
with protection from HIV shedding in chronically HIV-infected women. The 
hypothesis of this last Chapter was that cervical mucosal T cells would exhibit higher 
frequencies of polyfunctional responses to Gag than detected in the blood and this 
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Sexual transmission of HIV accounts for the majority of new infections worldwide 
(UNAIDS, 2008). In women, the mucosal surface of the female genital tract is ultimately 
the site of HIV infection and transmission (Prakash et al., 2001). While there is clear 
evidence that HIV-specific cytotoxic T lymphocytes (CTLs) in blood play an important 
role in controlling HIV replication systemically (Addo et al., 2003; Betts et al., 2001; 
Edwards et al., 2002; Kaufmann et al., 2004; Ramdaduth et al., 2005), there is 
comparatively little known about both CTL responses to HIV in the genital tract, and the 
factors that govern these responses.  HIV-specific mucosal CTLs have been detected in 
men and women during chronic HIV-infection (Musey et al., 2003; Ibarrondo et al., 
2005; Kaul et al., 2000a;2003; Shacklett et al., 2000; Gumbi et al., 2008; Sheth et al., 
2005). The potential importance of such CTLs in protection from HIV is highlighted by 
the fact that they have also been detected in individuals who, despite frequent exposure to 
HIV-1, fail to become productively infected (Kaul et al., 2000a). In chronically HIV-
infected men (Sheth et al., 2005) and women (Gumbi et al., 2008), the detection of HIV-
specific T cells in the genital tract was independent of HIV shedding and viral load in 
genital secretions.      
 
There is an urgent need for reliable, validated and non-invasive methods for investigating 
mucosal immune responses in the female genital tract. Such methods would be 
particularly valuable in HIV vaccine trial settings where intensive mucosal sampling is 
not an option. To date, however, the HIV-specific mucosal CTL literature has been 
dominated by biopsy approaches to isolating lymphocytes from rectal and gastrointestinal 
mucosal tissue (Ibarrondo et al., 2005; Anton et al., 2000; Guadalupe et al., 2003; 
Shacklett et al., 2003a; Critchfield et al., 2007; Musey et al., 1997). Fewer approaches are 
available for sampling mucosal tissue from the female genital tract (cervical lavages and 
cervical cytobrushes). The usefulness of both these methods are, however, constrained by 
the low numbers of ex vivo lymphocytes they yield (Kaul et al., 2000a; Shacklett et al., 











Here we investigate the feasibility of polyclonal in vitro expansion of cervical cytobrush-
derived T cells to investigate HIV-specific responses in the female genital tract. We show 
that cervical T cells sampled from women with chronic HIV-1 infection can be expanded 
and that the magnitude of expansion is significantly associated with initial ex vivo cell 
yield and viability. Following in vitro expansion, we found both the magnitude and 
breadth of HIV-specific T cell responses at the cervix correlate significantly with those 
detected in blood. Cervical responses were, however, generally only detectable in women 











2.2 Materials and Methods 
 
2.2.1 Study population 
Twenty-seven women with chronic HIV infection were enrolled. All women had CD4 
counts >300 cells/μl and were antiretroviral therapy naïve at the time of study. Samples 
were not collected if participants were menstruating. All women gave informed consent 
and the Research Ethics Committee of the University of Cape Town approved all aspects 
of the study.   
 
2.2.2 Collection and processing of cervical and blood specimens 
Cervical samples were collected using a cytobrush as previously described (Gumbi et al., 
2008; Passmore et al., 2006). Briefly, a Digene cervical cytobrush was inserted into the 
cervical os and rotated 360o. The cytobrush was immediately placed in 15 ml tubes 
containing ice cold transport medium or R10 (RPMI1640 medium, supplemented with 10 
% heat-inactivated human AB serum (AB), 5mM L-glutamine, fungizone, 50 U/ml 
penicillin and 50 μg/ml streptomycin). The cervical samples were kept in a Bench-top 
cooler (Nalgene Rochester, NY, USA) at 4oC until transport to the laboratory and were 
processed within 4 h of sampling. Of the 27 samples collected, 5/27 (18.5%) were 
discarded because they were visibly contaminated with blood. Red blood cell 
contamination was measured by macroscopic visual inspection of cells in suspension and 
following centrifugation. A previous study from our group has demonstrated that 
macroscopic assessment of red blood cell contamination has a threshold of sensitivity 
equivalent to ≤0.0005% PBMC contamination per cytobrush sample (Passmore et al., 
2006).   
 
Cervical cells were isolated from the cytobrush by flushing approximately 20 times using 
a sterile plastic disposable pipette to dislodge mucus. The cell suspension was centrifuged 












Whole blood was collected in ACD Vacutainer tubes [Becton Dickinson (BD) 
Biosciences, Plymouth, UK by venipuncture]. Peripheral blood mononuclear cells 
(PBMCs) were isolated from whole blood by density gradient centrifugation using Ficoll-
Histopaque (Sigma-Aldrich, Egham, Runnymede, UK) and LeucoSep® centrifuge tubes 
(Greiner Bio-one; Frickenhausen, Germany). Cells concentrations were adjusted to 1–2 x 
106 cells/ml and incubated overnight at 37 C, 5% CO2 for use in ELISPOT assays.  
Mononuclear cells were counted using Typan Blue staining to assess viability. 
 
2.2.3 Expansion of cervical T cells 
Polyclonal expansion of cervical cells was performed using anti-CD3 (Anti-CD3 
monoclonal antibody; Clone UCHT1; Lot no MAB100; R&D Biosystems; Minneapolis, 
MN, USA) in the presence of recombinant human interleukin-2 (rhIL-2; NIH AIDS 
Research and Reference Reagent Program, Germantown, MD). UCHT1 is a well 
characterised IgG1 mouse mAb that identifies a determinant present on all human T cells 
as and appears to share the same characteristics as OKT3 (Burns et al., 1982). Freshly 
isolated cervical cells were plated (at 4 x 100 µl per well per cytobrush) into 96-well 
round-bottomed plates pre-coated with anti-CD3mAb (10µg/ml). Irradiated autologous 
PBMCs (106cells/ml; 100μl/well; irradiated at 40 Gy) were added to each well as feeders.  
Recombinant human IL-2 was added to each well at a final concentration of 100 IU/ml 
(kindly provided by the NIH AIDS Reagent Program). Cervical cytobrush T cell lines 
were incubated at 37oC, 5 % C02 and cultures supplemented every 2 days with fresh R10 
containing rhIL-2 (100 IU/ml). Wells containing irradiated feeder cells alone in the 
presence and absence of anti-CD3mAb and rIL-2 were included on each plate to control 
for outgrowth of feeders. T cell lines were re-stimulated again after 14 days with anti-
CD3 mAb (10µg/ml) and fresh medium supplemented with rIL-2 (100 IU/ml). 
Throughout culture, all R10 was supplemented with 2 mg/ml fungizone, 50 U/ml 
penicillin and 50 μg/ml streptomycin and cell lines were monitored for bacterial and 
fungal infections, periodically counted and adjusted to 1 x 105 cells/well. 
 
Cervical cytobrush cells and T cell lines were analysed for expression of CD4 and CD8 T 











number of cervical mononuclear cells available on day 0 was limited, only 10% (v/v) of 
the sample was used for determination of CD4:CD8 ratio on day 0. The antibodies used 
were CD3-APC, CD8-FITC and CD4-FITC (BD Biosciences, San Jose, CA, USA). Cells 
were resuspended in 0.5mL of R10 and 50µl-100 µl (depending on cell count) of cell 
suspension was aliquoted for surface staining. Flow cytometric acquisition was 
performed using a four colour FACSCalibur flow cytometer (BD Biosciences, San Jose, 
CA, USA) and analyzed using FlowJo (Tree Star, Inc; Ashland, OR, USA) software. 
 
2.2.4 HIV-1 Gag peptides  
HIV-1 subtype C Du422 Gag overlapping peptides spanning the entire Gag sequence 
were kindly provided by Dr Clive Gray (National Institute for Communicable Diseases, 
Johannesburg, South Africa) and consisted of 66 (15- to 18-mer) peptides overlapping by 
10 amino acids. Lyophilized stocks of each peptide were dissolved in DMSO at a 
concentration of 20 mg/ml and stored at -80 0C.  The 66 Gag peptides were divided into 
five pools each containing 14 peptides (except for pool 5 that had 10 peptides).  
 
2.2.5 IFN-γ ELISPOT 
The production of IFN-γ by HIV Gag-specific T cells was detected by the ELISPOT 
assay.  Briefly, 96-well nitrocellulose plates were pre-coated with IFN-γ monoclonal 
antibody (clone 1-D1K; Mabtech, Stockholm, Sweden). Cervical mononuclear cells were 
washed twice, counted, and plated into wells either with or without HIV-1 subtype C Gag 
peptides (1 ug/ml) or in PHA. Fresh PBMC were plated in triplicate at 1 x 105 cells/well 
while expanded mucosal cells were plated at 0.5 x 105 cells/ml. Plates were incubated 
overnight at 37 0C in a 5 % CO2 humidified incubator. After washing, bound IFN-γ was 
detected by a second biotinylated IFN-γ mAb (clone 7-B6-1; Mabtech), followed by 
streptavidin-bound horseradish peroxidase (HRP) and visualisation was performed using 
a Nova Red substrate kit (Vector Laboratories, CA, USA). Finally, individual cytokine-
producing cells (spots) were counted using a CTL ELISpot reader (Cellular Technology, 
Jessup, Maryland, MD, USA). Totals for plated wells were averaged and normalized to 
numbers of IFN-γ spot-forming cells per 1 x 106 PBMC (SFU/106 PBMCs). Mean values 











stimulated wells to give net SFU/106 cells. Assays with a negative control background 
mean of less than 100 SFU/106 cells were considered valid and a positive response was 
defined as exceeding the mean + 2 standard deviations (Shacklett et al., 2000). 
 
2.2.6 Intracellular cytokine staining of PBMCs following HIV Gag stimulation 
To define which T cell subset was contributing to HIV Gag-specific IFN-  responses 
detected by ELISPOT, IFN-  production by PBMCs was also assessed using intracellular 
cytokine staining. PBMCs (2-3 x 106 cell/ml) were stimulated with HIV Gag peptides (1 
ug/ml), staphylococcal enterotoxin-B (SEB; 10 g/ml; Sigma-Aldrich Eghum, 
Runnymede, UK; positive control) or not stimulated (negative controls) for 6 h at 37oC, 
5% CO2.  Brefeldin A (10 g/ml; Sigma, St. Louis, MO, USA) was added after the first 
hour. Following 6 hours, cells were washed with FACS wash buffer (10 % FCS-PBS 
containing 0.01 % NaN3) and centrifuged at 200g for 5 min. The cells were fixed and 
permeabilised with 2 ml of BD cytofix/cytoperm solution (BD Biosciences-Pharmingen, 
San Diego, CA, USA) for 10 min at room temperature. Cells were then washed once with 
0.1 % w/v Saponin (Fluka;; Biochemica, Mulhouse, France) PBS (containing 5 % FCS 
and 0.01 % NaN3) at 200g for 5 min. Cells were then stained with phenotypic markers 
APC-labelled anti-CD3, PerCP-labelled CD4, and FITC-labelled anti-CD8 (BD 
Biosciences, San Jose, CA, USA). To detect IFN-γ, cells were simultaneously stained 
with PE-labelled anti-IFN-γ (BD Biosciences-Pharmingen, San Diego, CA, USA) for 30 
min on ice. Cells were washed with 2 ml of FACS wash buffer, centrifuged at 200g for 5 
min and fixed with 1 % paraformaldyde in PBS. Stained PBMC were acquired on a 
FACS Calibur flow cytometer (BD Biosciences, San Jose, CA, USA) and data were 
analyzed using either Cellquest (BD Biosciences, San Jose, CA, USA) version 4 or 
FlowJo (Tree Star, Inc) software version 6. To define a cut-off for positive HIV Gag 
responses by either CD8+ or CD4+ T cells, IFN-  responses to Gag peptides were 
initially evaluated in a panel of 10 HIV negative women (Western blood Transfusion 
Service (WBTS), Cape Town, South Africa). CD8+ or CD4+ T cell responses to Gag >3-











2.2.7 Impact of polyclonal expansion on Vβ T cell receptor usage by PBMCs 
The impact of polyclonal expansion on Vβ T cell receptor (TCR) usage by PBMCs was 
evaluated using the IOTest Beta Mark flow cytometry kit according to the manufacture‟s 
protocol (Immunotech, Marseille, France). The kit contains 8 distinct combinations of 
conjugated TCRVβ antibodies corresponding to 24 different specificities (Vβ1, Vβ2, 
Vβ3, Vβ4, Vβ5.1, Vβ5.2, Vβ5.3, Vβ7.1, Vβ7.2, Vβ8, Vβ9, Vβ11, Vβ12, Vβ13.1, 
Vβ13.2, Vβ13.6, Vβ14, Vβ16, Vβ17, Vβ18, Vβ20, Vβ21.3, Vβ22, Vβ23). Briefly, 
unexpanded (day 0) or polyclonally expanded (day 28) PBMCs (2-3 x 106 cells/ml) from 
four individuals (PID 23-26) were each divided into 8 BD FACS tubes. The 8 tubes were 
then stained with a panel of 24 Vβ family-specific antibodies (3 Vβ specificities/tube).  
While antibodies directed against Vβ specificities were restricted to FITC, PE and APC, 
we added anti-CD3 PerCP (Beckton Dickinson) to differentiate T cell subset. All tubes 
were incubated at 4oC for 30 min, then washed twice and fixed by the addition of 500 µl 
of BD Cell fix. Cells were acquired using a FACS Calibur flow cytometer (BD 
Biosciences, San Jose, CA, USA) and analyzed using FlowJo (Tree Star, Inc) software.   
 
2.2.8 Statistical analysis 
Statistical analyses were performed using GraphPad Prism 5 (Graph Pad San Diego 
California, CA, USA). The Mann-Whitney U test was applied for independent sample 
comparison, the Wilcoxon Ranks Test was used for matched non-parametric comparisons 
and Spearman Ranks or Pearson correlation was applied for correlation comparisons. A 
p-value of ≤ 0.05 was considered significant. Where indicated, the false discovery rate 
(FDR) step-down procedure was used to control for false-positive results when 
performing multiple comparisons (Columb and Sagadai, 2006). However, due to the 
rarity of the mucosal samples used throughout this study and because the analyses were 


















Twenty two women with chronic HIV infection were investigated for HIV Gag-specific 
cervical cytobrush-derived T cell responses following in vitro expansion (Table 2.1). All 
the study subjects were under the age of 40 years (median age of 31 years, range 22-39), 
had a median blood CD4 count of 451 (range 300-1,300) cells/μl and plasma viral load of 
10,097 (range 970-1,300,000). Five of the 22 (22.7%) women had visible vaginal 























Day 0 cervical  
cell counts 
Day 14 cervical  
cell counts 
Day 28 cervical  
cell counts 




1 33 1396 <50a Vaginal discharge 20,000 100,000 1,600,000 80  
2 26 414 9,500 Nil 10,000 100,000 680,000 68  
3 23 341 14,500 Nil 10,000 310,000 480,000 48  
4 30 428 <50a Nil 14,278 Contaminated Contaminated -  
5 28 698 1,800 Vaginal discharge 18,520 Contaminated Contaminated -  
6 28 341 100,573 Nil 40,000 130,000 560,000 14  
7 36 572 51,325 Nil 68,640 125,600 1,650,000 24  
8 26 607 4,013 Nil 75,800 114,000 Contaminated -  
9 31 482 27,250 Nil 80,000 140,000 990,890 12.4  
10 30 545 15,800 Nil 90,000 440,000 1780,000 19.8  
11 32 400 1300,000 Cervix inflamed 90,860 Contaminated Contaminated -  
12 31 393 41700 Nil 100,000 610,000 850,000 8.5  
13 22 301 2,200 Nil 100,000 270,000 1,750,000 17.5  
14 32 461 7,100 Nil 110,000 490,000 1,040,000 9.5  
15 31 788 1926 Nil 120,000 790,000 1,200,000 10  
16 33 451 30,000 Nil 120,000 260,000 1,900,000 15.8  
17 24 ND 3,649 Nil 135,721 617,600 1,460,000 10.8  
18 39 422 5,450 Nil 138,040 652,000 Contaminated -  
19 39 338 <50a Nil 180,000 240,000 1,200,000 6.7  
20 43 467 88000 Yeast 218,064 Contaminated Contaminated -  
21 37 300 10,097 Vaginal discharge 220,000 740,000 2,120,000 9.6  
22 38 482 970 Nil 240,000 530,000 2,850,000 11.9  
Median 31 451 10,097 5/22 (22.7%) 100,000 290,000 1,330,000 13.2  











2.3.1 Expansion of cervical cytobrush-derived T cells from women with chronic HIV-
 infection 
A median of 0.1 x 106 cells (range 0.01-0.2 x 106 cells) was obtained per cytobrush ex 
vivo (Table 2.1). The association between ex vivo cervical cell yields and both age and 
clinical HIV disease status (CD4 counts and viral load) were initially investigated. A 
significant positive association was observed between the age of women in the study and 
the yield of cervical cells obtained (p=0.0008; Pearson R=0.66) indicating that older age 
was associated with increased yield of cervical cells. There was no association between 
markers of disease status (CD4 count and viral load) and cervical yield (data not shown).  
However, all women included in this study were recruited during the chronic phase of 
infection with CD4 counts >300 cell/ l (CD4 counts ranging from 300-1300 cells/ l; 
Table 2.1). Age and clinical status was not associated with viability of cervical cytobrush 
cells in this study (data not shown). All women in the study were not menstruating at the 
time of cytobrush collection although we did not control for menstrual cycle stage. A 
recent study from our group has shown that ex vivo cervical cytobrush mononuclear cell 
yield are significantly associated with genital tract inflammation (Nkwanyana et al., 
2009). While inflammatory cytokine concentrations in genital secretions were not 
measured in this study, genital inflammatory mediators are likely to have a substantial 
impact on ex vivo cervical mononuclear cell yield.  
 
Cervical T cells were polyclonally expanded for either 28 days (18/22) or 42 days (4/22) 
to increase the yield of cells from the cervix for the identification of peptide responses to 
Gag by the IFN-  ELISPOT assay. Of the 22 cervical T cell lines initiated, 16/22 (72.7%) 
expanded. A median of 1.3 x 106 cells (range 0.5-2.9 x 106 cells) was obtained at day 28, 
which represented a 13-fold increase in T cell yield compared to ex vivo cell yields (Table 
2.1 and Figure 2.1A). Six of 22 lines (27.3%) were lost to contamination during the first 
few days of culture. Of these, 3/6 contaminated samples were collected from women with 
visible cervical discharge.  
 
While CD8 T cells were found to be the dominant T cell subset detected ex vivo 











we obtained a CD4:8 ratio of 1 (Figure 2.1B; p=0.006, Wilcoxon Rank Test).  Of the 
cervical lymphocytes isolated ex vivo, 90.9 % (± 7.5; mean±SD) were viable (range 70-
100 %). A significant positive correlation was found between the absolute number of 
cells obtained following expansion and both the number of cervical cells isolated ex vivo 
(p=0.01; R=0.62) and the ex vivo viability of cells (p=0.0002; R=0.71). Conversely, a 
significant negative correlation was found between fold expansion by 28 days and ex vivo 
cell number (p=0.004; R=-0.68), indicating that ex vivo cervical cells with the lowest 












Figure 2.1. Impact of ex vivo yield on expansion of cervical cytobrush-derived cervical mononuclear 
cells (CMC). (A) Comparison between day 0 and day 28 CMC yields in donors whose cervical CD3 cells 
expanded. (B) Comparison of CD4:CD8 ratio ex vivo (day 0) and day 28 in expanders.  CMC were cultured 
in vitro with anti-CD3 monoclonal antibody in the presence of rhIL-2. CMC counts and viability were 
performed by Trypan blue counting. CD4:CD8 ratios on cervical cell lines were analysed before and after 
polyclonal expansion using CD3-APC, CD8-FITC and CD4-FITC staining (Becton-Dickinson, San Jose, 
CA, USA) on a FACSCaliber flow cytometer and analysis was performed using FlowJo (Tree Star, Inc) 
software.  Wilcoxon Rank Test was applied to compare yield and CD4:CD8 ratios at day 0 and day 28.  P-



























































































2.3.2 Gag-specific responses by cervical T cells 
HIV-1 Gag-specific responses were mapped by IFN-  ELISPOT for 16 of 22 cervical T-
cell lines (72.7 %) from chronically HIV-infected women. These were compared with 
similarly identified responses identified in PBMC ex vivo of these women (Figure 2.2). 
Nine of the 16 (56.2 %) cervical lines from the chronically HIV-infected women showed 
clear evidence of HIV-specific T cell responses to Gag with a cumulative frequency of 
IFN-  producing cells ranging from 350-13553 SFU/106 cells. There was no correlation 
between cervical ex vivo yield, viability, expansion (day 28) yield, or plasma viral load 
and the magnitudes of HIV Gag-specific cervical T cell responses (data not shown).  
Eight of the nine cervical lines that exhibited Gag-specificity were derived from women 
with clearly detectable Gag-specific blood responses (>600 SFU/106 cells; Figure 2.2). 
There was only one participant (PID 1) who had a detectable cervical response to Gag but 































































































































































































































































































Figure 2.2.  Comparison of cervical and blood HIV Gag-specific IFN-γ responses in women with 
chronic HIV-infection. Blood (top panel) and cervical (bottom panel) IFN-γ responses to HIV-1 subtype C 
Gag peptide pools 1-5. Net spot forming units (SFU)/106 were calculated by subtracting background IFN-  
frequency from Gag peptide pool specific IFN-  frequencies in 16 women with chronic HIV-infection.  
Each stacked bar represents the cumulative IFN-  frequency for all five Gag peptide pools and the subjects 
have been ordered from highest to lowest blood T cell magnitude to Gag.  The contribution of CD4+ and 
CD8+ T cell subsets to overall IFN-  responses to HIV Gag peptides was determined by intracellular 
cytokine staining and FACS.  The T cell subset contributing to Gag-specific responses per donor is shown 
above each stacked bar for blood responses. The CD8 indicates CD8 only response, CD4 indicates CD4 
responses only while CD8/CD4 indicates that responses in both subsets were detected by flow cytometry. A 
* indicates that responses were not evaluated in either the blood or cervical compartment of these 












From the 16 women for which HIV Gag ELISpot mapping was performed (Figure 2.2), 
there was a significant correlation between the cervix and blood in both the total 
magnitude of IFN-  responses to Gag (Table 2.2 and Figure 2.3A; rho=0.7, p=0.002; 
Spearman Ranks test) and the individual Gag pool magnitudes of IFN-  responses per 
individual (Table 2.2 and Figure 2.3B; rho=0.51, p<0.0001; Spearman Ranks test).  
Despite good maintenance of specific Gag pool targeting between cervical and blood, 4/9 
(44.4 %) of women with detectable HIV-specific responses at the cervix had unique pool 
specificities that were not detected in blood (PID 1, 2, 17, and 19; Figure 2.2 and Table 
2.2).   
 
Table 2.2.  Comparison between breadth of response at cervix and in blood 
Patient ID Cumulative magnitude (SFU/106) Gag pools 
shared  
Gag pools differently targeted 




































































































0 – 8,040 
420 
0 – 13,553 



























Figure 2.3. Correlation between HIV Gag-specific IFN-γ response magnitudes detected at the cervix 
and in blood of HIV infected subjects. (A) Correlation between cumulative net IFN-  responses to Gag 
pools (sum of 5 pools) per chronically HIV-infected individual in each compartment (n=16 women for 
whom matched ELISPOT was conducted on cervical lines and PBMCs). (B) Correlation between 
individual Gag pools (1-5) at the cervix and in blood in HIV-infected women.  Each data point represents 
an individual‟s IFN-  response at the cervix and in blood. Spearman Rank Test was applied to test 
correlations and p-values <0.05 were considered significant.  Spearman R-value is shown on each plot. 
 
Individual peptide mapping was done on cervical lines derived from 4/9 women with 
detectable Gag pool responses who had sufficient cervical cell numbers to allow finer 
mapping (PID 2, 7, 15 and 19; Table 2.3). All 4 women had cervical T cell responses that 
preferentially targeted peptides in p24 and 3/4 women targeted the same peptide within 
p24 containing the HLA class I TL9 epitope (178GATPQDLNTMLNTVGGH194).  
Although the HLA genotypes for the participants in this study are not known, the 
peptides recognized by these 4 women had a number of previously characterized HLA 
class I and fewer HLA class II epitopes embedded within them (Table 2.3;predicted by 
the Los Alamos Database: 
http://www.hiv.lanl.gov/content/sequence/ELF/epitope_analyzer.html).         









































































































































Table 2.3. Epitope prediction from confirmed peptide specificities on cervical samples 



























































































B63, B57, B58 
B*35  
 
B*3910, B*4201, B*8101, B*0702, Cw*0802 
 


















15 p24 3,210 25 178GATPQDLNTMLNTVGGH194 B*3910, B*4201, B*8101, B*0702, Cw*0802 178GATPQDLNTMLNTVGGH194  




















Although the low cervical cell numbers generated in this study were insufficient to evaluate 
whether the cervical Gag-specific responses detected (Figure 2.2) were specific to the CD8+ or 
CD4+ T cell subsets, T cell subset-specific IFN-  responses to Gag were evaluated in matched 
blood samples from 11/16 women by intracellular cytokine staining. The criteria we used for 
scoring Gag-specific CD8+ and CD4+ T cell responses as positive or negative (3-fold 
background cut-off) was based on analysis of PBMC from 10 HIV negative women. In HIV-
infected women, the Gag-specific IFN-γ response frequency by CD8+ T cells ranged from 
undetectable (0% above background) to 8% above background. A similar analysis in uninfected 
women showed that Gag-specific IFN-γ responses ranged from undetectable to 1 % above 
background. The background levels in the CD4+ T cell compartment were lower compared to 
the CD8+ T cells, ranging from undetectable levels to 5% in HIV-infected women and ranging 
undetectable to 0.1% above background in HIV negative women. The majority of these women 
had only CD8+ T cell responses to Gag (7/11; PID 2, 6, 9, 12, 15, 19, 21), 3/11 women had 
Gag-specific responses in both CD4+ and CD8+ subsets (PID 7, 10, 22) and 1/11 women had 
only a CD4+ response (PID 16). Of these 11 women, 7 had detectable cervical responses to 
Gag. Five of these 7 women had exclusively CD8+ T cell responses to Gag in blood while 2/7 
had both CD4+ and CD8+ T cell responses. The T cell subset contributing to Gag-specific 
responses per donor is shown above each stacked bar for blood responses (Figure 2.2). 
 
While it was not possible to confirm which T cell subset was contributing to the cervical T cell 
responses detected in this study (Figure 2.2), the fact that the individual peptides mapped in 4 
individuals (Table 2.3) contained both HLA class I and II epitopes and that flow cytometry on 
matched blood samples showed both CD8+ and CD4+ responses systemically to Gag implies 
that both T cell subsets may be involved. The dominance of CD8+ responses in blood together 
with the number of HLA class I predicted epitopes suggests, however, that CD8+ T cells are 
likely to be the dominant T cell subset involved in the female genital tract as well. 
 
2.3.3 Impact of expansion on HIV-specificity and T cell Vβ repertoire in blood  
To evaluate the impact polyclonal expansion with anti-CD3mAb on skewing of Gag regions 











characterized ex vivo Gag-specific responses were examined before and following expansion 
by IFN-  ELISpot (Figure 2.4). The dominant ex vivo Gag regions targeted were maintained 
following in vitro expansion in all individuals. Compared to  ex vivo responses (day 0), there 
was an overall increase in the cumulative frequency of IFN-  producing cells following in vitro 
expansion, ranging from 2 to 11-fold. The frequency of Gag pool responses at day 0 were, 
however, significantly correlated with those following expansion for 28 days (Figure 2.4B; 
R=0.81; p<0.0001; Spearman Ranks Test) indicating that the specificity profile was largely 
maintained following expansion. In a single donor (PID 26), however, a unique specificity to 
pool 5 (485 SFU/million cells) was observed after expansion that was not detectable ex vivo.  
This highlights the possibility that specificities of low frequency that are not apparent ex vivo 
may become detectable following expansion due to the observed overall increase in cumulative 
frequency. It is also important to note that only 1/4 unique Gag specificities that we observed in 
cervical samples (PID 1) had a magnitude of <500 SFU/106 cells while unique cervical 
specificities from the other 3/4 donors (PID 2, 17, 19) had magnitudes of >1,500 SFU/106 cells. 
This implies that the unique cervical specificities we recorded for at least 3/4 cervical donors 
represent “real” unique responses and are not the result of expansion of previously low 
frequency events.  It should be noted, however, that an extrapolation of blood expansion 






































































































































Net SFU/106 PBMC (Day 0)
PID 23            PID 24          PID 25          PID 26
 
Figure 2.4.  Correlation between ex vivo and expanded HIV Gag-specific IFN-γ ELISpot responses in blood 
from chronically HIV-infected subjects. (A) PBMC from four HIV-infected women were assessed for HIV-
specific IFN-γ production ex vivo (top panel) and following in vitro expansion with anti-CD3 monoclonal antibody 
for 28 days (bottom panel). (B) Correlation between IFN-γ responses detected in PBMC ex vivo and after 28 days 
expansion.  HIV-1 subtype C Gag overlapping peptides were divided into 5 pools and responses in these donors to 
each Gag pool were assessed. Net IFN-γ response to Gag was calculated by subtracting background IFN-γ 
production in each individual from Gag-specific responses. Each dot (B) represents an individual donor‟s matched 
IFN-γ response to each of the 5 Gag pools in blood ex vivo and following expansion (day 28). Spearman Rank 











Changes in the T cell receptor (TCR) Vβ repertoire were next evaluated following 28 day 
expansion of PBMC with anti-CD3 and rhIL-2 in these 4 individuals (Table 2.4). The profile of 
TCR Vβ frequencies on day 0 in 3/4 the study subjects correlated significantly with profiles 
following in vitro polyclonal expansion (Patient 26: R=0.97, p<0.0001; Patient 24: R=0.69, 
p=0.0002, Patient : R=0.84, p<0.0001). In contrast, TCR Vβ frequencies for Patient 23 
following expansion did not correlate and this was likely due to expansion of certain Vβ types.  
In this individual, Vβ4 expanded 9.9-fold, Vβ7.2 expanded 4.6-fold while Vβ13.1 contracted 
7.6-fold over 28 days. Unlike in blood, experiments showing fluctuations in cervical TCRVβ 
specificities during the course of expansion could not be conducted because of limitations in  











Table 2.4.  T cell receptor Vβ usage ex vivo and following 28 days of in vitro expansion with anti-CD3 and rhIL-2 
TCR Usage 
























Vβ1 4.27 2.2 0.52  5.84 5.61 0.96  3.65 5.94 1.63  6.93 6.56 0.95 
Vβ2 3.02 0.78 0.26  6.69 5.55 0.83  3.56 6.59 1.85  3.38 5.21 1.54 
Vβ3 5.52 6.34 1.15  4.17 5.14 1.23  1.64 2.27 1.38  4.48 5.73 1.28 
Vβ4 0.64 6.24 9.75a  1.51 3.41 2.26  1.26 1.72 1.37  0.85 0.66 0.78 
Vβ5.1 3.22 3.52 1.09  3.85 4.26 1.11  3.12 6.19 1.98  4.5 5.71 1.27 
Vβ5.2 1.44 1.43 0.99  0.79 0.91 1.15  1.3 1.59 1.22  1.8 1.56 0.87 
Vβ5.3 2.19 0.96 0.44  1.45 1.44 0.99  1.43 1.32 0.92  0.92 1.09 1.18 
Vβ7.1 3.42 3.23 0.94  2.23 2.41 1.08  2.17 3.93 1.81  1.73 2.56 1.48 
Vβ7.2 0.97 4.47 4.61  1.36 1 0.74  0.66 1.56 2.36  0.34 0.85 2.50 
Vβ8 3.86 4.54 1.18  3.96 4.43 1.12  4.24 4.67 1.10  4.6 4.99 1.08 
Vβ9 3.4 1.69 0.50  2.18 2.58 1.18  3.56 2.37 0.67  5.09 2.52 0.50 
Vβ11 0.95 1.54 1.62  1.06 1.33 1.25  1.07 1.32 1.23  0.4 1.22 3.05 
Vβ12 2.17 0.82 0.38  1.47 1.4 0.95  2.17 3.02 1.39  1.53 3.57 2.33 
Vβ13.1 6.15 0.81 0.13  2.96 3.69 1.25  3.2 4.82 1.51  4.27 4.98 1.17 
Vβ13.2 1.3 1.41 1.08  2.62 2.61 1.00  1.24 1.59 1.28  0.97 1.66 1.71 
Vβ13.6 1.97 3.03 1.54  2.31 2.43 1.05  1.74 3.19 1.83  0.89 2.3 2.58 
Vβ14 2.72 2.73 1.00  10.55 11.1 1.05  6.27 4.24 0.68  3.15 3.52 1.12 
Vβ16 2.36 2.39 1.01  0.93 0.95 1.02  1.59 3.18 2.00  1.27 2.4 1.89 
Vβ17 2.54 4.06 1.60  3.57 3.8 1.06  2.47 6.23 2.52  5.96 4.39 0.74 
Vβ18 0.64 0.55 0.86  0.36 0.46 1.28  0.56 0.62 1.11  0.81 0.96 1.19 
Vβ20 3.03 3.37 1.11  2 2.41 1.21  2.61 3.48 1.33  2.38 3.19 1.34 
Vβ21.3 5.42 5.48 1.01  0.55 0.87 1.58  2.64 4.42 1.67  1.99 4.17 2.10 
Vβ22 2.55 5.16 2.02  3.87 3.94 1.02  2.43 4.68 1.93  3.54 3.94 1.11 
Vβ23 2 4.59 2.30  0.64 0.56 0.88  0.82 1.18 1.44  0.94 1.25 1.33 
Mean 
Pearson R-value 
Pearson p-value     
1.55 
0.1820b 
0.3946       
1.14 
0.9736 
<0.0001       
1.51 
0.6896 




aChanges in any Vβ subset from day 28 to day 0 that were >2 are denoted in bold.  bThe correlation between Vb TCR usage at day 0 and day 28 were tested using 
a Pearson test and R- and p-values shown. A total of 200, 000 events were acquired on a FACS Calibur (BD Biosciences; San Jose, CA,  USA).  The false 













Immunological events at the cervix are likely to influence susceptibility to heterosexually-
transmitted HIV infection. There is an urgent need for the development of validated, non-
invasive methodologies for investigating HIV-specific mucosal immune responses associated 
with HIV pathogenesis and for vaccine assessment specifically in the female genital tract (Kaul 
et al., 2000; Shacklett et al., 2003a). Although cervical cytobrushing is relatively non-invasive, 
low cervical cell yields associated with this approach have significantly impacted on thorough 
evaluation of HIV-specific T cell responses (Kaul et al., 2000a; Gumbi et al., 2008; Shacklett et 
al., 2003a). Although in vitro expansion of cervical cytobrush-derived T cells would 
circumvent the problem of low yield, there have been few studies investigating the ability of 
cervical cytobrush-derived T cells to expand in vitro either polyclonally or in response to HIV-
1 antigens.  This study shows that cervical T cells can be isolated by cytobrushing and 
polyclonally expanded in the majority of women studied.  Further, this study shows that HIV 
Gag-specific cervical T cell responses can be detected in HIV-infected women and correlate 
with responses detected in blood.   
 
With one exception, cervical responses to Gag were detected only in HIV-infected women with 
blood Gag-specific responses >1000 SFU/106. Although a 13-fold expansion of cervical cell 
numbers was achieved, the inability to resolve genital tract responses to Gag in individuals with 
less than 1000 SFU/106 cells in blood suggests that the approach described here may not be 
sensitive enough for the evaluation of vaccine efficacy. The reason for this is that vaccine 
induced T-cell responses to Gag are expected to be substantially lower than those found in HIV 
infected individuals. While the bottleneck imposed by non-invasive cytobrush sampling  
impinges on the sensitivity achievable in cellular assays  such as those described in this study, 
it is likely that a combination of even moderately improved sampling and cellular expansion 
methodologies could substantially lower the threshold above which HIV specific cellular 
responses could be detected. 
 
Cervical cytobrush-derived T cells were polyclonally expanded in vitro from 73% of samples 











anti-CD3 over 28 days. Ibarrondo et al. (2005) similarly expanded rectal biopsy-derived 
mucosal T cells from 12 HIV-infected individuals and reported a 4- to 10-fold expansion of 
CD8+ T cells over 14 days with bi-specific CD4/3 antibodies. Whereas their method selectively 
expanded CD8+ T cells, anti-CD3 expansion used in the present study expanded both CD4 and 
CD8 T cells with an overall 2-fold enrichment of CD4+ cells following expansion. This might 
be attributed to the fact that the expansion protocol used in this study was polyclonal with no 
specific T cell subset being targeted. Although the overall relative expansion described here 
was higher than previous studies (Ibarrondo et al., 2005), rectal biopsy mucosal sampling 
yielded 16- to 39-fold more cells than were obtained in our study from a single cytobrush. 
Although this study has focused on a single expansion protocol with anti-CD3mAb and rIL-2, 
it will be important in future studies to compare cervical T cell expansion kinetics using 
different expansion protocols, such as bi-specific antibodies (Jones et al., 2003), anti-CD3/28-
coated beads (T cell expander; Dynabeads; Invitrogen, Osla, Norway); and addition of 
alternative or complementary cytokines such as IL-7 and IL-15 (Chen et al., 2006; Kalamasz et 
al., 2004).  
 
In this study, 27% of cytobrush-derived cervical cultures that were initiated became 
contaminated within the first 24 hours of culture. Of these cytobrush samples, half were from 
women with macroscopic evidence of vaginal discharge, cervical inflammation or yeast 
infection indicating that concomitant cervical infections impact on the sterility of the sample 
for culture. Although the culture medium for transport of these samples to the laboratory and 
for processing contains penicillin, streptomycin and amphotericin B, these contaminations 
could possibly be minimized by including higher concentrations of amphotericin B and 
antibacterial agents specific for genital tract bacterial infections.  
 
From expanded cervical T cell lines, it was found that HIV Gag-specific cervical T cell 
responses were detectable in ~50% of women with chronic HIV-infection. From matched blood 
samples, 88% of these women had systemic responses to Gag. The magnitude of these mucosal 
responses correlate significantly with the magnitude of Gag-specific responses measured in 
blood and were largely restricted to women with >1,000 Gag-responsive cells/106. Similarly, 











cervix ex vivo during chronic infection with 8/10 women studied having matching responses at 
the cervix as they had in blood. Since Kaul et al. (2003) selected participants based on high 
response frequencies to Gag in blood; it is possible that this may have impacted on the strong 
compartmental overlap they described. In comparison, Shacklett et al. (2000) reported only 3/8 
chronically HIV-infected women with detectable HIV-specific responses in blood had a 
corresponding response at the cervix. Shacklett et al. (2000) also focused their study on women 
with well characterized high frequency responses in blood.  In contrast to these studies, Kaul et 
al. (2000) found in both HIV-infected and apparently HIV-resistant uninfected sex workers that 
ex vivo HIV-specific responses at the cervix were as prevalent as they were in blood, that 
responses in the two compartments largely correlated and that 95% of women with detectable 
HIV-specific cervical T-cells responses (40/42) had corresponding blood responses of less than 
1000 SFU/million cells.   
 
Recently, Gumbi et al. (2008) reported that ex vivo frequencies of HIV Gag-specific CD8 
responses in blood and at the cervix did not correlate. Unlike Kaul et al. (2003) and Shacklett et 
al. (2000), study (Gumbi et al., 2008) did not select women with high magnitude responses in 
blood and this may have impacted on the lack of concordance observed between compartments 
ex vivo.  Gumbi et al. (2008) also focused on ex vivo functional assessment rather than in vitro 
expansion used in the present study. Ex vivo cytobrush-derived T cell effector cell distribution 
is likely to differ substantially from phenotypes present after in vitro expansion, with the 
former being dominated by effector cells and the latter being dominated by expanded memory 
cells (Keating et al., 2005). Although the maturational status of ex vivo or expanded cervical T 
cells was not compared, this may play a role in the success of in vitro expansion. Naïve and 
memory CD8+ T cell subsets in humans have significantly different capacities to proliferate 
and differentiate in response to T cell receptor stimulation or cytokines (Geginat et al., 2003a, 
2003b).  There are a number of issues that may also impact on the extent of in vitro expansion 
of cytobrush-derived T cells including the stage of the menstrual cycle that cytobrushes were 
collected, concomitant sexually transmitted infections, and vaginal hygiene practises (Cohn et 












While in vitro polyclonal expansion of T cells is a useful approach to increase the number of 
cells available from inaccessible mucosal sites, antigen bias and epitope skewing introduced by 
polyclonal expansion (potentially favouring the outgrowth of certain populations at the expense 
of others) cannot be entirely excluded. This study shows here that both CD4+ and CD8+ 
cervical T cells were expanded and that similarly expanding PBMC did not significantly alter 
HIV Gag targeting nor Vβ T cell receptor repertoire in most individuals. Since some 
fluctuations were noted in TCR usage and the range of HIV Gag pools targeted in a minority of 
women, this suggest that some bias may be introduced by expansion in a subset of individuals.   
 
It is critical to determine what constitutes a positive response in T cell response assays.  
Various way of calculating positive cells have been previously developed and these include 
using two standard deviations above background responses as a cut-off as well as using a two 
to three-fold above background cut off (Trigona et al., 2003), using a 90th percentile cut-off 
based on background responses (Duvall et al., 2008). Others have resorted to using a ten event 
cut-off for polyfunctional T cells (Betts et al., 2006), or using a threshold value (Shacklett et 
al., 2003). Like in this present study, cut-off values may also be determined by evaluating 
cytokine responses in HIV-uninfected PBMC samples (Gumbi et al., 2008). Here, given the 
level of background and variability in specific response frequencies, we decided that an 
appropriate cut-off for positive HIV Gag responses was 3- fold above background which is 
much more stringent than previous studies. Kaul et al. (2003) used an arbitrary cut-off of 2-fold 
above background for IFN-γ ICS of cervical cytobrush samples. Kaul et al (2003) used an 
arbitrary cut-off of 100 SFU/106 cells for IFN- ELISPOT preformed on cervical cytobrush 
samples. Similarly, Shacklett et al. (2000) also used the same arbitrary cut-off of 100 SFU/106 
cells. In comparison, we use a relatively stringent cut-off of 3-fold above background for 
considering a response positive. 
 
In summary, this study evaluates the feasibility and efficacy of polyclonal in vitro expansion of 
cervical cytobrush-derived T cells from women with HIV infection. The low cell yields that 
can be recovered non-invasively from the female genital tract necessitates focused efforts to 
optimize effective expansion methodologies. Since we do not fully understand what would 











play an important role in preventing HIV acquisition, the incorporation of mucosal sampling at 
the female genital tract and understanding HIV-specific events at this site should be a high 
priority during HIV vaccine trials. The finding that cervical cytobrushing and anti-CD3-
mediated polyclonal expansion only enable detection of Gag-specific T cell responses in the 
genital tracts of women with correspondingly high systemic Gag-specific responses sets a 
benchmark against which to measure future efforts in this field and highlights the need for 
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Understanding the role of immunity in the female genital tract in the control of HIV 
transmission is central to our efforts to prevent new infections. Several approaches 
have been used to isolate mononuclear cells from the genital tract, including cervical 
biopsy (TOMBOLA Group, 2009) cervicovaginal lavage (CVL) and cytobrushing 
(Coombs et al., 2001). While cervical biopsies yield the most cells, this approach is 
invasive and can compromises the integrity of the cervical surface, inducing slow 
healing ulcerations (TOMBOLA Group, 2009) which might enhance local HIV-1 
replication in HIV-infected women (Lawn et al., 2000) or increase  susceptibility to 
infection in uninfected women. Cervical cytobrushing and CVL have a significant 
advantage of being non-invasive but both are constrained by the low numbers of ex 
vivo lymphocytes they yield (Gumbi et al., 2008; Shacklett et al., 2000; Kaul et al., 
2000a). Short-term polyclonal expansion of T cells derived from the cervical 
compartment would offer a useful approach to overcome the limitation of low cell 
yields (Iqbal et al., 2005).  
 
Several methods to expand T cells have been used, including immobilised anti-CD3 
(Yang et al., 1996), immobilised anti-CD3 with anti-CD28 (Azuma et al., 1992; 
Levine et al., 1996) or bi-specific monoclonal antibodies directed at both CD3 and 
CD4 or CD8 (Jones et al., 2003). Bi-specific antibodies are, however, not currently 
commercially available. Recently, anti-CD3 and anti-CD28 monoclonal antibodies 
covalently linked to super-paramagnetic beads have been applied to expand cells 
(Dynabeads) (Hippen et al., 2008; Onlamoon et al., 2006; Trickett et al., 2002).   
 
Distinct maturational phenotypes or „memory subsets‟ of T cells differ in their ability 
to clonally expand and become activated following stimulation. Compared to naïve T 
cells, memory T cells show lower activation thresholds and proliferate more 
vigorously (Sallusto et al., 2004). Further, the expansion potential of memory subsets 
differs between distinct memory classes, with central memory T cells exhibiting the 
highest proliferative capacity, followed by effector memory and then terminally 













the female genital tract are predominantly effector memory in phenotype (Nkwanyana 
et al., 2009), which is likely to impact on the ability of these cells to expand in vitro.   
While stimulation of T cells via the CD3-T cell receptor (TCR) plays a critical role in 
determining the fate of T cells (Sallusto et al., 2004), the presence of appropriate 
homeostatic cytokines is likely to play a major role in driving T cell proliferation, 
differentiation and survival, both in vivo (Rochman et al., 2009; Zhang et al., 1998; 
Sallusto et al., 2004) and in vitro (Onlamoon et al., 2006). Interleukin (IL)-2 is the 
predominant growth factor used to support proliferation of T cells during in vitro 
expansion, with the use of concentrations ranging from 20 IU/ml (Smith et al., 1995) 
to 1800 IU/ml described (Winstone et al., 2009). In addition, IL-7 plays an important 
role in the maintenance and antigen-independent proliferative ability of naïve T cells 
(Soares et al., 1998). IL-15 is essential for the homeostatic proliferation of memory 
CD8+ T cells and natural killer (NK) cells (Rochman et al., 2009) and it has also been 
reported to affect the homeostasis of memory CD4+ T cells in the absence of IL-7 
(Purton et al., 2007a, 2007b). Interleukin-15 shares many biological functions with 
IL-2 (Picker et al., 2006). Interleukin-15 can also drive antigen-independent 
proliferation and differentiation of central memory to effector memory (Geginat et al., 
2003; Picker et al., 2006). 
 
While understanding and defining protective HIV-specific immunity in the female 
genital tract during HIV infection and transmission is recognized to be important, we 
and others have shown that few cells can be recovered ex vivo limiting the depth of 
analysis that can be performed (Nkwanyana et al., 2009; Gumbi et al., 2008; Shacklett 
et al., 2000; Kaul et al., 2000). The aim of the present study was therefore to compare 
in vitro expansion methods (anti-CD3, anti-CD3/CD28 or Dynal anti-CD3/CD28 
beads) and cytokine combinations (IL-2, IL-7 and IL-15) to maximize the yield of T 
cells derived from the female genital tract of women infected with HIV-1. We identify 
maturational characteristics of T cells derived from the female genital tract that may 















3.2 Materials and Methods 
 
3. 2.1 Study participants  
Eighteen HIV-infected women from the Nyanga Day Hospital in Cape Town, South 
Africa were recruited for this study. All women had CD4 counts ≥300 cells/μl and 
were not on antiretroviral therapy at the time of study. Women menstruating, who 
were post-menopausal, had undergone a hysterectomy, or had visible or reported 
evidence of genital tract infections or discharges were excluded from the study. All 
women gave written informed consent, and the Research Ethics Committee of the 
University of Cape Town approved all aspects of the study.   
 
3.2.2 Polyclonal expansion methods 
The ability of anti-CD3, anti-CD3/anti-CD28 and Dynal anti-CD3/CD28 beads to 
expand T cells in the presence of differing combinations of IL-2, IL7 and IL-15 were 
compared. Table 3.1 summarizes the expansion methods and cytokine combinations 
used in this study. Expansions were performed in 96-well microtitre round bottomed 
plates (Greiner Bio-one; Frickenhausen, Germany). Wells were coated overnight at 
4°C with immobilized anti-CD3 (final concentration 10μg/ml; MAB100; R&D 
Biosystems, Minneapolis, MN, USA), either alone or in combination with anti-CD28 
[final concentration of 10μg/ml; L293, Becton Dickinson (BD) Biosciences-
PharMingen, San Diego, CA, USA; (Azuma et al., 1992), in a final volume of 
50μl/well in phosphate buffered saline (GIBCO
®  PBS, Invitogen™, Carlsbad, CA, 
USA).  The coated plates were washed three times with PBS to remove unbound or 
excess antibody. Alternatively, Dynal magnetic beads (Dynabeads®) coated with anti-
CD3 and anti-CD28 antibodies (T-cell expander; Invitrogen Dynal, AS, Oslo, 
Norway; (Trickett et al., 2002)) were added to wells at varying bead-to-target cell 
ratios (1:5, 1:1 and 3:1) in a final volume of 200 l/well [cell suspension + R10 
medium (RPMI1640 medium, supplemented with 10 % human AB (HAB) serum, 
5mM L-glutamine, 50 U/ml penicillin and 50 μg/ml streptomycin (GIBCO
®   
Invitrogen™) and 2mg/ml fungin® (Invivogen, San Diego, CA, USA)]. Differing 













Germantown, Maryland, MD, USA), IL-7 (20 ng/ml; R&D Biosystem) and IL-15 (20 
ng/ml; R&D Biosystems) were added to cultures (Table 1).  
 




IL-2 (IU/ml) IL-7 (ng/ml) IL-15 (ng/ml) 
Anti-CD3 immobilized 200 - - Yang et al. (1996) 
Anti-CD3 immobilized 200 20 20 Liu et al. (2006) 
Anti-CD3/anti-CD28 immobilized 200 - - Levine et al. (1996) 
Dynal anti-CD3/CD28 beads (1:5)* 200 - - Kalamasz et al. (2004) 
Dynal anti-CD3/CD28 beads (1:1) 200 - - Onlamoon et al. (2006) 
Dynal anti-CD3/CD28 beads (3:1) 200 - - Kalamasz et al. (2004) 
Dynal anti-CD3/CD28 beads (1:1) 200 20 20 Onlamoon et al. (2006) 
* Anti CD3/CD28 bead-to-T cell ratios 
 
3.2.3 Isolation of peripheral blood mononuclear cells (PBMCs) 
Whole blood was collected in ACD anti-coagulated vacutainer tubes (BD 
Biosciences, Plymouth, UK). Peripheral blood mononuclear cells (PBMC) were 
isolated by density gradient centrifugation using Ficoll-Histopaque (Sigma-Aldrich, 
Egham, Runnymede, UK) and LeucoSep® centrifuge tubes (Greiner Bio-one, 
Frickenhausen, Germany). 
 
3.2.4 Polyclonal expansion of PBMCs 
Broad comparison of in vitro expansion methods were initially performed using 
PBMCs because ex vivo cervical T cell yield precluded comprehensive comparisons 
of methodology. The two most efficient methods for expanding PBMCs were then 
applied to expand fresh cervical cytobrush-derived mucosal cells. Briefly, PBMCs 
from HIV-infected women were subjected to the seven different expansion conditions 
described in Table 3.1. PBMCs were added to respective wells at 1x10
5
 PBMC/well 
in R10 medium.  Expansion with each method was performed in triplicate. Cells were 
cultured in a 5% CO2 at 37
o
C for 7 days and fresh R10 medium with cytokines was 
replenished after every 2 days. Cells were removed for cell counting on days 3, 5 and 
7. When the cell density exceeded 2 x 10
6













yellow, cultures were split to a density of 0.5 x 10
6
 cells/ml. Comparison of cell yields 
and T cell viability was determined by Guava automated cell counting (Guava 
Technologies, Hayward, CA, USA) and Trypan staining using a Fast Read 
Haemocytometer by microscopy (Sigma-Aldrich, Irvine, UK), respectively.  
 
3.2.5 Collection and processing of cervical cytobrush specimens 
Cervical cytobrush samples were collected from the female genital tract of all women 
under speculum examination using a Digene cervical sampler as previously described 
(Gumbi et al., 2008; Iqbal et al., 2005; Nkwanyana et al., 2009; Passmore et al., 
2006). A Digene cytobrush was inserted into the cervical os and rotated 360
o
 and 
immediately placed into 3ml ice transport R10 medium. The cervical cytobrushes 
were transferred to 4
o
C in a Nalgene (Rochester, NY, USA) bench-top cooler until 
transported to the laboratory. Cervical cytobrushes with visible blood contamination 
were discarded (Passmore et al., 2006). Cells were processed within 4h of collection 
by flushing the cytobrush ~30 times with R10. The cell suspension was then 
transferred to a clean 15ml tube and centrifuged at 1000 x g for 10 min. The pelleted 
cells were resuspended in 500 l R10. The absolute number of CD3+ T cells in each 
cytobrush sample was counted using a Guava automated cell counter (Guava 
Technologies) according to the method described by Nkwanyana et al. (2009). 
Viability of cervical mononuclear cells was determined by Trypan staining (Sigma-













3.2.6 Polyclonal expansion of cervical cytobrush-derived T cells 
Cervical T cells were expanded using either anti-CD3/IL-2, Dynal (1:1)/IL-2 or Dynal 
(1:1)/IL-2/IL-7/IL-15. Cervical cells were resuspended in R10 at 0.5-1 x 10
6
 cells/ml 
and added to each well at 100 ul/well. Due to limited cell numbers, cervical cell 
expansions per donor were performed from multiple donors, rather than as replicates.  
Cervical cells were cultured as for PBMC.   
 
3.2.7 Assessment of T cell maturational status by flow cytometry 
Distinct memory T cell subsets were identified by differential staining with 
fluorescent antibodies directed against CD45RO, CCR7 and CD27. Cells were 
phenotyped on days 0 and day 7 after expansion. The following antibodies and 
fluorochromes were used in this study: CD3-Allophycocyanin-H7 (CD3-APC-H7), 
CD4-FITC, CD8-PerCp-Cy5.5, CD27-PE (all BD Biosciences, San Diego, CA, 
USA), CCR7-APC (R&D Systems, Minneapolis, MN, USA), CD45RO-Texas Red-
PE (Beckman Coulter, Marseille, France), CD14-PacBlue (BD Biosciences San 
Diego, CA, USA), and CD19-PacBlue (Invitrogen, Carlsbad, CA, USA). Cells were 
stained with antibodies directed at phenotypic (CD3, CD4 and CD8) and maturational 
markers (CD45RO, CCR7 and CD27). Violet amine reactive dye („ViVid‟; 
InvitrogenTM Molecular ProbesTM, Eugene, OR, USA) was included in the staining 
protocol.  Cells were stained for 30 min and washed in wash buffer (1% FCS in PBS).  
Approximately 200 000 events were acquired on an LSRII flow cytometer (BD 
Biosciences; San Jose, CA, USA). Data analysis and colour compensation were 
performed using FlowJo software v8.5.3 (Tree Star, Inc; Ashland, Oregon, OR, USA). 
Dead cells (ViVid
+
), monocytes (CD14+), and B cells (CD19+) were excluded from 
the analysis. Fluorescence minus one (FMO) controls were used to set gates.  
 
3.2.8 Statistical analysis 
Statistical analyses were performed using GraphPad Prism 5® (GraphPad Software, 
San Diego California USA). The Mann-Whitney U test was applied for independent 
sample comparison, the Wilcoxon Ranks Test was used for matched non-parametric 
comparisons and Spearman Ranks correlation was applied for assessing the 













mucosal samples used throughout this study and because the analyses in this Chapter 













3.3 Results  
 
3.3.1 Characteristics of women 
Eighteen HIV-infected women were included in this study to compare methods for 
polyclonal expansion of T cells from the female genital tract and blood (Table 3.2).  
Their median age was 34 years (range 26-43). They had a median blood CD4 count of 
396 cells/ l (range 302-811 cells/ l) and a median plasma viral load of 6000 RNA 
copies/ml (range undetectable-170,000). These women were the same group of 
women as those studied in Chapter 2. 
 
Table 3.2. Clinical characteristics of HIV-infected women included in this study 
 
Group PID Age CD4 count 
(cells/ l) 
HIV viral load 
(RNA copies/ml) 



















































































































3.3.2 Comparison of polyclonal expansion methods for expanding T cells from 
 blood 
PBMCs from HIV-infected women were initially used to compare a broad panel of in 
vitro expansion methods because ex vivo cervical T cell yield did not allow for such 
comprehensive and parallel comparisons of methodology. The performances of seven 
different expansion protocols (Table 3.1) were compared to expand T cells from blood 
of five donors (PID 1-5 of Table 3.2; Figure. 3.1). Anti-CD3 and IL-2 treatment 
resulted in a median of 4.5-fold (range 3.7–5.3) expansion of CD3+ T cells in blood in 
7 days (compared to day 0). Inclusion of anti-CD28 or addition of IL-7 and IL-15 to 
this combination did not significantly improve expansion (4.8-fold in the presence of 
anti-CD28 and 5.1-fold in the presence of IL-7 and IL-15; p=0.33 and p=0.18, 










Figure 3.1. Comparison of polyclonal expansion methods for expanding T cells from blood. 
PBMC were expanded using seven different combinations of expansion protocols and cytokine 
cocktail: anti-CD3/IL-2 (dark blue), anti-CD3/anti-CD28/IL-2 (medium blue), anti-CD3/IL-2/IL-7/IL-
15 (light blue), Dynal anti-CD3/CD28 beads (3:1)/IL-2 (yellow), Dynal anti-CD3/CD28 beads 
(1:5)/IL-2 (light orange), Dynal anti-CD3/CD28 beads (1:1)/IL-2 (dark orange), and Dynal anti-
CD3/CD28 beads (1:1)/IL-2/IL-7/IL-15 (red). Bars represent the median of 5 donors cell recovery after 
3, 5 and 7 days.  Error bars represent the interquartile range for measurements taken from five donors.  
The figures on top of the bars represent median fold expansion after culturing. Wilcoxon Rank Test 




































































































Dynal beads were tested at three bead-to-target cell ratios (3:1, 1:1, and 1:5) and in the 
presence or absence of IL-7 and IL-15 (Figure 3.1). At all bead-to-target cell ratios 
tested, Dynal bead expansion significantly improved yields compared to immobilized 
anti-CD3 and IL-2 (p=0.008). The greatest improvement in T cell yields was observed 
when an equal number of Dynal beads-to-T cells (1:1) was used (6.7-fold expansion 
with Dynal 1:1 compared to 4.5-fold for anti-CD3; p=0.008). Addition of IL-7 and IL-
15 in the presence of Dynal beads (1:1) improved expansion yields slightly (7.1-fold; 
p=0.3 compared to Dynal beads 1:1 and IL-2 alone).   
 
None of the expansion methods assessed significantly impacted on the viability of 
PBMCs compared to day 0. Compared to expansion with anti-CD3 and IL-2, 
expansion with Dynal beads (1:1) and IL-2 both in the presence and absence of 
additional IL-7 and IL-15 resulted in improved PBMC viability [p=0.008 for 















Table 3:3. Impact of in vitro expansion methods on viability of PBMC 
Stimulus Cytokines Cocktail 
Percentage viability following expansion 
Day 3 Day 5 Day 7 
Median IQR Median IQR Median IQR 
Anti-CD3 immobilized IL-2 86.2 (67.0-86.3) 83.9 (74.3-85.9) 79.2 (77.4-83.7) 
Anti-CD3 immobilized IL-2, IL-7, IL-15 85.9 (66.4-86.0) 84.0 (75.7-84.6) 82.7 (79.8-82.8) 
Anti-CD3/anti-CD28 immobilized IL-2 73.1 (70.5-74.6) 81.4 (80.6-87.9) 85.3 (82.3-87.9) 
Dynal anti-CD3/CD28 beads (1:5)* IL-2 84.4 (70.8-86.9) 84.1 (72.6-84.2) 81.0 (80.9-81.3) 
Dynal anti-CD3/CD28 beads (1:1) IL-2 86.4 (85.6-87.4) 84.3 (83.1-84.3) 93.3 (76.5-95.7) 
Dynal anti-CD3/CD28 beads (3:1) IL-2 84.8 (82.7-84.8) 74.1 (74.0-74.2) 71.8 (69.4-73.7) 
Dynal anti-CD3/CD28 beads (1:1) IL-2, IL-7, IL-15 92.9 (90.8-94.1) 81.3 (79.2-81.7) 94.4 (87.1-95.0) 















From these experiments, we concluded that Dynal beads at a ratio of 1:1 in the 
presence of IL-2, IL-7 and IL-15 generated the greatest increase in CD3+ yield in 7 
days. 
 
To investigate the impact of HIV infection on in vitro expansion kinetics, we 
compared the expansion kinetics of PBMCs from 10 uninfected women (from 
Western Province Blood Transfusion Services, Cape Town, South Africa) to PBMCs 
from HIV-infected women (Table 3.4). While a similar hierarchy of performance was 
observed for the 7 expansion methods in HIV- compared with HIV+ individuals, the 
magnitude of expansion was found to be 2-3-fold higher in HIV- individuals than 
those infected with HIV (Table 3.4; p<0.01). This confirms that HIV infection 
significantly reduces the polyclonal expansion efficiency of T cells and that the 













Table 3.4. Comparison of expansion kinetics of PBMC from HIV-infected and uninfected women 
Stimulus HIV-infected 






























































3.3.3 Impact of polyclonal expansion of PBMCs on T cell memory phenotype 
The impact of each expansion method was next investigated on blood memory T cell 
phenotypes based on differential expression of CD45RO, CD27 and CCR7 (Figure 
3.2 and Figure 3.3). Figure 3.2A shows a representative plot of the gating strategy 
used to define naive and total memory based on CD45RO and CD27 expression, 
while Figure 3.2B shows the strategy used to define distinct memory subsets. The 
following phenotypes were defined: naïve T cells (CD45RO-CCR7+CD27+), 
intermediate memory T cells (CD45RO-CCR7-CD27+), effectors (CD45RO-CCR7-
CD27-), transitional memory T cells (CD45RO+CCR7-CD27+), effector memory 
(CD45RO+CCR7-CD27-), and central memory T cells (CD45RO+CCR7+CD27+) 
(Burgers et al., 2009). In order to simplify the analysis, only the proportions of 
effector memory and central memory are represented on figure 3.2, the rest of the 










Figure 3.2. Impact of polyclonal expansion on T cell memory phenotype in blood. Cells were first 
gated on singlets, live cells and then lymphocytes. From this gate, CD3+ cytokine-producing T cells 
were gated, and then further gated on CD4+ and CD8+ T cells. Gates for each of the memory subsets 
were defined based on CCR7 and CD27 expression. Representative plots showing (A) naïve and 
antigen-experienced cells (total memory) based on differential staining with CD27 and CD45RO; and 
(B) differentiation markers expression (CD45RO, CD27 and CCR7) on CD8+ T cells from blood. 












































































































































































Before expansion, a median of 80% (range 65-91%) of CD8+ T cells and 64% (range 
46-81%) of CD4+ T cells were antigen experienced (including CD45RO+ and 
CD45RO-non-naïve effector cells; Figure 3.3 top panel).  Following expansion, 
significantly increased frequencies (>95%) of both CD4+ and CD8+ T cells expressed 

























































Figure 3.3. Impact of polyclonal expansion on T cell memory phenotype in blood. Comparison of 
the frequency of total (top panel), effector memory (middle panel) and central memory (bottom panel) 




 T cells in chronically HIV-infected 
individuals (n = 5) before and after expansion using seven different protocols. Each box and whisker 
plot shows the median (central line), IQR (outer lines of box) and 5-95% range (error bars) of 5 HIV-






















































































































































































































































































































































































































































































































































































Since CD45RO+ memory T cells predominated in blood following expansion, the 
impact of expansion on distinct memory subsets (effector memory and central 
memory, Figure 3.3 middle and bottom panel) was further evaluated. It was noted that 
anti-CD3 and IL-2 stimulation (in the presence or absence of anti-CD28 and/or IL-7 
and IL-15) resulted in the accumulation of cells with an effector memory phenotype 
(CD45RO+CCR7-CD27-) compared with unexpanded PBMC and cells expanded 
with Dynal beads (Figure 3.3). In contrast to anti-CD3, Dynabeads expansions (with 
or without IL-7 and IL-15) resulted in the accumulation of with a central memory 
phenotype. It was noted that expansion of PBMC with Dynal beads at a higher ratio of 
bead:PBMC (3:1 and 1:1) resulted also in a significantly higher proportion of cells 
with a central memory phenotype, compared with unexpanded PBMC (p=0.01 and 
p=0.03, respectively).  Similar results were observed for both CD4+ and CD8+ cells. 
 
3.3.4 Comparison of methods for expanding cervical T cells 
A median of 112800 cervical cells (range 91,320-156,000) was obtained per 
cytobrush ex vivo from the 18 HIV-infected women included in this study (Table 3.2).  
From the results of the PBMC expansions, the three best performing methods [(1) 
anti-CD3/IL-2, (2) Dynal beads (1:1)/IL-2, and (3) Dynal beads (1:1)/IL-2/IL-7/IL-
15] were selected to expand cervical cytobrush-derived cells (Figure 3.4).  Fifteen of 
18 cytobrushes (83.3%) expanded successfully while 3/18 (16.7%) became 
contaminated during culture (Table 3.2). This resulted in five independent 
cytobrushes were successfully expanded for each of the three expansion methods 
tested (Table 3.2). Despite a wide variation in HIV load (<50–170,000 RNA 
copies/ml), no significant difference in the distribution of viral loads between 






























Figure 3.4. Comparison of polyclonal expansion methods for expanding cervical cytobrush-
derived T cells. Cervical cells obtained from HIV-infected women were cultured with either anti-
CD3/IL-2 (n=5; blue bars), Dynal anti-CD3/CD28 beads (1:1)/IL-2 (n=5; orange) and Dynal anti-
CD3/CD28 beads (1:1)/IL-2/IL-7/IL-15 (n=5; red). Bars represent the yield of cells obtained from each 
donor pre- and post-expansion.  Wilcoxon Rank Test was used to compare day 0 and day 7 yields.  
Figures on top of the bars represent fold expansion relative to day 0. 
 
Expansion with anti-CD3 and IL-2 resulted in a median of 3.3-fold (range 2.2-5.7) 
increase in cervical CD3+ cells following 7 days expansion with a median yield of 
328,000 cells [range 236,000-538,600] and median viability of 87% (range 84.5-89.5; 
Figure 3.4; Table 3.5). Compared with anti-CD3 and IL-2 expansion, Dynal beads 
(1:1) and IL-2 resulted in a significant improvement in cervical cell yields with and 
without additional cytokines IL-7 and IL-15 (p=0.004 and p=0.04, respectively; 
Figure 3.4).  Dynal beads (1:1) and IL-2 alone yielded a median of 524,000 cells 
(range 396000-736000) with a median of 4.7-fold increase and a median cellular 
viability of 91.5% (range 90.25-93.5%). Dynal beads (1:1) and IL-2, IL-7 and IL-15 
resulted in a median of 624000 (range 496000-756000) with a median 5.6-fold 
increase.  Compared to expansion with anti-CD3 and IL-2, expansion with Dynal 
beads (1:1) and IL-2 both in the presence and absence of additional IL-7 and IL-15 























































































































































































































































































































































p=0.02 for Dynal+IL-2+IL-7+IL-15]. From these experiments, it was concluded that 
Dynal beads (1:1) in the presence of IL-2, IL-7 and IL-15 generated the most 
significant increase in CD3+ T cell yields and viability in 7 days from cervical 
cytobrush specimens compared to ex vivo yields (p<0.001).   
 




Percentage viability following expansion 
 
P-value Day 0 Day 7 
Median IQR Median IQR 
  Anti-CD3 immobilized  IL-2  98.0 (96.0-100) 87.0 (84.5-89.5) - 
Dynal anti-CD3/CD28 beads (1:1)* IL-2 
94.0 (90.0-98.0) 91.5 (90.3-93.5) 0.05 
Dynal anti-CD3/CD28 beads (1:1) IL-2, IL-7, IL-15 
96.0 (95.0-96.0) 96.0 (94.0-98.0) 0.02 
* Anti CD3/CD28 bead-to-T cell ratios 
 
3.3.5 Impact of expansion on memory T cell phenotype in the female genital tract 
The impact of expansion on the memory phenotype of T cells derived from the cervix 
was next investigated (Figure 3.5). Figure 3.5A shows a representative plot of the 
gating strategy used to define cervical naive and total memory based on CD45RO and 
CD27 expression, while Figure 3.5B shows the strategy used to define distinct 
memory subsets at the cervix. Before expansion, a median of 97.8% (range 66.7-
100.0) of CD4+ T cells and 95.3% (range 80-100.0) of CD8+ T cells from the cervix 
were found to be antigen experienced CD45RO+ T cells (Figure 3.6, top panel).  
Significantly more cells from the cervix expressed CD45RO compared to blood for 
both CD4+ (p=0.0005) and CD8+ T cells (p<0.0001) reflecting the trafficking of 
antigen-specific cells to mucosal sites.  There were no significant changes observed in 
the frequency of total memory T cells before and after expansion from cervical 
cytobrush-derived cells (Figure 3.6 upper panel), since memory T cells made up the 
majority of the population before and after expansion. The impact of expansion on 
distinct cervical T cell memory subsets (effector memory, and central memory was 
evaluated; Figure 3.6; middle and lower panels respectively). Expansion of cervical 
cells for 7 days with anti-CD3 and IL-2 resulted in significantly increased frequencies 
of effector memory CD8+ T cells compared to fresh cytobrush samples (Figure 3.6).  













significantly reduced frequencies of effector memory T cells (p=0.02 and p=0.0005, 
respectively) for CD4+ T cells. While central memory T cells comprised only 2.8% 
(range 0.0-11.1) of CD4+ and 0.3% (range 0.0-3.3) of CD8+ T cells before expansion, 
all expansion methods resulted in enrichment for this memory subset. In particular, 
expansion with Dynal beads (1:1) with and without IL-7 and IL-15 resulted in a 4.2-
fold (p=0.0.03) to 11.2-fold increase (p<0.0001) in the frequency of CD4+ T cells and 
81.1-fold (p=0.0002) to 154.3-fold increase (p<0.0001) in the frequency of CD8+ T 








Figure 3.5. Impact of polyclonal expansion on T cell memory phenotype at the cervix. Cells were 
first gated on singlets, live cells and then lymphocytes. From this gate, CD3+ cytokine-producing T 
cells were gated, and then further gated on CD4+ and CD8+ T cells. Gates for each of the memory 
subsets were defined based on CCR7 and CD27 expression. (A) Representative plots showing naïve 
and antigen-experienced T cells (total memory) based on differential expression of CD27 and 


















































cells. A total of 200, 000 
events were acquired on an LSRII flow cytometer (BD Biosciences; San  







      
A














































































































































Figure 3.6. Impact of polyclonal expansion on T cell memory phenotype at the cervix. Comparison 
of the frequency of total (top panel), effector memory (middle panel) and central memory (bottom 




 T cells at the cervix of chronically 
HIV-infected individuals (n = 5) before and after expansion for 7 days using three different protocols. 
Cervical cells were expanded using the methods that yielded best expansion in PBMC experiments 
[Dynal Beads (1:1)/IL-2 and IL-2/IL-7/IL-15] and compared with anti-CD3/IL-2 alone. Each box and 
whisker plot shows the median (central line), IQR (outer lines of box) and 5-95% range (error bars) of 







































































































































































































































































































































Figure 3.7 provides a summary of phenotypic changes following expansion of PBMC 
and cervical cytobrush cells, including all combinations of phenotypes observed with 
the markers we used. While it is clear that effector memory T cells predominate at the 
cervix ex vivo, effector and naïve cells predominate in fresh blood. Anti-CD3 
expansion in the presence of IL-2 maintains this dominance of effector memory T 
cells in cervical samples while it enriches for this population in expanded PBMCs. In 
contrast, Dynal beads (particularly in the presence of IL-7 and IL-15) favour the 
accumulation of central memory subsets in both cervical and PBMC samples. The 
transitional memory T cell frequencies were generally unchanged irrespective of the 
expansion method used with the exception of a significant reduction in the frequency 
of this subset in CD4+ T cells only following expansion with Dynal beads (1:1) and 


































Figure 3.7. Summary of the phenotypic changes observed in distinct T cell subsets at the cervix 
and blood of HIV-infected women after 7 days of expansion. Eight memory subsets were defined 



















































cells. Correlation between fresh and expanded 
cells memory phenotypes was performed using Spearman Rank test and Spearman Rho and p-values 









CD45RO- CCR7+CD27+   [Naïve]
CD45RO- CCR7- CD27+ [Intermediate]
CD45RO- CCR7- CD27- [Effector]
CD45RO- CCR7+CD27-
CD45RO+CCR7- CD27+ [Transitional Memory]















Based on significantly improved cell yields and viability, it was concluded that the 
combination of Dynal beads (1:1) and IL-2, IL-7 and IL-15 was superior to the other 
methods for expanding both cervical and blood-derived T cells. This method, 
however, selects for enrichment of central memory over effector memory T cells in 
cervical samples, resulting in expanded cervical cells differing from those present 
before expansion. Although anti-CD3 and IL-2 offered the poorest improvement in 
yield for both PBMC and cervical cells, this method best conserved the memory 
profile of cervical CD4+ cells following expansion (Figure 3.7; Spearman Rho=0.76; 
















Understanding T cell responses to HIV in the female genital tract is important since 
the majority of new HIV infections and transmissions are via this route. Isolation of 
immune cells from the female genital tract using non-invasive methods is 
characterized by low cell yields that hamper thorough evaluation of immune function.  
Although phenotypic and functional qualities of genital immunity have previously 
been investigated ex vivo (Gumbi et al., 2008; Kaul et al., 2000; Shacklett et al., 
2000), there is a need to develop methods to improve yields or expand immune 
subsets in vitro (Ibarrondo et al., 2005; Iqbal et al., 2005; Shacklett et al., 2003a). Few 
studies have directly compared expansion methods (Robinson et al., 2002; Kalamasz 
et al., 2004) or compared their ability to expand cytobrush-derived T cells from the 
female genital tract.  
 
This study compared the efficiency of immobilized anti-CD3 alone or in combination 
with anti-CD28 and Dynal bead-bound anti-CD3/CD28 to expand cervical cytobrush-
derived cells and PBMCs in the presence of various combinations of γ-chain 
cytokines; IL-2, IL-7 and IL-15. Dynal beads in the presence of IL-2, IL-7 and IL-15 
were found to be superior to other methods tested in terms of their ability to expand 
both cervical and blood-derived T cells, but this method enriched for central memory 
T cells.  In contrast, anti-CD3 and IL-2 offered the poorest improvement in yield for 
both PBMC and cervical cells but best conserved the effector memory profile of 
cervical cells followi g expansion.  
 
The strength and duration of signalling that T cells receive, determines their fate 
(Kalamasz et al., 2004). Kalamasz et al. (2004) reported that optimal expansion of T 
cells depends on engagement of both the CD3/T cell receptor (TCR) complex and co-
stimulation with anti-CD28. In this study, the benefit of co-stimulation by addition of 
anti-CD28 in the presence of anti-CD3 and IL-2 did not significantly improve 
expansion yield of PBMCs nor alter the memory profile of expanded cells compared 
to anti-CD3 and IL-2 alone. Since expansion in general selected for enrichment of the 
memory T cell pool and memory T cells are known to have differing requirements for 













experiments is likely to be dampened by the reduced need of memory cells for this 
secondary signal (Kalamasz et al., 2004; Sallusto et al., 2004).  
 
This study shows that there are significant changes that occur in individual memory 
subsets depending on the expansion method applied. Generally, anti-CD3 expansion 
in the presence of IL-2 alone resulted in the accumulation of effector memory cells, 
while Dynal beads resulted in selective accumulation of central memory T cells from 
both cervix and blood.  Previous studies have shown that varying the concentration of 
bead to target cells when using Dynal beads impacts significantly on expansion of 
naïve versus antigen-experienced cells with high bead:cell ratios favouring naïve cell 
expansion and low bead:cell ratios favour antigen-specific cell expansion (Kalamasz 
et al., 2004). The highest yield of T cells was obtained at beads:cell ratios of 1:1 
followed by 1:5 and then 3:1, indicating that bead-to-cell ratio impacted on expansion 
kinetics. This finding supports previous observations that TCR signalling strength is 
important in driving T cell proliferation (Kalamasz et al., 2004). Further, it was found 
that reducing the signal achieved by reducing the beads-to-cell ratio resulted in 
accumulation of effector memory T cells while increasing the signal by increasing the 
beads-to-cell ratio favoured the accumulation of central memory T cells. It was 
speculated that the differing phenotypes of T cells that result from the various 
expansion protocols tested represent a change in the phenotype of the cells present 
initially (activation induced maturation and cycling) rather than a selective expansion 
of an existing T cell population. 
 
T cells derived from the female genital tract were predominantly antigen-experienced 
and more highly-differentiated, with effector memory T cells being the most 
predominant subset at the cervix. Effector memory cells constitute the major 
population of CD4+ T cells in extra-lymphoid effector sites such as the intestinal 
lamina propria and the lung (Sallusto et al., 2004). The difference in the memory 
status of T cells derived from cervical cytobrush samples compared to blood may also 
explain the difference in expansion potential of these cells. The female genital tract is 
colonized by abundant commensal and sometimes pathogenic microflora (Zhou et al., 
2004). It was speculated that continuous exposure of immune cells residing in the 
genital tract to bacterial products might result in increased T cell activation, 













In this study, supplementation with IL-7 and IL-15 following stimulation with Dynal 
beads resulted in accumulation of central memory T cells. Previous studies have 
shown that these growth promoting cytokines override the increased tendency of 
effector memory T cells to undergo apoptosis (Sallusto et al., 2004), by inducing 
telomerase activity (Son et al., 2000) and upregulating anti-apoptotic molecules 
(Boise et al., 1995). Addition of IL-7 and IL-15 in combination with immobilized 
anti-CD3 resulted in selective accumulation of effector memory CD4+ T cells, which 
is more consistent with the reported tendency of these cytokines to “protect” effector 
memory cells from apoptosis. 
 
A limitation of this study is that it focused only on expansion of cervical and blood-
derived T cells from HIV-infected women. It was shown in blood that HIV-infection 
impacts on the extent of expansion of T cells and is therefore also likely to influence 
in vitro expansion of T cells from the genital tract. It has been previously shown that 
the memory profiles of T cells isolated from the cervix of HIV-infected and 
uninfected women are similar (Nkwanyana et al., 2009). However, since (1) HIV 
infection may impact on the baseline characteristics of cervical cells and their ability 
to expand in vitro and (2) the value of this approach would be best applied to 
uninfected HIV vaccine clinical trial participants, it is likely that this data may under 
estimate the expansion potential of T cells from the genital tract. It is therefore 
important to expand these studies to include cervical T cell expansion from HIV 
negative women.  
 
Conditions that improve the rate of expansion and viability of T cells derived from the 
female genital tract will not only reduce the time required to improve yields but also 
reduce the risk of expansion bias and contamination.  This study demonstrates here 
that the extent of expansion of cervical T cells might be impacted by the 
predominance of effector memory T cells ex vivo. The relative expansion of cervical 
T cells expanded with either anti-CD3/IL-2 or Dynal/IL-2 was 1.4-fold lower than the 
extent of expansion observed for PBMCs.  It was concluded that cervical T cell yields 
can be best improved by expansion with Dynal beads (1:1) in the presence of IL-2, 
IL-7 and IL-15, while memory T cell profiles can best be maintained by expansion 
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Although phenotypic and functional qualities of genital immunity have previously 
been investigated ex vivo (Gumbi et al., 2008; Kaul et al., 2000a; Shacklett et al., 
2000), these studies were hampered by low yields making the development of 
methods to expand immune subsets in vitro valuable for more indepth studies of 
mucosal HIV immune responses (Ibarrondo et al., 2005; Shacklett et al., 2003).   
 
HIV-specific T cell populations at the rectal and genital mucosa have largely been 
shown to overlap in specificity and clonality with those detected in blood (Shacklett et 
al., 2000; Kaul et al., 2000a; Musey et al., 2003a; Ibarrondo et al., 2005). In Chapter 
2, it was demonstrated that the magnitude of IFN-  responses to HIV Gag and specific 
Gag regions targeted by cervical T cell lines from chronically HIV-infected women 
overlapped with those detected in blood, suggesting that the compartments were 
connected. Recent studies comparing the functional complexity of HIV-specific T 
cells at mucosal sites and blood have demonstrated the existence of polyfunctional 
HIV-specific T cells at mucosal sites such as brochiavilar (Brenchley et al., 2008) and 
gastrointestinal tract (Critchfield et al., 2007; Macal et al., 2008; Ferre et al., 2009).  
In these studies, HIV-infected individuals naïve to ART had enhanced HIV Gag 
responsiveness by mucosal CD8+ T-cells compared to PBMC (Critchfield et al., 
2007; Macal et al., 2008; Ferre et al., 2009). Despite recent suggestions that the 
magnitude of multifunctional cells do correlate with HIV clinical status (Critchfield et 
al., 2007), the cause and effect relationship between these responses and HIV clinical 
parameters is unclear (Brenchley et al., 2008; Critchfield et al., 2007; Macal et al., 
2008; Ferre et al., 2009). 
 
It has previously been documented that HIV Gag-specific CD8+ T cells responses 
detected by intracellular staining for IFN-γ production or with MHC class I tetramers 
by flow cytometry (Ramduth et al., 2005), or by IFN-  Elispot (Ogg et al., 1998; 
Edwards et al., 2002; Masemola et al., 2004) were associated with better control of 
HIV. Studies investigating the relationship between the quality or magnitude of HIV-
specific CTL responses and HIV clinical status have, however, generated conflicting 
results. Some have reported an inverse relationship between the magnitude and 











IFN-  Elispot) and HIV viral load (Ogg et al., 1998; Edwards et al., 2002). 
Conversely, others have reported a positive relationship between plasma viral load 
and the total HIV-specific, Env-, and Nef-specific CD8+ T-cell frequency (Betts et 
al., 2001) while others observed no correlations between the magnitude (Addo et al., 
2003; Kaufmann et al., 2004, Ramduth et al., 2005) or breadth (Addo et al., 2003; 
Kaufmann et al., 2004; Masemola et al., 2004) of total HIV-specific T cell responses 
in both CD8+ and CD4+ T cell compartments and viral load, when the entire HIV 
genome was analysed. Recently, Critchfield et al. (2007) showed that the percentage 
of Gag-specific CD8+ T-cells in the rectal mucosa which were capable of >3 
simultaneous effector functions (polyfunctional) were significantly associated with 
blood CD4 counts and inversely associated with plasma viral load.  In the female 
genital tract, however, Gumbi et al. (2008) showed that IFN-γ+ T cell responses to 
HIV Gag were not associated with protection from HIV genital tract shedding. 
 
The aim of this Chapter was to compare the magnitud  of polyfunctional HIV Gag-
specific responses from ex vivo and in vitro expanded cervical and blood-derived T 
cell lines from HIV-infected women. In this study, Cells that simultaneously 
expressed three or four cytokines in response to HIV peptide stimulation were 
considered “polyfunctional.” Polyclonal cervical and blood T cell lines were 
generated using anti-CD3 or Dynal anti-CD3/CD28 expansion in the presence of IL-2, 
IL-7 and IL-15 (optimized in Chapter 3). Polychromatic flow cytometry was used to 
simultaneously assess the frequency of expression of CD107a, IFN-γ, TNF-α, and 
MIP-1β by CD8+ and CD4+ T cells in response to HIV Gag stimulation.  
 
Finally, the relationship between the magnitude and complexity of T cell responses to 
HIV in each compartment were compared with markers of HIV disease progression 

















4.2 Materials and Methods 
 
4.2.1 Study participants and sample collection 
Twenty eight chronically HIV-infected women were recruited from the Nyanga Day 
Hospital in Nyanga, Cape Town, South Africa for this study. All HIV-infected women 
were naive to anti-retroviral (ARV) therapy at the time of study. Women, who were 
menstruating, post-menopausal, had undergone a hysterectomy, or had visible 
evidence of genital tract infections or discharges were excluded from the study. All 
women gave written informed consent, and the Research Ethics Committee of the 
University of Cape Town approved all aspects of the study (UCT REC REF 
206/2002). 
 
4.2.2 PBMC isolation 
Forty millilitres of whole anti-coagulated blood was collected in ACD vacutainer 
tubes (BD Biosciences, Plymouth, UK) from each woman. Peripheral blood 
mononuclear cells (PBMC) were isolated by density gradient centrifugation using 
Ficoll-Histopaque (Sigma-Aldrich, Egham, Runnymede, UK) and LeucoSep® 
centrifuge tubes (Greiner Bio-one, Frickenhausen, Germany) as previously described 
in Chapter 2 section 2.2.2 and fresh samples were used.  
 
4.2.3 Collection and processing of cervical cytobrush specimens 
Cervical cytobrush samples were collected from the female genital tract of all women 
under speculum examination using a Digene cervical sampler as previously described 
(Chapter 2, section 2.2.2). Cervical cytobrush-derived T cells were either investigated 
fresh or following polyclonal expansion. The absolute number of CD3+ T cells in 
each cytobrush sample was counted using a Guava automated cell counter (Guava 
Technologies) according to the method described by Nkwanyana et al. (2009). 
Viability of cervical mononuclear cells was determined by Trypan staining (Sigma-













4.2.4 Polyclonal expansion of cervical and blood-derived T cell lines 
Cervical cytobrush and blood-derived T cells were expanded using either Dynal anti-
CD3/CD28 beads (16/28 women enrolled); anti-CD3 (7/28 women enrolled); or 
investigated directly ex vivo (7/28 women enrolled). Dynal anti-CD3/CD28 beads 
were used in the presence of IL-2, IL7 and IL-15 while immobilized anti-CD3 was 
used in the presence of IL-2 alone (to mimic expansion reported in Chapter 2) 
according to the method described by Chapter 3, section 3.2.2.  Table 4.1 summarizes 
the expansion methods and cytokine combinations used in this study. Cervical and 
blood cells were cultured in a 5% CO2 at 37oC for a total of 14 days and fresh R10 
medium with cytokines was replenished every 2 days. T cell yields and viability was 
determined by Guava automated cell counting (Guava Technologies, Hayward, CA, 
USA) and Trypan staining using a Fast Read Haemocytometer by microscopy 
(Sigma-Aldrich, Irvine, UK), respectively. 
 




IL-2 (IU/ml) IL-7 (ng/ml) IL-15 (ng/ml) 
Anti-CD3 immobilized 200 - - Yang et al. (1996) 
Dynal anti-CD3/CD28 beads (1:1) 200 20 20 Onlamoon et al. (2006) 
* Anti CD3/CD28 bead-to-T cell ratios 
4.2.5 Antibodies used for flow cytometry  
The following antibodies were used to investigate the phenotype and functionality of 
cervical and blood HIV Gag-specific T cell responses: CD3-Allophycocyanin-H7 
(CD3-APC-H7), CD4-PerCp-Cy5.5, CD107-FITC, TNF-α-Cy7-PE, MIP1-β-PE, IFN-
-Alexa fluor 700 (all BD Biosciences, San Diego, CA, USA), CD8-quantum dot 
(QD)  605 (Invitrogen, Carlsbad, CA, USA), CD14-PacBlue (BD Biosciences San 
Diego, CA, USA), and CD19-PacBlue (Invitrogen, Carlsbad, CA, USA).  All 
antibodies were pre-titered to optimal concentrations.  
 
4.2.6 Intracellular cytokine staining 
Intracellular cytokines staining (ICS) assays and phenotypic staining were carried out 











blood T cell lines. Ex vivo cervical and blood-derived T cell lines were rested 
overnight at 37oC, 5% CO2 while expanded T cell lines were deprived of IL-2, IL-7 
and IL-15 for 24hrs prior to stimulation with HIV Gag peptides. HIV-1 subtype C 
Du422 Gag overlapping peptides spanning the entire Gag sequence were kindly 
provided by the NIH AIDS Research and Reference Reagent Program (Bethesda, 
Maryland, USA) and consisted of 121 peptides (15-mer overlapping by 11 amino 
acids). The Du HIV strains used are close to a South African consensus sequence 
(Williamson et al., 2003).  
 
For these experiments, cervical and blood-derived T cells were stimulated with (1) 
pooled HIV Gag peptides (1 μg/ml); (2) Staphylococcus enterotoxin B (SEB, 5 
mg/ml; positive control); (3) PMA (0.1 g/ml)/ionomycin (0.1 g/ml) [positive 
control]; and (4) media alone (negative control). To each stimulation, 10μl of R10 
stimulation mix (4.5 ml R10, 500 l DNase I, anti-CD49d (1 g/ml), anti-CD28 (1 
g/ml), BFA (0.5 g/ml) and monensin (10 g/ml) (Sigma Aldrich) was added. In 
addition, anti-CD107a-FITC antibody (5 l) was included in each stimulation tube.  
With the exception of PMA, cells were stimulated with antigen for 16 h at 37 C, 5 % 
CO2 (Thermo Electron Corporation). For PMA/ionomycin stimulation, cells were 
incubated for only 4 h.  
 
Following stimulation, cells were washed with FACS wash buffer (1% FBS and 
0.01% NaN3, GIBCO® PBS, Invitogen™, Carlsbad, CA, USA) and centrifuged at 838 
x g for 3 (2300rpm) min at 4 ºC. Cells were re-suspended in 50 l PBS containing 
violet viability reactive dye (“Vivid”; Invitrogen) and incubated for 20 min at room 
temperature. For surface staining, a staining mix, consisting of anti-CD19-Pacific 
Blue, anti-CD14-Pacific Blue, anti-CD8-Qdot 605, anti-CD4-PerCP-Cy5.5 and PBS, 
was prepared and cells were stained for 20 min at room temperature. Cells were fixed 
and permeabilized at room temperature for 20 min using Cytofix/Cytoperm buffer 
(BD Biosciences) and stained intracellularly with anti-CD3-APC-H7, anti-IFN- -
Alexa fluor 700, anti-TNF- -PE-Cy7, and anti-PE-MIP-1β. All staining were 
prepared in PBS and a final volume of 50 l was added to each sample. Cells were 
washed, and finally resuspended in 1% paraformaldeyde (Cell fix BD Biosciences) 











Samples were acquired on the LSRII (BD Biosciences) with FACSDiva software 
version 6.0 (BD Biosciences). The number of events collected ranged between 
200,000 and 1,000,000 for both blood and cervix. Data analysis was performed using 
FlowJo v8.8.6 (Tree Star). Dead cells (ViVid), monocytes (CD14+), and B cells 
(CD19+) were excluded from the analysis. For experiments measuring four functional 
responses (CD107a, IFN- , MIP-1β, and TNF- ), individual cytokine gates were 
evaluated alone and also processed through Boolean combinations. Flow cytometry 
data were biexponentially transformed in order to include all events. Fluorescence 
minus one (FMO) was used to set gates. SPICE software (kindly provided by Dr 
Mario Roederer, Vaccine Research Center, NIAID/NIH, Bethesda, MD) was used to 
analyze functional complexity data. 
 
4.2.7 Gating strategy used to detect HIV-specific T cell responses to Gag 
 The gating strategy used to detect CD8+ and CD4+ T cell responses using the 
optimized polychromatic panel are illustrated in Figure 4.2. A singlet gate based on 
forward scatter was followed by a viability gate (ViVid negative) and then selection 
of lymphocytes based on forward/side scatter. CD3+ T cells were then selected from a 
lymphocyte gate and gated against a cytokine to cater for cytokine-producing T cells 
that may down-regulate CD3 and CD8 expression, thereby becoming dim cells. 
Gating on CD4- and CD8- (after the CD3+ gate) and then CD8+ and CD4+ 
respectively ensured that these two subsets were discriminated and double positive 
cells were excluded from analysis. These cells were further subdivided into individual 
populations consisting of cells positive for IFN-γ, TNF-α, CD107a and MIP-1β. 
Values from these populations were either analyzed directly or the populations were 
further subdivided into all possible combinations of functions as previously described 
(Betts et al., 2006; Critchfield et al., 2008; Ferre et al., 2009). In all cases, values were 






























Figure 4.1. Gating scheme used for polychromatic flow cytometry of HIV Gag-specific T cell responses in the female genital tract and blood. Cells were first gated on 
singlets, live cells and then lymphocytes. From this gate, CD3+ cytokine-producing T cells were gated, and then further gated on CD4+ and CD8+ T cells. Gates for each of 







































































































































































































4.2.8 Statistical analysis 
Statistical analyses were performed using GraphPad Prism 5® (GraphPad Software, 
San Diego California USA), Pestle version 1.6.2 and SPICE version 5.1 (both kindly 
provided by Dr Mario Roederer, Vaccine Research center, NIAID, NIH). Mann-
Whiteny U test was applied for independent sample comparison, the Wilcoxon Ranks 
Test was used for matched non-parametric comparisons and Spearman Ranks 
correlation was applied for correlation comparisons. The false discovery rate (FDR) 
step-down procedure was used to reduce false-positive results when performing 
multiple comparisons (Columb and Sagadai, 2006). P-values ≤ 0.05 were considered 
significant. As stated in Chapters 2 and 3, due to the rarity of the mucosal samples 
used throughout this study and because the analyses were mainly exploratory, 
multiple comparison adjustment was not widely performed. In addition, guidelines for 
statistical correction of multiparameter flow cytometry data has not been standardized 












4.3 Results  
 
Twenty eight chronically HIV-infected women were included in this study to compare 
the functional complexity of HIV Gag-specific T cell responses in the female genital 
tract with those detected in blood. Of these 28 women, cervical and blood T cell 
responses were measured immediately ex vivo from 5/28 while the remaining 23/28 
cervical and blood samples were expanded into T cell lines using short term in vitro 
expansion with either Dynal beads (16/23) or anti-CD3 antibodies (7/23). The clinical 
details of each of these groups of women are included in Table 4.2. All women were 
naïve to anti-retroviral therapy at the time of study. The median age of all of the HIV-
infected women was 35 years (ranging from 33 to 37 years). Their median CD4 cell 
counts were 295 cells/ l (IQR 260-431 cells/ l) and their median plasma viral load 
was 7500 HIV RNA copies/ml (IQR 2,600-15,000 copies/ml). Twenty five of 28 
(89.3%) of HIV-infected women had detectable HIV RNA in plasma. In the genital 
tract, 22/28 (78.6%) of these women had detectable HIV RNA [4950 copies/ml in 
cervical secretions (IQR 753-9,850)]. There was no significant difference between the 
three groups with respect to age, CD4 count, plasma and cervical viral load. None of 













Table 4.2: Clinical status of the HIV-infected women included in this Chapter 
 
Characteristic Dynal beads expansion Anti-CD3 expansion Direct Ex vivo 
N 16 7 5 
Age [years; median (IQR)] 35 (33-37) 38 (33-37) 35 (34-37) 
CD4 count [cell/μl; median (IQR)] 311(263-442) 275 (246-342) 328 (288-365) 
Plasma viral load [RNA copies/ml; median (IQR)] 10,900 (5325-81,750) 59,50(3,425-7,200) 6,800 (510-7,500) 
Number of women with detectable HIV RNA in plasma [N/Total (%)] 14/16 (87.5%) 6/7 (85.7%) 5/5 (100%) 
Genital tract viral load [RNA copies/ml; median (IQR)] 9,400 (2,300-14,000) 625 (450-800) 600 (460-725) 















4.3.1 Feasibility of ex vivo polychromatic assessment of the magnitude and 
 complexity of cervical cytobrush-derived HIV-specific T cell responses 
Cervical cytobrush sampling of the female genital tract classically yields relatively 
few cells (Nkwanyana et al., 2009), making thorough immunological analysis 
difficult. This dissertation has previously explored in vitro polyclonal expansion to 
improve genital tract T cell yields (Chapter 2 and Chapter 3) although direct 
comparison with ex vivo genital tract T cell responses was not possible because 
splitting the sample would have compromised the success of in vitro expansion. To 
illustrate the impact of low cervical cytobrush yield on the quality of immunological 
analyses (particularly when multiple functions are being assessed simultaneously), the 
magnitude and complexity of ex vivo cervical T cell responses (compared to blood) to 
HIV Gag were initially investigated using intracellular cytokine staining of CD8+ and 
CD4+ T cells for IFN- , CD107a, TNF- , and MIP-1β. The representative figures in 
Figure 4.2 illustrate the differences in quality of the multiparameter flow cytometry 













Figure 4.2. Representative plots of Gag-specific CD8 T cell responses as measured by 
polychromatic flow cytometry ex vivo at the cervix or in blood. Gates for each of the four functions 
were set based on FMOs and the unstimulated (negative) control.  The percentages shown in each gate 
represent the frequency of CD8+CD3+ live T cells producing each of the respective cytokines. 
 
A median of 110,235 cervical mononuclear cells (range 105,890-113450 cells; n=5) 
were obtained ex vivo per cytobrush.  These ex vivo derived cervical cells were split 
Direct ex vivo CMC
Direct ex vivo PBMC





























































































into three tubes and either (1) not stimulated, (2) stimulated with HIV Gag or (3) 
stimulated with PMA/ionomycin. From ex vivo cervical specimens, total CD3+ T cell 
event counts captured per stimulation condition for analysis ranged from 185-1008 
events (with a median of 525 events; with all cells per condition acquired). This was 
significantly lower than ex vivo events acquired from matching blood samples where 
cell numbers are not a limiting factor (p=0.001; Table 4.3). Of these CD3+ events, 
CD4+ T cell captured events made up the minority and ranged from 20–140 (with a 
median of 96 events) while CD8+ events made up the majority and these ranged from 
145–5594 events (with a median of 379 events). When event counts for individual 
cytokine responses to HIV Gag were evaluated, the number of positive CD107a, IFN-
γ, MIP1-β and TNF-α events captured by flow cytometry ranged from 0 to 7 events 
(Table 4.3). Such low event counts are obviously not conducive to accurate statistical 
analysis using Boolean conditions and this data strongly supports the need for 
improved yields of cells acquired from the female genital tract. In vitro expansion of 
T cells from cytobrushes offered a feasible method to overcome these limitations 
(Chapter 2 and 3).   
 
There are a number of ways of determining what constitutes a positive response. In 
this study, a positive response was taken as net percentage response (subtraction of 
the background unstimulated sample value). All medians were below 0.05 % for both 
CD4+ and CD8+ T cell subsets in blood. The level of non-specific cytokine  
production for ex vivo cervical samples was higher than in blood, with medians that 




















Table 4.3: Ex vivo blood and cervix event counts for HIV Gag positive responses 
 
Parameters 
Positive Event counts 
Cervix (N=5) Blood (N=23) 
CD3 ─ 525 (86 - 7240) 71,041 (28,699 – 156,222 
CD4 ─ 96 (9 - 837) 9,011 (6,279 – 26,176) 
CD8 ─ 379 (63 - 5594) 35,682 (8,797 – 85,494) 
CD4:CD8 ─ 0.25 0.25 
CD107a CD4 0 (0 - 8) 2 (0 - 822) 
CD8 6 (1 - 244) 1,064 (0 - 4486) 
IFN-γ CD4 0 (0 - 2) 7 (0 - 567) 
CD8 3 (0 - 11) 304 (0 – 2,684) 
MIP1-β CD4 0 (0 - 10) 32 (0 - 971) 




CD4 0 (0 - 13) 2 (0 - 590) 
CD8 0 (0 - 46) 1 (0 - 609) 
 
 
4.3.2 Polyclonal expansion of HIV-specific T cells from the female genital  
Cervical-cytobrush and blood-derived T cells were expanded with either Dynal beads 
in the presence of IL-2, IL-7 and IL-15 (n=16) or anti-CD3 in the presence of IL-2 
(n=7) from chronically HIV-infected women. For these expansion experiments, a 
median of 113450 cervical mononuclear cells (range 104,595-126,470 cells; n=23) 
were obtained ex vivo per cytobrush (Table 4.4). Following in vitro expansion with 
Dynal beads, this number was increased to a median of 1.8 x 106 cells (range 1.3-2.2 x 
106 cells) in 14 days of culture in the presence of IL-2, IL-7 and IL-15. This 
represents a 15-fold increase in cervical T cell numbers compared to ex vivo cell 
yields. In comparison, anti-CD3 expansion yielded a median of 1.1 x 106 cells (range 
1.1-1.3 x 106 cells; 10-fold) after 14 days and this was significantly lower than 
obtained from Dynal bead expansion (p=0.004 for yield; Table 4.4). Of the 23 
cervical T cells lines initiated, 1/23 (4.3%) became contamination during the first few 
days of culture and were excluded from further analysis. T cell lines derived from 
PBMCs showed a significant  fold increase in T cell numbers in comparison to 
matched cervical lines after 14 days of expansion with either anti-CD3 (19 vs.10-fold; 
p=0.02) or Dynal beads (29 vs. 15-fold; p=0.0006) [Table 4.5].  
 
Ex vivo cervical mononuclear cell viability ranged from 88-92% (with a median of 











Dynal beads expansion, the median viability of cervical lymphocytes was 85% 
(ranging from 80-90%) while expanded blood median viability was 92% (ranging 
from 88-97%). After anti-CD3 expansion, the viability of cervical and blood 
lymphocyte were a median of 80% (ranging from 80-86%) and 88% (ranging from 
87-93%), respectively and these were significantly different between the two 
compartments (p=0.03). However, comparison between the two methods showed a 
significant difference in blood T cell median viabilities (p=0.04) but not for cervical 














Table 4.4: Comparison of T cell expansion kinetics and viability for cervical cytobrush and blood-derived T cells using Anti-CD3 alone or Dynal anti-
CD3/28 T cell expander beads  
 
Characteristic 
Dynal Beads expansion Anti-CD3mAb expansion 
P-value 
Dynal Beads  Anti-CD3 expansion 









Ex vivo T cell recovery 0.11x 106 (0.1-0.13 x 106) 0.11x 106 (0.1-0.12 x 106) 0.1 100,000 100,000 ─ 
Percentage ex vivo T cell  viability 90 (88-93) 88 (89-91) 0.89 99 (98-100) 98 (97-98) 0.1 
Expanded T cell recovery 1.8 x 106 (1.3-2.2 x 106) 1.1 x 106 (1.1-1.3 x 106) 0.004 3.6 x 106(3.3-3.9x 106) 1.9 x 106(1.6-2.2x 106) 0.0002 
Percentage expanded T cell  viability 84.5 (80-90) 80 (80-86) 0.63 92 (88-96.5) 88 (87-92.5) 0.04 











Figure 4.3 provides a representative figure to illustrate the improvement in the quality 
of plots for multiparameter flow cytometry data collected from cervical mucosal T 
cells after they were expanded using Dynal beads. Expanded cervical samples showed 
increased levels of background cytokine production, with a median of approximately 
1.5% for both CD4+ and CD8+ T cell compared to ex vivo cervical samples (median 












Figure 4.3. Representative plots of Gag-specific cervical CD8 T cell responses as measured by 
polychromatic flow cytometry ex vivo or following in vitro expansion with Dynal beads in the 
presence of IL-2, IL-7 and IL-15 for a period of 2 weeks. Gates for each of the four functions were 
set based on FMOs and the unstimulated (negative) control.  The percentages shown in each gate 
represent the frequency of CD8+CD3+ live T cells producing each of the respective cytokines. 
 
Following polyclonal expansion of cervical specimens, expanded cervical CD3+ T 
flow cytometry event counts resulted in a median of 6,546 CD3+ events (ranging 
from 4,225-10,395 events) after Dynal beads expansion, which was significantly 
higher than obtained ex vivo (p=0.01). Similarly, anti-CD3 expansion of cervical T 
cells resulted in a median of 6,661 CD3+ events (ranging from 3,443-9,543). This was 
significantly higher than events acquired from ex vivo cervical samples (p=0.01; Table 
4.5). Dynal beads expansion resulted in a median of 2,200 CD4+ T cell events 
(ranging from 1,014–4,182 events) compared to a median of 2,847 CD8+ events 
(ranging from 1022–3433 events). It was interesting to note that Dynal beads 
expansion of CD4+ T cells were 2.6-fold higher (although not significantly different) 
than anti-CD3 expansion while anti-CD3 expansion of CD8+ T cells was 1.4-fold 
 
Direct ex vivo CMC
Expanded CMC





























































































higher than Dynal beads. When event counts for individual cytokine responses were 
evaluated, the number of positive CD107a, IFN-γ, MIP1-β and TNF-α events captured 
by flow cytometry ranged from 3-46 events and 1-38 following Dynal beads and anti-





























Positive Event counts:  
  
Direct Ex vivo (IQR) 
N=5 
Dynal Beads expansion (IQR) 
N=16 
Anti-CD3 expansion (IQR) 
(N=7) 
CD3  525 (185 – 1,008) 6,546 (4,225 – 10,395) 6,661 (3,443 – 9,543) 
CD4  96 (20 - 140) 2,200 (1,014 – 4,182) 858 (283 – 1,564) 
CD8  379 (145 - 576) 2,847 (1,022 – 3,433) 4,073 (1,231 – 6,188) 
CD4:CD8 ratio  0.15 1.1 0.18 
CD107 CD4 0 (0 - 1) 6 (4 - 25) 7 (4 - 21) 
 CD8 6 (3 - 44) 46 (30 - 129) 38 (15 - 73) 
IFN- + CD4 0 (0 - 1) 13 (2 - 33) 3 (2 - 6) 
 CD8 3 (0 - 8) 20 (8 - 83) 5 (1 - 34) 
MIP-1β+ CD4 0 (0 - 1) 9 (4 - 14) 4 (1 - 24) 
 CD8 7 (0 – 159) 37 (16 - 66) 21 (19 - 181) 
TNF- + CD4 0 (0 - 1) 3 (1 - 16) 1 (1 - 3) 











4.3.3 Comparison between ex vivo versus in vitro expanded cervical T cell 
 responses to HIV Gag 
Although fresh ex vivo and expanded cervical responses were not evaluated from the 
same women due to cell number constrants, the differences in magnitude or functional 
profile of HIV-specific responses from fresh ex vivo or in vitro expanded cervical T 
cell lines were investigated (Figure 4.4). The individual and cumulative frequencies of 
cytokines produced by both CD8+ (Figure 4.4A and 4.4B) and CD4+ (Figure 4.4C 
and 4.4D) T cells were determined. Ex vivo cervical CD8+ T cells responding to HIV 
Gag predominantly produced MIP1-β and CD107a. Cervical T cell lines expanded 
with Dynal beads had significantly higher frequencies of cumulative functional 
responses (sum of the 4 functions) by CD8+ T cells to HIV Gag than fresh or anti-
CD3 expanded T cell lines (Figure 4.4 A; p≤0.05). The frequency of CD8+ T cells 
expressing CD107a in response to Gag stimulation following anti-CD3 expansion was 
significantly lower than those detected following Dynal beads expansion (p=0.007). 
Frequencies of CD8+ T cells producing IFN-γ and MIP1-β following Dynal bead 
expansion were significantly higher than either fresh or anti-CD3 expanded lines 
(Figure 4.4 A; p≤0.05). In addition to these two cytokines; MIP1-β and CD107a, Gag-
specific responses also included IFN-γ production, following Dynal bead expansion 
(Figure 4.4B). After anti-CD3 expansion, CD107a expression was lost by cervical 
CD8+ T cells in all individuals while TNF-α production was gained (Figure 4.4B).  
 
Cervical CD4+ T cells responding to HIV Gag were present at low frequencies 
(Figure 4.4C and D) compared to CD8+ T cells responses. The total magnitude of 
HIV Gag-specific responses by CD4+ T cells was significantly higher in Dynal bead 
expanded T cell lines compared to fresh samples (Figure 4.4C; p<0.05). At the 
individual cytokine level, significantly higher frequencies of expanded CD4+ T cells 
produced IFN-γ in response to Gag stimulation compared to fresh cells (p=0.03; 
Figure 4.4C). IFN-γ responses predominated in Dynal beads expanded CD4+ T cells 

























Figure 4.4. Comparison between fresh and expanded cervical T cell 
responses to HIV Gag. Comparison of the net magnitude of cumulative and 
individual cytokine responses expressed as percentages of (A) total CD8+ 
and (C) CD4+ T cells in chronically HIV-infected individuals before (blue 
boxes), or after Dynal bead (orange boxes) or anti-CD3 expansion (purple 
boxes). (B and D) The cumulative frequency for four T cell functions 
investigated; CD107a (yellow), IFN-γ (blue), TNF-α (green) and MIP1-β 
(red) was investigated. Each box and whisker plot shows the median (central 
line), IQR (outer lines of box) and 10-90% range (error bars) of HIV-
infected individuals. Responses are plotted after background subtraction and 
the middle lines on the plots represent median response after background 
subtraction. Mann Whitney Test was used to compare fresh and expanded 
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4.3.4 Comparison between fresh versus expanded cervical polyfunctional T cell 
responses to HIV Gag 
Polyfunctionality in HIV-specific responses was next compared in fresh versus 
expanded cervical T cell lines (Figure 4.5). HIV Gag–specific CD8+ and CD4+ T 
cells responses at the cervix before and after expansion showed only low to 
undetectable magnitude frequencies of four-functional cells. Compared to direct ex 
vivo samples, there was a higher frequency of Gag-specific tri-functional CD8+ T 
cells detected in expanded cervical samples (0% vs. 0.2%) and they made up only a 
small proportion of Gag responsive cells (2%) (Figure 4.5A and B). The net frequency 
of dual-functional cells was highest in Dynal beads expanded cells (2.5%); followed 
by fresh cervical samples (1.5%) and lowest for anti-CD3 expanded cells (1%). The 
proportion of HIV Gag–specific dual functional cells was lower in fresh samples 
(10%) than in expanded CMCs (15%). In the CD8+ T cell compartment, mono-
functional responses were the predominant responses detected (Figure 4.5A) making 
up ~80% of HIV-specific responses, irrespective of whether the cells were expanded 
or analysed fresh (Figure 4.5B). Due to the low frequencies of HIV-specific CD4+ T 
cell events detected in fresh samples, polyfunctionality could only reliably be assessed 
in expanded samples (Figure 4.5 C and D). Analogous to CD8+ T cells, 
monofunctional cells predominated in CD4+ T cell compartment, making up >90% of 
the responses to Gag. Following Dynal beads expansion, both the magnitude (0.25 % 
vs. 0.1%) and proportion (5% vs 2.5%) of dual-functional CD4+ T cells was higher 
than that detected after anti-CD3 expanded cervical cells (Figure 4.5C and D). There 
were no significant differences within the magnitude or proportion of any 
combinations of functions in both the CD8+ and CD4+ T cell compartment between 
the methods investigated.   
 
Expansion did not result in reduced polyfunctional T cell responses at the cervix and 
cells tended to retain the same proportion of polyfunctionality pre- and post-
expansion. Because pre- and post-expansion in the same cervical samples could not be 
compared, these types of experiments were performed in blood to validate the impact 







































Figure 4.5. Comparison of polyfunctional HIV-specific T cell responses in fresh cervical (green 
dots), or Dynal bead (Blue dots) and anti-CD3 (red dots) expanded cervical T cell lines from 
HIV-infected women. (A) Net frequency of CD8+ T cell responses. (B) Relative proportion of the 
combinations of functions (4+, 3+, 2+ and 1+ functional cells).  (C) Net frequency and (D) relative 
proportion of Gag-specific responses for each polyfunctional CD4+ T cells subset. For the CD4+ 
cervical T cell compartment, only expanded T cell line functionality is shown. Responses were 
considered 4-, 3-, 2- or 1-functional if any combination of 4, 3, 2 or 1 of the 4 functions investigated 
were detected, respectively.  The middle bars on the plots represent median response after background 
subtraction.  Mann-Whitney U test was used to compare blood and cervical responses.  
 
4.3.5 Investigation in blood of the impact of in vitro expansion on the magnitude 
of HIV-specific T cells (matched pre- versus post-expansion) 
Because polyclonal expansion of T cells may introduce expansion bias with certain T 
cell clonotypes potentially out competing others (refer to Chapter 2, section 2.3), the 
effect of in vitro expansion with Dynal anti-CD3/28 T cell expander beads or anti-

























































































































































































































CD3 on HIV-specificity of PBMC-derived T cells was evaluated pre- and post-
expansion in matched samples. The magnitude and the cumulative frequency of HIV 
Gag-specific T cell responses from 28 chronically infected individuals are shown in 
Figure 4.6. No significant differences between the total magnitudes (sum of the 4 
functions) of responses in blood for both CD8+ and CD4+ T cells was observed when 
comparing fresh to expanded HIV Gag-specific responses (Figure 4.6 A and C, 
respectively).  
 
Fresh and Dynal bead-expanded HIV Gag-specific CD8+ T cell responses detected in 
blood were predominantly CD107a+ (Figure 4.6A), although the net frequency of 
CD107a+ events in fresh blood was significantly higher than frequencies detected 
following Dynal bead (p=0.009) and anti-CD3 (p=0.01) expansion. Generally, low 
magnitudes (<0.02%) of Gag-specific CD8+ T cells producing TNF-  were observed 
before and after expansion. Both fresh and Dynal bead expanded blood-derived T cell 
lines produced CD107a, IFN-  and MIP-1  in response to Gag while anti-CD3 
expanded lines only produced IFN-  and MIP-1β but failed to express CD107a 
(Figure 4.6B). Strikingly, this dropping away of CD107a expression in expanded 
blood samples was not previously observed in expanded cervical samples (Figure 
4.4). The background levels of cytokine production in media control wells for both 
CD4+ and CD8+ T cell subsets following polyclonal expansion of PBMC was lower 
(below 1.2%) compared to expanded CMC (below 1.5%), however this was higher 
than background levels obtained in fresh PBMC (below 0.05%). 
 
Fresh and anti-CD3 expanded HIV-specific CD4+ T cell responses in blood were 
predominantly MIP1-β+, while Dynal bead expanded CD4 T cell lines produced IFN-
 (Figure 4.6C and D). Compared with fresh and anti-CD3 expansion, Dynal bead 
expanded T cell lines produced a broader range of cytokines in response to HIV Gag 
stimulation (Figure 4.6C and D). TNF-  production was only noted in Dynal bead 
expanded T cell lines and the net frequencies of TNF-  were significantly higher in 
Dynal expanded compared to fresh PBMCs (p=0.02). CD107a expression in response 













Figure 4.6. Impact of polyclonal expansion on the cumulative and 
individual net frequencies of functional responses to HIV Gag measured 
in fresh versus expanded blood T cell lines. (A and C) Comparison of the 
net magnitude of total or individual cytokine responses expressed as 
percentages of (A) total CD8+ and (C) CD4+ T cells in chronically HIV-
infected individuals before (blue bars) and after Dynal beads (orange bars) or 
anti-CD3 expansion (purple bars). (B and D) The cumulative frequency of 
HIV Gag-specific responses by CD8+ (B) and CD4+ (D) T cells producing 
CD107a (yellow), IFN-γ (blue), TNF-α (green) and MIP1-β (red) was 
investigated. Each box and whisker plot shows the median (central line), 
IQR (outer lines of box) and 10-90% range (error bars) of HIV-infected 
individuals. Responses are plotted after background subtraction. Mann 
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Since matching analysis was performed on fresh and expanded T cell lines from blood 
in each of the women included in this study, the relationship between the net 
magnitude of total and individual cytokine responses in fresh and expanded blood 
lines was investigated. Despite CD107a frequencies being significantly reduced 
following both Dynal and anti-CD3 expanded blood T cell lines (Figure 4.6A), the 
frequency of CD8+ T cells expressing CD107a after expansion was significantly 
correlated with frequencies of CD107a measured in fresh blood samples in response 
to Gag stimulation, irrespective of the expansion method used (p=0.003 for Dynal and 
p=0.009 for anti-CD3; Spearman Ranks test). Despite very low frequencies of TNF-α 
being produced in response to Gag, the frequencies of CD8+ (p=0.04 for Dynal and 
p=0.05 for anti-CD3) and CD4+ T cells (p=0.02) producing TNF-α in response to Gag 
were significantly associated before and after Dynal bead and anti-CD3 expansion. 
 
4.3.6 Investigation in blood of the impact of polyclonal expansion on 
 polyfunctional T cell responses to HIV Gag (pre- versus post-expansion) 
The impact of in vitro expansion using Dynal beads or anti-CD3 on the frequency of 
polyfunctional T cell responses to HIV Gag was investigated (Figure 4.7). T cells 
positive for CD107a, IFN-γ, MIP-1β and TNF-α were subdivided into 15 possible 
combinations of functions and these were examined as previously described 
(Critchfield et al., 2008). Figure 4.7A and C shows net frequencies of Gag-specific 
CD8+ and CD4+ T cell responses that were 1, 2, 3 or 4 functional (based on 
combinations of expression of CD107a, IFN-γ, MIP-1β and/or TNF-α). Figure 4.7B 
and D shows the proportion of these combinations of functions (4+, 3+, 2+ and 1+ 
producing cells) relative to the total magnitude of Gag-specific responses.   
 
HIV Gag–specific CD8+ T cells responses in blood, irrespective of whether they had 
been expanded on not, showed very low net frequencies (median of 0%; range, 0-
0.5%) of four-functional cells. Few Gag-specific tri-functional CD8+ blood T cells 
were detected in fresh blood and they made up only a small proportion of Gag 
responsive cells (2%) and these were higher than those observed in expanded blood 
(1%) (Figure 4.7A and B, respectively). The frequency of dual-functional cells was 
comparable between fresh PBMCs (1%), anti-CD3 (0.8%) and Dynal beads (1.2%) 











was ~10-15% in fresh and expanded PBMCs. The median frequency of HIV Gag–
specific mono-functional cells in fresh PBMCs was 3.2% and this was lower than 
observed for Dynal beads (4.3%) and anti-CD3 expanded (5.8%) PBMCs. The 
frequencies of Gag-specific CD8+ T cell responses in both fresh and expanded blood 
were dominated by monofunctional cells (~80-90%). HIV Gag–specific CD4+ T cells 
responses in blood before and after expansion were predominately mono-functional 
(~90-95%; Figure 4.7C and D). Fresh and expanded HIV Gag–specific CD4+ T cell 
showed only a low proportion of dual-functional cells (~2-5%) with no tri- and four-
functional cells being detected (Figure 4.7A D). These finding suggests that there are 
low frequencies of polyfunctional cells in blood of chronically HIV-infected 
individuals and the majority of HIV Gag responses are dominated by mono-functional 
























































Figure 4.7.  Impact of expansion on the polyfunctional profile of HIV-specific T cell responses 
detected in blood. The (A) net frequency and (B) relative proportion of CD8+ T cell responding to 
HIV Gag in fresh (grey circles) and expanded (black circles) PBMCs. The (C) magnitude and (D) 
proportion of CD4+ T cells responding to HIV Gag in fresh (red dots), Dynal (black dots) or anti-CD3 
expanded (grey dots) PBMCs. Responses were considered 4-functional if all 4 of the markers included 
in the polyfunctional panel were detected (IFN- , MIP- , TNF-  and CD107a).  Responses were 
considered 3-, 2- or 1-functional if any combination of 3, 2 or 1 of the 4 functions investigated were 
detected, respectively.  The middle bars on the plots represent median net responses (after background 
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4.3.7 Comparison between the frequency and quality of Gag-specific T cell 
 responses at the cervix and in blood after expansion with Dynal beads  
The magnitude and functionality of Gag responses detected in cervical T cell lines 
were compared with those detected in matched blood T cell lines (Figure 4.8 and 4.9).  
The total magnitude of CD8+ HIV Gag-specific T cell responses (the sum of all 4 
responses measured) detected at the cervix was significantly higher than those 
detected in matching blood T cell lines derived from the 16 HIV-infected women 
expanded with Dynal beads (p=0.004; Figure 4.8A). Of the individual functions 
measured, CD107a expression was the predominant responses detected in HIV-
specific CD8+ T cell responses from both compartments although higher frequencies 
of cervical CD8+ T cells expressed CD107a than blood (p=0.007; Figure 4.8A). 
Similarly, the frequency of MIP1-β expression by Gag-specific CD8+ T cells at the 
cervix was significantly higher than detected in blood (p=0.03). Although the 
cumulative frequency of cervical Gag specific CD8+ T cell responses was higher than 
blood, both blood and cervix showed similar cytokine response profiles (Figure 4.8B).   
 
HIV-specific CD4+ T cells were found to produce a broader range of cytokines in 
both blood and cervix (Figure 4.8D) than CD8+ T cells, in that they exhibited all four 
of the functions measured (CD107a, IFN-γ, MIP-1β and TNF-α) while CD8+ T cells 
only produced 3 of these functions (CD107a, IFN-γ, and MIP-1β but not TNF-α). A 
median of 1.7% (range 0-3.2) of CD4+ T cells present at the cervix produced IFN-  in 
response to Gag and this was significantly higher than IFN-  responses detected in 
blood [median of 0.3 (range 0.0-0.63); p=0.002]. Blood and cervical CD4+ T cells 
showed a similar functional profile in response to Gag stimulation with all 4 functions 








































Figure 4.8. Comparison between female genital tract and blood CD8 and CD4 T cell responses to 
HIV Gag in T cell lines expanded with Dynal beads from HIV-infected women. (A) Total and 
individual frequencies of CD8+ responses detected in blood (pink boxes) and cervix (dark blue boxes) 
from Dynal bead expanded lines. (B) Cumulative frequencies of CD8+ CD107a (yellow bar), IFN-γ 
(blue bars), MIP-1β (red bars), and TNF-α (green bars) T cell responses in PBMC and cervix (CMC).  
(C) Total and individual frequencies of CD4+ responses detected in blood (pink boxes) and cervix 
(dark blue boxes) from Dynal bead expanded lines. (B) Cumulative frequencies of CD4+ CD107a 
(yellow bar), IFN-γ (blue bars), MIP-1β (red bars), and TNF-α (green bars) T cell responses in PBMC 
and cervix (CMC).  Each box and whisker plot shows the median (central line), IQR (outer lines of 
box) and 10-90% range (error bars) of 16 HIV-infected individuals. Wilcoxon Rank Test was used to 














































































































































































































































































































4.3.8 Comparison between the frequency and quality of Gag-specific T cell 
 responses at the cervix and in blood after expansion with anti-CD3 
 In contrast to Dynal bead expanded T cell lines, no significant differences between 
either total or individual frequencies of CD8+ (Figure 4.9A and B) and CD4+ T cell 
(Figure 4.9C and D) responding to HIV Gag were found when cervical and blood-
derived T cell lines expanded with anti-CD3 were compared. In contrast to Dynal 
bead expanded T cell lines which predominantly expressed CD107a in response to 
Gag, anti-CD3 expanded CD8+ T cell responses in blood and at the cervix were 
dominated by MIP1-β (Figure 4.9B). In contrast to Dynal bead expanded CD4+ T 
cells which exhibited all 4 functions measured (CD107a, IFN-γ, MIP-1β and TNF-α), 
CD4+ T cells resulting from anti-CD3 expansion were predominantly producing a 
more restricted subset of these (MIP1-β and IFN-γ; Figure 4.9D). There were no 
significant differences detected in the frequency of CD4+ T cells at the cervix and in 




















































Figure 4.9. Comparison between female genital tract and blood CD8 and CD4 T cell responses to 
HIV Gag in T cell lines expanded with anti-CD3 from HIV-infected women. (A) Total and 
individual frequencies of CD8+ responses detected in blood (pink boxes) and cervix (dark blue boxes) 
from anti-CD3 expanded lines. (B) Cumulative frequencies of CD8+ CD107a (yellow bar), IFN-γ (blue 
bars), MIP-1β (red bars), and TNF-α (green bars) T cell responses in PBMC and cervix (CMC).  (C) 
Total and individual frequencies of CD4+ responses detected in blood (pink boxes) and cervix (dark 
blue boxes) from expanded lines. (B) Cumulative frequencies of CD4+ CD107a (yellow bar), IFN-γ 
(blue bars), MIP-1β (red bars), and TNF-α (green bars) T cell responses in PBMC and cervix (CMC). 
Each box and whisker plot shows the median (central line), IQR (outer lines of box) and 10-90% range 
(error bars) of 7 HIV-infected individuals. Wilcoxon Rank Test was used to compare fresh and 




















































































































































































































4.3.9 Comparison of polyfunctional HIV-specific T cell responses in Dynal bead-
 expanded blood and cervical T cell lines 
The frequency of polyfunctional HIV-specific responses at the cervix and blood was 
compared (Figure 4.10 and Figure 4.11, respectively). Following Dynal beads 
expansion, there were very low frequencies (median of 0%; range, 0-0.5%) of HIV 
Gag-specific four functional CD8+ T cells in both blood and cervix (Figure 4.11A and 
B). Although few Gag-specific tri-functional (CD107a, IFN-γ, MIP-1β) CD8+ 
cervical T cells were detected and they made up only a small magnitude (0.2%) and 
proportion (~2%) of Gag responsive cells (Figure 4.10A and B, respectively), these 
were higher than those observed in blood (although not significantly). Similarly, 
cervical cells had a greater magnitude and proportion of dual-functional (CD107a and 
MIP1-β) Gag-specific CD8+ T cells than blood (2.5% vs. 0.5%) and (15% vs.10 %) 
respectively, although this was not significant. The frequency of Gag-specific CD8+ 
T cell responses in both blood and cervix were dominated by monofunctional cells 
(>80%). Although the net frequency of HIV Gag-specific monofunctional cells was 
significantly higher at the cervix than detected in blood (Figure 4.10A; p=0.002) 
following Dynal beads expansion, the relative proportion of monofunctional cells at 
the cervix was lower than detected in blood, although this was not significant (Figure 
4.10B). This finding suggests that a significantly higher frequencies of cervical T cells 
responded to Gag compared to blood and these genital cells tended to have a higher 
proportion of cells with ≥2 functions compared to blood.  
 
Like CD8+ T cells, monofuctional CD4+ T cell responses dominated Gag-specific 
responses detected in blood and cervix (Figure 4.10C and D). Of the CD4+ mono-
functional responses detected at the cervix, IFN-γ responses made up ~30% of total 
responses to Gag. Blood CD4+ responses, in contrast, were predominantly MIP1-β+ 
(~30%). Although the frequencies of Gag-specific CD4+ mono-, and dual-functional 
T cell were higher at the cervix than in blood, these were not significantly different 































Figure 4.10. Polyfunctional HIV-specific T cell responses between Dynal beads expanded blood 
(red dots) and cervix (blue dots) from 16 chronically HIV-infected women. (A) Frequency of 
CD8+ responses within each functional category. (B) Proportion of CD8+ T cell responses within each 
functional category. (C) Frequency of CD4+ T cell responses for each polyfunctional subset. (D) 
Proportion of CD4+ polyfunctional responses. Responses were considered 4-functional if all 4 of the 
markers included in the polyfunctional panel were detected (IFN-γ, MIP-1β, TNF-α and CD107a).  
Responses were considered 3, 2 or 1-functional if any combination of 3, 2 or 1 of the 4 functions 
investigated were detected, respectively. The middle bars on the plots represent median response after 
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4.3.10 Comparison of polyfunctional HIV-specific T cell responses in anti-CD3-
 expanded blood and cervical T cell lines 
Similar to Dynal beads expansion, very low frequencies of T cell lines generated by 
anti-CD3 expansion were four-functional (Figure 4.11). Only a small proportion (2%) 
of Gag-specific tri-functional CD8+ T cells (IFN-γ, MIP-1β and TNF-α) were 
detected in both blood and cervix (Figure 4.11A and 4.10B, respectively). Similar 
frequencies (~1%) and proportions (~15%) of Gag-specific dual-functional CD8+ 
cells were detected in both blood and at the cervix following anti-CD3 expansion. 
Mono-functional Gag-specific T cell responses dominated both blood and cervical 
CD8+ T cell responses (Figure 4.11A and B). These mono-functional subsets 
accounted for approximately 80% of the total Gag specific CD8+ T cell responses in 
both compartments (Figure 4.11B).  
 
After anti-CD3 expansion, the magnitude of HIV Gag-specific dual-, tri-, and four 
functional CD4+ T cell was approximately 0.5% while that for mono- functional cells 
was ~3% in both blood and cervix (Figure 4.11C and 4.10D). However, the 
proportion of HIV Gag-specific dual-functional cells was higher in blood than at the 
cervix (10% vs. 2%). Mono-functional responses also dominated the Gag-specific 
CD4+ T cell responses and these made up close to 100% for cervical cells and 85% in 













































Figure 4.11. Polyfunctional HIV-specific T cell responses between anti-CD3 expanded  blood 
(red) and cervix (blue) from 7 chronically HIV-infected women. (A) Frequency of CD8+ responses 
within each functional category. (B) Proportion of CD8+ T cell responses within each functional 
category.  (C) Frequency of CD4+ T cell responses for each polyfunctional subset. (D) Proportion of 
CD4+ polyfunctional responses. Responses were considered 4-functional if all 4 of the markers 
included in the polyfunctional panel were detected (IFN-γ, MIP-1β, TNF-α and CD107a). Responses 
were considered 3, 2 or 1-functional if any combination of 3, 2 or 1 of the 4 functions investigated were 
detected, respectively. The middle bars on the plots represent median response after background 
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4.3.11 Relationship between the frequency and functional profile of HIV Gag-
 specific responses at the cervix and in blood 
To investigate whether HIV-specific responses detected in blood correlated with those 
detected in the female genital tract, the relationship between both the magnitude and 
complexity of HIV Gag-specific T cell responses in blood and cervical T cell lines 
(expanded with Dynal beads or anti-CD3) was evaluated. A significant correlation 
between blood and cervix in the total magnitude of CD4+ T cell responses was 
observed after Dynal beads expansion (p=0.002; Spearman Rank). For CD4+ T cells 
responding to Gag, there was a significant correlation between cervix and blood for 
CD107a (Rho=0.8; p=0.003) and TNF-α (Rho=0.7, p=0.004; Spearman Ranks test). 
For CD8+ T cells, there was a significant correlation between cervix and blood for 
CD107a (Rho=0.8, p=0.0002), IFN-γ (Rho=0.6, p=0.01) and TNF-α (Rho=0.8, 
p=0.0006) following Dynal bead expansion (Spearman Ranks test). This data shows 
that the magnitude of blood and cervical T cell responses to HIV Gag were broadly 
shared between compartments 
 
Following anti-CD3 expansion, a significant correlation between blood and cervix in 
the total magnitude of CD8+ T cell responses was observed (Rho=0.89; p=0.01; 
Spearman Rank). Similar to responses detected after Dynal beads expansion, the 
frequency of anti-CD3 expanded CD8+ T cells in blood and at the cervix expressing 
CD107a (Rho=0.87,  p=0.01), IFN-γ (Rho=0.8, p=0.03), and TNF-α (Rho=0.88, 
p=0.01) correlated significantly (Table 4.7; Spearman Ranks test). For CD4+ T cells, 
both the total magnitude (Rho=0.88, p=0.01) and the frequency of cells in blood and 
at the cervix expressing CD107a (Rho=0.87, p=0.01) were significantly associated.  
Similarly to Dynal beads expansions, this data shows that the responses magnitudes of 
blood and cervical T cells following anti-CD3 expansion are associated between 
compartments and confirms that immune cells can traffic freely between blood and 















The relationship between polyfunctional T cell responses (2+, 3+ and 4+ functions) 
detected in blood and at the cervix was next investigated (Figure 4.12). A significant 
association was observed between blood and cervical polyfunctional CD8+ T cell 
responses to Gag in T cell lines expanded with Dynal beads but not anti-CD3 (Figure 
4.12 A and B, respectively). Because CD4+ T cell polyfunctional T cell responses 
were detected on comparatively low frequencies compared to CD8+ T cell 
polyfunction, no significant associations between compartments were found for CD4+ 













Figure 4.12. Relationship between polyfunctional HIV Gag-specific CD8+ T cell responses 
detected at the cervix and in blood of HIV-infected women following Dynal bead (A) or anti-CD3 
expansion (B). Polyfunctional responses were defined as the total of 2+, 3+ and 4+ functions in blood 
and at the cervix of CD8+ T cells. Spearman Rank Test was applied to test correlations and p-values 
<0.05 were considered significant.  Spearman Rho score is shown on each plot.  
 
4.3.12 Relationship between HIV clinical status and HIV-specific responses 
 detected in the female genital tract or blood  
To investigate whether there was a relationship between HIV clinical status and 
functional/polyfunctional characteristics of HIV Gag-specific T cells in blood or at the 
cervix, the relationship between individual response profiles and markers of HIV 
disease progression (plasma viral load and CD4 counts) were evaluated (Figure 4.13 
and 4.14). As previously described (Gumbi et al., 2008), HIV viral loads in plasma 
were found to be significantly associated with the amount of HIV detected in genital 








































































































secretions in this study (Rho=0.75, p=0.0008; Figure 4.13A). A significant inverse 
relationship was observed between plasma viral loads and the frequency of CD8+ T 
cells producing CD107a in blood (Rho=-0.53, p=0.04) and at the cervix (Rho=-0.64, 
p=0.03) in Dynal bead expanded T cell lines (Figure 4.13B and C). Since a significant 
positive association was previously demonstrated between blood and cervical CD107a 
expression for both CD8+ and CD4+ T cells in response to Gag (p=0.002 and 
p=0.003, respectively; Table 4.6), this similar relationship between HIV plasma viral 
load and CD107a expression in both compartments is likely to reflect this. As with 
Dynal bead expanded T cell lines, the frequency of fresh blood CD8+ T cells 
producing CD107a in response to HIV Gag stimulation correlated inversely with 
plasma and cervical viral loads (Figure 4.13D and E). There were no other significant 
relationships identified between any other T cell responses in either compartment and 


































Figure 4.13. Relationship between HIV clinical status and blood or cervical CD8+ T-cell 
responses to Gag in fresh or Dynal bead expanded T cell lines. (A) Correlation between plasma and 
cervical viral load. Relationship between Dynal beads expanded blood (B) and cervical (C) CD8+ T-
cell responses (shown as percentages of cells producing CD107a) and plasma viral load. (E) 
Association between CD107a expression in fresh PBMC and plasma (D) and cervical (E) load. 
Spearman Rank Test was applied to test correlations and p-values <0.05 were considered significant.  




















































































































































































































































































The frequency of Gag-specific CD8+ T cell polyfunctional responses detected in 
blood (sum of 2, 3 and 4-functional responses) was significantly inversely associated 
with plasma viral loads (Rho=-0.51, p=0.04) and weakly positively associated with 
blood CD4 counts (Rho=0.33; p=0.21) (Figure 4.14 A and B). Previously, the 2+, 3+, 
and 4+ functions were shown to correlate between compartment (Figure 4.11) and 
here, the frequency of Gag-specific polyfunctional CD8+ T cell responses at the 
cervix were significantly positively associated with blood CD4 counts (Rho=0.56; 
p=0.03; Figure 4.14 C) and significantly inversely associated with plasma viral loads 
(Rho=0.52; p=0.04; Figure 4.14 D). In contrast to CD8+ T cell polyfunctionality, the 
frequency of polyfunctional CD4+ T cell responses in blood and at the cervix were 





































Figure 4.14. Relationship between HIV clinical status and polyfunctional Gag-specific CD8+ T 
cell responses in blood and at the cervix. (A) Comparison between polyfunctional responses (sum of 
2, 3 and 4-functions) in blood and blood CD4 counts. (B) Comparison between blood polyfunctional 
responses and plasma viral load. (C) Comparison between cervical CD8+ polyfunctional responses and 
blood CD4 counts. Relationship between cervical polyfunctional responses and plasma viral load. 
Spearman Rank Test was applied to test correlations and p-values <0.05 were considered significant.  






































































































































































































































































4.4 Discussion  
 
While there is clear evidence that HIV-specific cytotoxic T lymphocytes (CTLs) in 
blood play an important role in controlling HIV replication systemically (Addo et al., 
2003; Betts et al., 2001; Edwards et al., 2002; Kaufmann et al., 2004; Ramduth et al., 
2005), their frequency and the complexity of their effector function at the cervix is not 
well understood. Cervical cytobrushing is relatively non-invasive, but low cervical 
cell yields associated with this approach have significantly impacted on thorough 
evaluation of HIV-specific T cell responses (Kaul et al., 2000; Gumbi et al., 2008; 
Shacklett et al., 2003a). Although in vitro expansion of cervical cytobrush-derived T 
cells would circumvent the problem of low yield, there have been few studies 
investigating the ability of cervical cytobrush-derived T cells to expand in vitro 
(Chapter 2 and Chapter 3). Furthermore, little is known about how these polyclonal 
techniques differ in the amount of bias they may introduce into HIV-specific T cells 
from the cervical mucosa. This study compared the efficiency of immobilized anti-
CD3 and Dynal bead-bound anti-CD3/CD28 to expand cervical cytobrush-derived 
cells and PBMCs in the presence of various combinations of γ-chain cytokines (IL-2, 
IL-7 and IL-15) using expansion protocols optimized in Chapter 3.  
 
This Chapter showed that HIV-specific cervical and blood T cell responses are largely 
monofunctional (>80% of responses were either single functional CD107a, IFN-γ, 
MIP-1β or TNF-α) although significantly higher frequencies of cervical CD8+ T cells 
were shown to be polyfunctional (≥2 functions simultaneously) than CD8+ T cells 
from blood (1.96% vs. 1.08%). The functional profile (CD107a, IFN-γ and TNF-α) in 
response to Gag stimulation by CD8+ T cells in blood and at the cervix correlated 
significantly. In the CD4+ compartment, a more restricted functional profile 
(comprising only CD107a, and TNF-α expression) were significantly associated 
between blood and cervix. Furthermore, this Chapter showed that the frequency of 
polyfunctional CD8+ T cells responding to Gag (total of 2+, 3+ and 4+ functions) 
correlated significantly between the blood and cervix, regardless of the expansion 
technique employed. There were no significant associations in the CD4+ T cell 
compartment and this may be the result of polyfunctional responses being present in 
such low overall proportions that associations were not evident or relevant. It was 











increased levels of background cytokine responses by ELISpot, here expanded T cell 
lines were deprived of IL-2, IL-7 and IL-15 for 24hrs prior to stimulation with HIV 
Gag peptides. This resulted in comparable background cytokine levels between fresh 
and expanded cells. Because analysis of multiparameter flow cytometry data has not 
been standardised in the field, in order to simplify analysis in this study, a positive 
response was taken as net percentage response (subtraction of the background 
unstimulated sample value). 
 
The finding that relatively low frequencies of blood T cells were polyfunctional in 
chronically HIV-infected women confirms the findings of previous studies (Betts et 
al., 2006; Brenchley et al., 2008; Critchfield et al., 2007; Macal et al., 2008; Ferre et 
al., 2009). Betts et al. (2006) has shown that polyfunctional HIV-specific CD8 T cells 
are rarely found in the blood of individuals with progressive HIV infection. In this 
study, only a small proportion of three and four-functional CD8+ T cells (~1%) were 
detected in blood, with most Gag-specific T cell responses being mediated by mono-
functional T cells. Furthermore, the magnitude and proportion of 3 functional T cells 
was higher at the cervix compared to blood following Dynal beads expansion, 
although this was not significant.  
 
Several studies have confirmed the existence of polyfunctional HIV-1 specific T cells 
at mucosal sites such as rectum and lungs (Brenchley et al., 2008; Critchfield et al., 
2007; Macal et al., 2008; Ferre et al., 2009). Brenchley and colleagues (2008) 
simultaneously measured expression of IFN-γ, TNF-α and IL-2 in HIV-infected 
individuals after stimulation with HIV Gag, Pol, Nef, and Env peptides and showed 
that ~ 5% of HIV-specific CD8+ T cells in lungs were polyfunctional compared to (< 
1% in blood CD8 T cells. Moreover, HIV-specific CD4+ T cells from lungs were 
present at significantly higher frequencies and manifested a significantly more 
polyfunctional response (~ 15%) compared to HIV-specific CD4+ T cells from blood 
(<1%). In their study, Brenchley et al. (2008) also reported that the majority of 
responses present in both lungs and blood were monofunctional (~ 80%). At the rectal 
mucosa, Critchfield et al. (2007) evaluated five distinct effector functions (CD107a, 
IFN-γ, MIP-1β, IL-2 and TNF-α) of HIV Gag-specific CD8+ T-cells and found that 
rectal CD8+ responses had a higher frequency of Gag specific responses compared to 











stimulation was 5.9% for therapy-naïve HIV-infected individuals and nearly one-half 
of the rectal response in these patients was comprised of polyfunctional cells capable 
of 3, 4, or 5 responses, simultaneously. In blood of HIV-infected individuals not on 
ART, the mean percentage of HIV Gag-specific CD8+ T-cells was lower than in 
rectal mucosa (3.8% vs. 5.9%) and approximately 30% of these responses were 
derived from cells capable of >3 responses. Ferre et al. (2009) measured the 
production of CD107a, IFN-γ, MIP-1β, IL-2 and TNF-α and reported that HIV Gag-
specific CD8+ T-cell responses in rectal mucosa were more strongly associated with 
controller status than blood responses. The magnitude of Gag-specific mucosal CD8+ 
T-cell responses was higher in controllers (6.6%) compared to non-controllers (4.1%) 
and persons on HAART (1.4%). Controllers had higher frequencies of mucosal CD8+ 
T cells capable of 3 or more simultaneous effector functions than non-controllers. In 
addition, controllers with protective alleles had a significantly greater frequency of 
HIV-responsive T cells at the rectal mucosa than measured in blood (7.4% vs 3.0%). 
Taken together, the finding from this Chapter and from previous studies shows that 
blood and mucosal compartments (cervix, lungs and rectal) are dominated by mono-
functional T cells. The complexity of T cell responses increases in HIV-infected 
individuals who were controlling HIV better in both blood and mucosa.   
 
Studies investigating the relationship between the magnitude or breadth of HIV-
specific CTL and HIV clinical status have reported conflicting findings.  Some studies 
have found no direct relationship (Dalod et al., 1999; Addo et al., 2003). Others have 
reported an inverse relationship suggesting that high frequencies of HIV-specific 
CTLs are associated with low plasma viraemia (Ogg et al., 1998; Edwards et al., 
2002). In direct contrast, others have found a positive correlation between plasma 
viral load and the total HIV-specific, Env-, and Nef-specific CD8+ T-cell frequency 
implying that antigenic load was associated with high frequencies of responses (Betts 
et al., 2001). Few studies have evaluated the relationship between the frequency or 
complexity of HIV-specific T cell responses at mucosal surfaces and HIV clinical 
status.  Critchfield et al. (2007) reported that the frequency of polyfunctional rectal 
mucosal Gag-specific CD8+ T-cells was associated to clinical status (positively with 
blood CD4 count and inversely with plasma viral loads) suggesting that these 
responses may play an important role in mucosal immune surveillance. This is further 











were enriched among individuals who control HIV in the absence of therapy compare 
to non-controllers (Critchfield et al. 2007). In this Chapter, a significant inverse 
relationship between plasma viral loads and CD8+ T cells producing CD107a in fresh 
blood, expanded blood and expanded cervical lines was observed. This indicates that 
the ability of CD8+ T cells from both the cervix and in blood to degranulate was 
highest in women with lowest plasma viral loads. It was also found that blood CD8 T 
cell producing CD107a correlated with both plasma and cervical viral load. Although 
one might speculate that cervical polyfunctional responses suppress HIV genital 
shedding, this study found no relationship between cervical polyfunctional T cell 
responses and cervical viral loads. Similarly, in a study by Gumbi et al. (2008), 
monofunctional IFN-γ+ T cell responses to HIV Gag were not associated with 
protection from HIV genital shedding.  
 
The present study found that the polyfunctionality of cervical Gag-specific CD8+ T-
cells was positively related to blood CD4 count and inversely related to plasma viral 
load. Thus, immunologic features of circulating HIV-specific CTLs may contribute to 
the apparent control of viral replication. Alternatively, worse clinical disease status 
may be associated with compromised HIV-specific polyfunctional responses. Since a 
number of studies have identified deficits in HIV-specific CD8 T cell responses in the 
absence of CD4 helper functions in individuals with low CD4 T cell counts, the later 
explanation may be more accurate. Accumulation of polyfunctional HIV-specific 
cellular responses have been associated with restoration of mucosal CD4 + T cells, 
despite persistent mucosal CD4+ T-cell proviral reservoirs and immune activation in 
individuals on long-term HAART (Macal et al., 2008). Taken together, these studies 
point at the importance of polyfunctional T cells in mucosal compartments. In the 
present Chapter, HIV-infected women who were controlling viraemia were also more 
likely to have better responses because they were not so immunocompromised 
compared to HIV-infected women who were not controlling viraemia. 
 
Despite several studies showing polyfunctional cells associate with control of HIV 
and other infections, their function is still controversial.  HIV studies have shown the 
importance of polyfunctional T cells in individuals who naturally control virus, have 
low viral loads and do not progress to disease (Betts et al., 2006; Duvall et al., 2008; 











this topic, it is still unclear whether polyfunctionality controls viral replication or is 
the result of low viral loads. 
 
Comparison between expanded blood and cervical T cell responses to Gag showed 
that the magnitude of responses correlated significantly between compartments 
[CD107a, TNF-α, and IFN-γ in CD8+ T cells; CD107a and TNF-α in CD4+ T cells]. 
Ibarrondo et al. (2005) found that both the magnitude and breadth of HIV-specific 
CTL responses in blood mirrored those seen in the rectal mucosal compartment 
during chronic HIV infection (using IFN-γ ELISpot). Ibarrondo et al. (2005) found 
that discordant CTL responses were only found in responses that were of a low 
frequency in either compartment. Although a subset of functions were significantly 
altered following expansion in this study (CD107a for CD8+ T cells and TNF-α for 
CD4+ T cell), I found that half of the CD8+ functional responses (CD107a and TNF-
α) were significantly associated following expansion while only a quarter of CD4+  
functional responses (TNF-α) were associated pre- and post-expansion. Minor 
fluctuations in Gag-specific responses following expansion might have been as a 
result of a change in memory phenotype observed following expansion. Results from 
Chapter 3 have shown that polyclonal expansion of cervical cytobrush-derived cells 
and PBMCs using Dynal beads in the presence IL-2, IL-7 and IL-15 enriched for 
central memory T cells while anti-CD3 expansion maintained the effector memory 
dominant phenotype of cervical cytobrush cells. Effector memory cells are associated 
with rapid effector functions (Sallusto et al., 2004). Romero et al. (2007) showed in 
humans that significantly higher frequencies of effector memory CD8 T cells 
expressed cytolytic perforin and granzyme B and display greater cytotoxic abilities 
than central memory cells. In contrast, Barber et al. (2003) showed in mice that in 
vivo re-activated central memory CD8 T cells are equally efficient at cytotoxic killing 
as effector memory cells. Romero et al. (2007) suggested that central memory may be 
more effective at mediating protective immunity by virtue of their ability to 
proliferate, which may be particularly important for persistent infections. Since the 
HIV-infected women included in this study were not taking ARVs and T cell culture 
did not include ARVs, it was likely that the ongoing viral replication that is likely to 
have occurred during polyclonal expansion of T cells might have been responsible for 












Besides the measurement of four T cell functions mentioned in this study, there are 
other cytokines that could have been evaluated. IL-2 is one of the primary cytokines 
that CD4+ T cells secrete upon antigen recognition (reviewed in Malek et al., 2004). 
The ability of blood CD4+ T cells to secrete IL-2 has been shown to inversely 
correlate with viral control in chronic HIV infection (Harari et al., 2004). It would 
have been interesting to investigate whether similar correlations are observed in 
cervical CD4+ T cells.  
 
In summary, this Chapter shows that ex vivo evaluation of cervical cytobrush T cell 
responses to Gag are hampered by low cell yields making polychromatic evaluation of 
the complexity of these responses problematic. This Chapter has highlighted the need 
to improved yields of cells acquired from the female genital tract and in vitro 
expansion of T cells from cytobrushes was found to be a feasible method to overcome 
these limitations. The data presented in this Chapter suggests that expanded T cell 
from both the genital tract and blood generally maintain their cytokine response 
profiles following in vitro expansion. Furthermore, this study shows that HIV Gag-
specific polyfunctional T cell responses were detectable in the female genital tract of 
HIV-infected women. These polyfunctional cells were largely present in women with 
high CD4 T cell counts in blood and low plasma viral loads. HIV-specific profiles 
(polyfunctional and cytokines secreted) correlated between compartments. Because of 
the differing microenvironments in blood and at the cervix, it is important to 
understand the differences in immune pressures imposed on HIV in these 
























































More than 90% of new HIV infections occur in developing countries, with the 
majority of infections occurring in Sub-Saharan Africa (UNAIDS, 2008). HIV is 
spread mainly through heterosexual contact among adults in Africa. Amongst young 
adults in South Africa, the prevalence of HIV is highest in women (UNAIDS, 2008) 
and several factors have been proposed to account for this apparent increased 
susceptibility of young women to HIV infection. Ray et al. (2000) suggested that this 
may be due to an increased mucosal area of exposure in the female genital tract, 
increased susceptibility through greater mucosal trauma, the presence of undiagnosed 
sexually transmitted infections, prolonged exposure to infected male secretions and 
other immunological differences between men and women. HIV transmission is 
dependent on the concentration of virions in the genital secretions, with increased 
heterosexual transmission of HIV being associated with higher viral loads in blood 
(Lee et al., 1996; Quinn et al., 2000).  
 
Mucosal T cell responses and early events 
HIV targets the mucosal immune system early during infection and depletes most of 
the CD4 T cells at this site (Koup et al., 1994; Reynolds et al., 2005; Miller et al., 
2005).  Mucosal surfaces also represent the major route of HIV transmission.  Studies 
in macaques infected with SIV have suggested that mucosal T cells may be actively 
involved in the early defense against HIV-1 infection (Lohman et al., 1995). Most 
studies in humans have focused on analysis of HIV-specific immunity in blood 
(reviewed in Pope et al., 2004). Despite the recognized importance of mucosal tissues 
during transmission and disease progression, comparatively few studies have 
described immunity at these sites. In humans, mucosal tissues are more difficult to 
sample with only small numbers of cells being recovered non-invasively from these 
tissues. Because mucosal immunity to HIV will not only be a desirable but also a 
necessary component of an effective HIV vaccine, there is a clear need to establish 
reliable and sensitive methods for investigating mucosal immune responses in future 














Aims and major findings 
This dissertation describes the optimisation and validation of methods that can be 
applied to bulk up cervical cytobrush-derived T cells from the female genital tract.  
This study describes an approach to overcome some of the limitations of low cell 
yields through the use of polyclonal in vitro expansion of cervical T cells from 
cytobrush samples using either anti-CD3 monoclonal antibody or Dynal bead 
stimulation in the presence of various combinations of -chain cytokines (IL-2, IL-7 
and IL-15). This was achieved by comparing the specificity and breadth of cervical 
and peripheral blood T cell IFN- , CD107a, TNF-  and MIP-1  responses to HIV-1 
sub-type C overlapping Gag peptides. Furthermore, this dissertation investigated the 
role of multifunctional cervical mucosal T-cell in chronically HIV-infected 
individuals in determining clinical status. This study is one of the most 
comprehensive to date in comparing and optimizing mucosal mononuclear cell 
expansion protocols. Evaluation of HIV-specific immune responses, particularly at 
the genital tract, will provide new information for the better understanding of virus–
host interaction during HIV infection and subsequent loss of viral control and disease 
progression. 
 
T cell recovery and phenotyping 
Anti-CD3 in the presence of IL-2 was shown to successfully expand cervical T cells 
and yield sufficient cells to map individual HIV-specific peptide response by ELISpot 
(Chapter 2). The finding that cervical cytobrushing and anti-CD3-mediated polyclonal 
expansion only enabled detection of Gag-specific T cell responses in the genital tracts 
of women with correspondingly high systemic Gag-specific responses set a standard 
against which future efforts in this field can be measured and demonstrated the need 
for more efficient expansion methodologies. Conditions that improve the rate of 
expansion and viability of T cells derived from the female genital tract will not only 
reduce the time required to improve yields but also reduce the risk of expansion bias 
and contamination. The efficiency of immobilized anti-CD3 alone (described in 
Chapter 2) was compared to alternative expansion modalities including anti-CD3 in 
combination with anti-CD28; or Dynal bead-bound anti-CD3/CD28 to expand 
cervical cytobrush-derived cells and PBMCs in the presence of IL-2, IL-7 and IL-15 











CD3/IL-2 or Dynal/IL-2 was 1.4-fold lower than the extent of expansion observed for 
PBMCs. This demonstrates that the extent of expansion of cervical T cells may be 
lower than blood T cell expansion and may be affected by the predominance of 
effector memory T cells sampled by cytobrush ex vivo. Previous studies have reported 
that effector memory T cells have a reduced proliferative capacity which has been 
shown to correlate with reduced telomere length (Sallusto et al., 1999). Despite this, it 
was confirmed in Chapters 3 and 4, using several alternative expansion methods, that 
cervical cytobrush-derived T cells can be expanded sufficiently in vitro to 
significantly improve yields of T cells available and subsequently the type of analysis 
that can be conducted. In Chapter 3, it was concluded that cervical T cell yields can be 
best improved by expansion with Dynal beads (1:1) in the presence of IL-2, IL-7 and 
IL-15 while memory T cell profiles were best maintained by expansion with anti-CD3 
in the presence of IL-2 alone.  
 
Although previous studies have shown that responses were better after in vitro stim 
with HIV antigen (Goonetilleke et al., 2006., Hanke et al., 2007) where in vitro 
peptide-stimulated culture expanded both CD4+ and CD8+ T-cell responses, which 
were often undetectable in ex vivo assays, and showed more than 24-fold increases in 
the frequency of specific T cells measured by ex vivo IFN-γ ELISPOT, this study 
used polyclonal expansion which did not selectively expand HIV-specific T cells and 
therefore some of the response after expansion declined. Our results, however, are 
supported by previous reports which highlighted the idea that TCR signalling strength 
coupled with the co-stimulation with anti-CD28 are important factors in driving T cell 
proliferation as well as expansion of antigen specific cells (Kalamasz et al., 2004., 
Onlamoon et al., 2006). 
 
Correlation between plasma and cervical viral load 
There have been a number of studies showing a significant association between 
plasma viraemia and genital viral loads and that plasma viral load was one of the best 
predictors of HIV shedding in genital secretions (Uvin et al., 1997; Iversen et al., 
1998; Goulston et al., 1998; Clyde et al., 1999). Similarly, in this study, there was a 
significant association between plasma viral load and HIV genital shedding. Higher 
plasma viral load, lower CD4 T cell counts and the presence of sexually transmitted 











secretions (Garcia-Bujalance et al., 2004). Understanding changes in HIV species 
between these two compartments is crucial for studying the effects of systemic or 
antiviral therapy and the epidemiology of viral transmission (Coombs et al., 2001). 
 
Viral and T cell compartmentalisation between compartments 
In depth comparison of the phylogenetic relatedness between genital and plasma-
derived HIV during chronic infection has demonstrated distinct phenotype and genetic 
differences, suggesting some degree of compartmentalization between these distinct 
sites (Ellerbrook et al., 2001; Overbaugh et al., 1996; Philpott et al., 2005). It was 
suggested that there is a continual process of migration of a restricted population of 
HIV-infected cells to mucosal sites from systemic circulation and that this is followed 
by localized HIV-1 expansion and independent evolution of the new quasispecies 
(Poss et al., 2005). Because of these difference is viral genotype and phenotype that 
have been identified; it has led many researchers to speculate that HIV-specific 
immune responses by T lymphocyte subsets at the mucosal compartments are also 
likely to differ from those in blood. This is likely to be partially due to the presence of 
detectable compartment-specific diversity in HIV genotypes present in each 
compartment (Musey et al., 2003) and also because the mucosa represents a distinct 
milieu with higher antigen exposure. Studies comparing the specificity of HIV 
targeted responses at the genital mucosa and blood during the chronic phase of HIV-
infection have yielded conflicting data. Some have demonstrated that there are some 
differences in HIV targeting between cervical and peripheral blood CTL (Shacklett et 
al., 2000; Ibarrondo et al., 2005), while others have shown that the blood and mucosal 
compartments have largely overlapping HIV-1 epitope specificities (Musey et al., 
1997; 2003a; Kaul et al., 2000a; Musey et al., 2003a; Ibarrondo et al., 2005). Based 
on these conflicting findings, there is a clear need to further investigate the issue of 
compartmental T cell diversity to HIV. In this dissertation, it was found that HIV 
Gag-specific blood T cell responses were detectable in 14/16 (88%) women with 
chronic HIV-infection while 8/16 (50%) of these had matched cervical responses to 
Gag (Chapter 2). It has previously been shown that identical HIV-specific CTL clones 
were present in both blood and mucosal compartments of the same HIV-infected 
individual, demonstrating that a subset of blood and mucosal HIV-specific CTL can 
have a common origin and can traffic freely between these distinct compartments 











between compartments and largely target the same regions of Gag (Chapter 2) and 
with overlapping response profiles (Chapter 4). Similarly, Kaul et al. (2003) showed 
concordance between HIV-specific responses in blood and at the cervix ex vivo during 
chronic infection with 8/10 women studied having matching responses at the cervix as 
they had in blood. Shacklett et al. (2000) reported only 3/8 chronically HIV-infected 
women with detectable HIV-specific responses in blood had a corresponding response 












The existence of polyfunctional T cells at the cervix and other mucosal sites 
This study used polychromatic flow cytometry to simultaneously assess whether HIV 
specific T-cell response quality is an important factor in HIV disease progression at 
the female genital tract. This study detected only a small proportion of three and four-
functional CD8+ T cells (~1%) at the cervix and the frequency of these polyfunctional 
responses were not significantly different from those detected in blood (<0.5%). Most 
of the Gag-specific T cell responses in both compartments were mediated by mono-
functional T cells. Previously, Betts et al. (2006) showed that polyfunctional HIV-
specific CD8 T cells are rarely found in the blood of individuals with progressive HIV 
infection. However, several studies of functional capacity and the magnitude of HIV-
specific T cells in other mucosal sites and have confirmed the existence of 
polyfunctional HIV-1 specific T cells at mucosal sites (Brenchley et al., 2007; 
Critchfield et al., 2007; Macal et al., 2008; Ferre et al., 2009). Brenchley and 
colleagues (2007) simultaneously measured expression of IFN-γ, TNF-α and IL-2 in 
26 therapy naïve individuals and showed that HIV-specific CD8+ T cells in lungs 
tended towards a more polyfunctional phenotype (~5%) compared to blood CD8 T 
cells (<1%). Moreover, HIV-specific CD4+ T cells from lungs were present at 
significantly higher frequencies and manifested a significantly more polyfunctional 
response (~15%) compared to HIV-specific CD4+ T cells from blood (<1%). The 
majority of responses present in both lungs and blood were monofunctional (~80%). 
At the rectal mucosa, Critchfield et al. (2007) evaluated five distinct effector functions 
(CD107a, IFN-γ, MIP-1β, IL-2 and TNF-α) of HIV Gag-specific CD8+ T-cells in 
rectal mucosa and blood and found that rectal CD8+ responses are stronger (all 31 
non-overlapping categories combined) compared to PBMC (5.9% vs. 3.8%). Their 
data showed that blood and mucosal compartments (cervix, lungs and rectal) are 
predominated by mono-functional T cells, however, the complexity of T cell 
responses seems to increases in individuals who were controlling HIV better in both 
blood and cervix.   
 
Correlation between T cell responses and HIV clinical status 
A significant inverse relationship was observed between plasma viral load and CD8+ 
T cells producing CD107a in fresh blood, expanded blood and expanded cervical 
lines.  This indicates that the ability of CD8+ T cells from both the cervix and in 











found that blood CD8 T cell producing CD107a correlated with both plasma and 
cervical viral load. Although one might speculate that cervical polyfunctional 
responses suppresses HIV genital shedding, this study found no relationship between 
cervical polyfunctional T cell responses (or any subset of individual T cells responses) 
and cervical viral load. In a study from our laboratory by Gumbi et al. (2008), 
monofunctional IFN-γ+ T cell responses to HIV Gag also were not associated with 
protection from HIV genital shedding. The present study found that the 
polyfunctionality of cervical Gag-specific CD8+ T-cells was positively related to 
blood CD4 count and inversely related to plasma viral load. While it could be argued 
that the measurement of four functions will not necessarily provide more relevant 
information than the measurement of a single function, recent findings have in fact 
demonstrated the added value of this approach. Recently, Critchfield et al. (2007) 
reported that the frequency of rectal mucosal Gag-specific CD8+ T-cells capable of 3, 
4 or 5 simultaneous effector functions was significantly associated to blood CD4 
count and inversely related to plasma viral load suggesting that these responses may 
play an important role in mucosal immune surveillance, as suggested by their relative 
enrichment among persons who control HIV in the absence of therapy (Critchfield et 
al. 2007). Thus, immunologic features of circulating HIV-specific CTLs may 
contribute to the apparent control of viral replication. Alternatively, worse clinical 
disease status may be associated with compromised HIV-specific polyfunctional 
responses. Since a number of studies have identified deficits in HIV-specific CD8 T 
cell responses in the absence of CD4 helper functions in individuals with low CD4 T 
cell counts. Accumulation of polyfunctional HIV-specific cellular responses have 
been associated with restoration of mucosal CD4 + T cells, despite persistent mucosal 
CD4+ T-cell proviral reservoirs and immune activation in individuals on long-term 
HAART (Macal et al., 2008). Taken together, these studies point at the importance of 
polyfunctional T cells in mucosal compartments. In the present study, women 
controlling viraemia are also more likely to have better responses because they are not 
so immunocompromised. Viral load correlate between compartments as do magnitude 
of responses (Chapter 2) and functional profile of responding cells (Chapter 4).  
Together this implies that both virus and T cells in blood traffic to genital tissue 
during chronic infection and blood serves as the major reservoir for virus and T cell 













This dissertation presents evidence that cervical T cells can be isolated by 
cytobrushing and in vitro polyclonal expansion of T cells is a useful approach to 
increase the number of cells available from inaccessible mucosal sites. There were 
significant changes that occurred in individual memory subsets depending on the 
expansion method applied which is expected since the very act of expansion of T cells 
would drive differentiation. It is important, however, to note that the ability to obtain 
cultured T cells that retain a similar functional phenotype as their unexpanded 
counterparts is important to the usefulness of expansion methods. Generally, anti-CD3 
expansion in the presence of IL-2 alone resulted in the accumulation of effector 
memory cells, while Dynal beads resulted in selective accumulation of central 
memory T cells from both cervix and blood. Different bead-to-cell concentrations led 
to different proportions of effector and central memory and this was attributed to TCR 
signalling strength. This data suggests that the optimal expansion technique depends 
on what the cells are to be used for following expansion.  
 
Recommendations 
Despite great advances in flow cytometry, allowing multiple functional markers to be 
investigated, thus enhancing the potential to discover correlates of control, there are 
still unanswered questions regarding the issue of which parameters are to be 
measured, and which immunological method should be used to provide the most 
relevant information. Although HIV-specific T cells are capable of producing a wide 
range of cytokines, including granulocyte-macrophage colony-stimulating factor 
(GM-CSF), IL-5, IL-8, IL-13, these are rarely measured in the majority of HIV 
studies (Goonetilleke et al., 2006). In addition, the most important cytokines or 
functions to measure are still not well known (Betts et al., 2006; 2008; Hunt et al., 
2008; Deeks et al., 2004).  One of the limitations in this present study lies in the use 
of a surrogate markers such as CD107a which might not necessarily or accurately 
reflect direct T cell cytotoxicity. CD107a is a surface-expressed marker so it does not 
prove that degranulating cells can actually kill target cells, although CD107a 
expression has been shown to directly correlate with cytotoxic activity (Betts et al., 
2003). However, perforin expression by ex vivo HIV-specific CD8+ T cells was 
recently shown to be significantly higher in elite controllers compared to patients with 











specific CD8+ T cells to rapidly express perforin might define a novel correlate of 
control in HIV infection. It might be more reliable to include markers such as 
perforin, granzyme A or B, or even granulysin. It may be useful in future studies to 
explore a wider range of surrogate markers for cytotoxicity as well as proliferation. In 
addition, it might be meaningful to consider viral suppression assays as these are more 
biologically relevant to T cell functioning.  
 
Another weakness of this study and many other studies is the use of HIV Gag 
peptides derived from consensus subtype C sequences in determining T cell 
responses. The problems with these consensus sequences are that they may not match 
the actual circulating virus.  
 
Although this study clearly identified the presence of low frequencies of 
polyfunctional T cells at the cervical mucosa, it was not clear what the nature of the 
causal relationship was between these responses and tissue viral loads. In addition, it 
may have been useful to include additional cytokines such as IL-2 in the functional 
evaluations conducted. Because of the differences observed in expansion of HIV- and 
HIV+ PBMCs, it would also be important in future studies to evaluate the effect of 
including ARVs in culture on expansion kinetics and yield. This is likely to result in 
increased cellular yields after expansion of HIV+ cells.  
 
Another limitation of this study was that asymptomatic STIs such as BV and HSV-2 
were not measured or controlled for. These have an effect on inflammation and hence 
might affect cellular recruitment to the female genital tract, which in turn has an effect 
on cytobrush composition and hence affect polyclonal expansion. However, this study 
set a platform to identify key questions for future studies.  
 
Finally, due to the rarity of the mucosal samples used in this study, this thesis was 
mainly a hypothesis generating work and analyses were mainly explanatory and 
therefore not corrected for multiple comparisons. 
  
Conclusions  
In summary, this study shows that ex vivo evaluation of cervical cytobrush T cell 











of the complexity of these responses problematic under Boolean conditions. Direct ex 
vivo data strongly supported the need for improved yields of cells acquired from the 
female genital tract and in vitro expansion of T cells from cytobrushes offered a 
feasible method to overcome these limitations. HIV Gag-specific cervical T cell 
responses can be detected in HIV-infected women and correlate with responses 
detected in blood. T cells derived from the female genital tract were predominantly 
effector memory in phenotype. Furthermore, HIV Gag-specific cervical T cell were 
shown to be mostly monofunctional and these did not differ markedly across the two 
methods tested. These polyfunctional cells were largely present in women with high 
blood CD4 count and low plasma viral load and cervical viral load. It is likely that 
polyfunctional responses are a consequence of an intact immune system in individuals 
with low viral replication, rather than the cause of low virus replication. HIV-specific 
functional profiles investigated in Chapter 4 were quite broadly shared between 
compartments. Because of the differing microenvironments in peripheral blood and 
cervix, it is important to understand the differences in immune pressures imposed on 
HIV in these compartments. Since we do not fully understand what would constitute 
protective immunity against HIV, and immunity at the genital mucosa is likely to play 
an important role in preventing HIV acquisition, the incorporation of mucosal 
sampling at the female genital tract and understanding HIV-specific events at this site 
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